Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

Articles published in
J Acquir Immune Defic Syndr
    October 2021
  1. DELLE DONNE V, Massaroni V, Ciccarelli N, Lombardi F, et al
    Impact of the COVID-19 Pandemic on Health Care Is Negatively Associated With Psychosocial Well-Being in an Italian Cohort of People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:e11-e14.
    >> Share

  2. ALESSANDRI-GRADT E, Unal G, Baron A, Leoz M, et al
    Performance Analysis of Three Commercial Kits Designed for RNA Quantification of HIV-1 Group O Variants.
    J Acquir Immune Defic Syndr. 2021;88:220-227.
    >> Share

  3. CAMPBELL L, Barbini B, Burling K, Cromarty B, et al
    Safety of Tenofovir Alafenamide in People With HIV Who Experienced Proximal Renal Tubulopathy on Tenofovir Disoproxil Fumarate.
    J Acquir Immune Defic Syndr. 2021;88:214-219.
    >> Share

  4. WOMACK JA, Murphy TE, Ramsey C, Bathulapalli H, et al
    Brief Report: Are Serious Falls Associated With Subsequent Fragility Fractures Among Veterans Living With HIV?
    J Acquir Immune Defic Syndr. 2021;88:192-196.
    >> Share

  5. HULL SJ, Tessema H, Thuku J, Scott RK, et al
    Providers PrEP: Identifying Primary Health care Providers' Biases as Barriers to Provision of Equitable PrEP Services.
    J Acquir Immune Defic Syndr. 2021;88:165-172.
    >> Share

  6. LEMOS MP, Nandi V, Dragavon J, Fleming I, et al
    HIV-1 Nucleic Acids Identify Rectal HIV Exposures in Self-Collected Rectal Swabs, Whereas Y-Chromosome Single Tandem Repeat Mixtures Are Not Reliable Biomarkers of Condomless Receptive Anal Intercourse.
    J Acquir Immune Defic Syndr. 2021;88:138-148.
    >> Share

    September 2021
  7. RAJU S, Astemborski J, Drummond MB, Ramamurthi HC, et al
    HIV is Associated with Impaired Pulmonary Diffusing Capacity Independent of Emphysema.
    J Acquir Immune Defic Syndr. 2021 Sep 24. pii: 00126334-900000000-95797.
    >> Share

  8. AUNG S, Hardy N, Chrysanthopoulou SA, Kyaw A, et al
    Stigma Determines Antiretroviral Adherence in Adults with HIV in Myanmar.
    J Acquir Immune Defic Syndr. 2021 Sep 17. pii: 00126334-900000000-95804.
    >> Share

  9. MURNANE PM, Ayieko J, Vittinghoff E, Gandhi M, et al
    Machine learning algorithms using routinely collected data do not adequately predict viremia to inform targeted services in postpartum women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95807.
    >> Share

  10. HOGH J, Gelpi M, Skovsgaard MH, Afzal S, et al
    HIV infection is associated with type 2 diabetes mellitus.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95806.
    >> Share

  11. SORENSEN EW, Gelpi M, Knudsen AD, Benfield T, et al
    Switch To Insti, But Not Long-Term Stable Insti, Is Associated With Excess Weight Gain In People Living With Hiv.
    J Acquir Immune Defic Syndr. 2021 Sep 14. pii: 00126334-900000000-95805.
    >> Share

  12. KERSCHBERGER B, Aung A, Mpala Q, Ntshalintshali N, et al
    Predicting, diagnosing and treating acute and early HIV infection in a public sector facility in Eswatini.
    J Acquir Immune Defic Syndr. 2021 Sep 3. pii: 00126334-900000000-95815.
    >> Share

  13. HAGINS D, Kumar P, Saag M, Wurapa AK, et al
    Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study.
    J Acquir Immune Defic Syndr. 2021;88:86-95.
    >> Share

  14. GUTIERREZ J, Porras TN, Yoo-Jeong M, Khasiyev F, et al
    Cerebrovascular Contributions to Neurocognitive Disorders in People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;88:79-85.
    >> Share

  15. MOLDT B, Parvangada A, Martin R, Pace C, et al
    Evaluation of Broadly Neutralizing Antibody Sensitivity by Genotyping and Phenotyping for Qualifying Participants to HIV Clinical Trials.
    J Acquir Immune Defic Syndr. 2021;88:61-69.
    >> Share

  16. SEWELL WC, Powell VE, Ball-Burack M, Mayer KH, et al
    Brief Report: "I Didn't Really Have a Primary Care Provider Until I Got PrEP": Patients' Perspectives on HIV Preexposure Prophylaxis as a Gateway to Health Care.
    J Acquir Immune Defic Syndr. 2021;88:31-35.
    >> Share

  17. MALONE J, Reisner SL, Cooney EE, Poteat T, et al
    Perceived HIV Acquisition Risk and Low Uptake of PrEP Among a Cohort of Transgender Women With PrEP Indication in the Eastern and Southern United States.
    J Acquir Immune Defic Syndr. 2021;88:10-18.
    >> Share

  18. CHANG JJ, Bruxvoort K, Chen LH, Akhavan B, et al
    Brief Report: COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System.
    J Acquir Immune Defic Syndr. 2021;88:1-5.
    >> Share

  19. SARDA V, Gomez C, Soria J, Sarmiento J, et al
    Factors Associated With Coronavirus Disease 2019 Morbidity in a Cohort of People Living With Human Immunodeficiency Virus.
    J Acquir Immune Defic Syndr. 2021;88:e7-e9.
    >> Share

    August 2021
  20. BENNETT CL, Ogele E, Pettit NR, Bischof JJ, et al
    Multi-Center Study of Outcomes Among Persons with HIV who Presented to US Emergency Departments with suspected SARS-CoV-2.
    J Acquir Immune Defic Syndr. 2021 Aug 31. pii: 00126334-900000000-95816.
    >> Share

  21. BROWN LK, Chernoff M, Kennard BD, Emslie GJ, et al
    Site-Randomized Controlled Trial of a Combined Cognitive Behavioral Therapy and a Medication Management Algorithm for Treatment of Depression Among Youth Living with HIV in the United States.
    J Acquir Immune Defic Syndr. 2021 Aug 30. pii: 00126334-900000000-95818.
    >> Share

  22. TEMBO TA, Simon KR, Kim MH, Chikoti C, et al
    Pilot-testing a Blended Learning Package for Health Care Workers to Improve Index Testing Services in Southern Malawi: An Implementation Science Study.
    J Acquir Immune Defic Syndr. 2021 Aug 30. pii: 00126334-900000000-95817.
    >> Share

  23. NGURE K, Mugo NR, Bukusi EA, Kiptinness C, et al
    Pills, injections, rings or implants? PrEP formulation preferences of PrEP-experienced African women for HIV prevention.
    J Acquir Immune Defic Syndr. 2021 Aug 25. pii: 00126334-900000000-95819.
    >> Share

  24. DAT VQ, Lyss S, Hoai Dung NT, Hung LM, et al
    Prevalence of advanced HIV disease, cryptococcal antigenemia and suboptimal clinical outcomes among those enrolled in care in Vietnam.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95822.
    >> Share

  25. MCCREE DH, Beer L, Jeffries WL 4th, Tie Y, et al
    Sociodemographic Correlates of Self-reported Discrimination in HIV Health Care Settings among Persons with Diagnosed HIV in the United States, Medical Monitoring Project, 2018-2019.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95821.
    >> Share

  26. CICCULLO A, Borghi V, Giacomelli A, Cossu MV, et al
    Five years with dolutegravir plus lamivudine as a switch strategy: much more than a positive finding.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95820.
    >> Share

  27. ORKIN C, Ajana F, Kityo C, Koenig E, et al
    Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials.
    J Acquir Immune Defic Syndr. 2021 Aug 20. pii: 00126334-900000000-95811.
    >> Share

  28. KRENISKE P, Mellins CA, Dolezal C, Morrison C, et al
    Predictors of attempted suicide among youth living with perinatal HIV infection and perinatal HIV exposed uninfected counterparts.
    J Acquir Immune Defic Syndr. 2021 Aug 16. pii: 00126334-900000000-95824.
    >> Share

  29. LUCKETT PH, Paul RH, Hannon K, Lee JJ, et al
    Modeling the Effects of HIV and Aging on Resting-State Networks using Machine Learning.
    J Acquir Immune Defic Syndr. 2021 Aug 16. pii: 00126334-900000000-95823.
    >> Share

  30. MUCCINI C, Pinyakorn S, Sirivichayakul S, Kroon E, et al
    Brief Report: Prevalence Trend of Transmitted Drug Resistance in a Prospective Cohort of Thai People With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2021;87:1173-1177.
    >> Share

  31. FISHER MC, Fazzari MJ, Hanna DB, Patel VV, et al
    Brief Report: Acute Kidney Injury in People Living With HIV Hospitalized With Coronavirus Disease 2019: Clinical Characteristics and Outcomes.
    J Acquir Immune Defic Syndr. 2021;87:1167-1172.
    >> Share

  32. GILLES I, Lesage S, Barbieux C, Alessandrini M, et al
    Brief Report: Representations and Willingness of People Living With HIV in Switzerland to Participate in HIV Cure Trials: The Case of Gene-Modified Cell Therapies.
    J Acquir Immune Defic Syndr. 2021;87:1154-1160.
    >> Share

  33. JONGEN VW, Zimmermann HML, Boyd A, Hoornenborg E, et al
    Transient Changes in Preexposure Prophylaxis Use and Daily Sexual Behavior After the Implementation of COVID-19 Restrictions Among Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2021;87:1111-1118.
    >> Share

  34. DETTINGER JC, Pintye J, Dollah A, Awuor M, et al
    "What is this PrEP?"- Sources and accuracy of HIV Pre-Exposure Prophylaxis (PrEP) awareness among adolescent girls and young women attending family planning and maternal child health clinics in Western Kenya.
    J Acquir Immune Defic Syndr. 2021 Aug 9. pii: 00126334-900000000-95825.
    >> Share

  35. FRENKEL LM, Leavitt Morrison R, Fuller TL, Isabel Gouvea M, et al
    Vaginal Viral Shedding with Undetectable Plasma HIV Viral Load in Pregnant Women Receiving Two Different Antiretroviral Regimens: A Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2021 Aug 7. pii: 00126334-900000000-95826.
    >> Share

  36. LE GUILLOU A, Buchbinder S, Scott H, Liu A, et al
    Population Impact and Efficiency of Improvements to HIV PrEP Under Conditions of High ART Coverage among San Francisco Men Who Have Sex with Men.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95830.
    >> Share

  37. WIGGILL T, Mayne E, Perner Y, Vaughan J, et al
    Changing patterns of Lymphoma in the Anti-Retroviral Therapy Era in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95829.
    >> Share

  38. BROPHY JE, Lessler J, Ssekubugu R, Kennedy CE, et al
    Prevalence of untreated HIV and associated risk behaviors among the sexual partners of recent migrants and long-term residents in Rakai, Uganda.
    J Acquir Immune Defic Syndr. 2021 Aug 5. pii: 00126334-900000000-95828.
    >> Share

  39. DAILEY A, Johnson AS, Hu X, Gant Z, et al
    Trends in HIV Care Outcomes Among Adults and Adolescents - 33 Jurisdictions, United States, 2014-2018.
    J Acquir Immune Defic Syndr. 2021 Aug 4. pii: 00126334-900000000-95827.
    >> Share

  40. WEST CA, Chang GC, W Currie D, Bray R, et al
    Unawareness of HIV Infection Among Men Aged 15-59 Years in 13 Sub-Saharan African Countries: Findings From the Population-Based HIV Impact Assessments, 2015-2019.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  41. VOETSCH AC, Duong YT, Stupp P, Saito S, et al
    HIV-1 Recent Infection Testing Algorithm With Antiretroviral Drug Detection to Improve Accuracy of Incidence Estimates.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  42. DOMAOAL RA, Sleeman K, Sawadogo S, Dzinamarira T, et al
    Successful Use of Near Point-of-Care Early Infant Diagnosis in NAMPHIA to Improve Turnaround Times in a National Household Survey.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  43. BRAY R, Palma AM, Philip NM, Brown K, et al
    Is Interview Length Associated With Blood Test Participation? Evidence From Three Population-Based HIV Impact Assessment Surveys Conducted From 2016 to 2017.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  44. REID G, Voetsch AC, Stupp P, McCracken S, et al
    Improving Sampling Efficiency for Determining Pediatric HIV Prevalence in National Surveys: Evidence From 8 Sub-Saharan African Countries.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  45. JAHUN I, Greby SM, Adesina T, Agbakwuru C, et al
    Lessons From Rapid Field Implementation of an HIV Population-Based Survey in Nigeria, 2018.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  46. METZ M, Smith R, Mitchell R, Duong YT, et al
    Data Architecture to Support Real-Time Data Analytics for the Population-Based HIV Impact Assessments.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  47. PATEL HK, Duong YT, Birhanu S, Dobbs T, et al
    A Comprehensive Approach to Assuring Quality of Laboratory Testing in HIV Surveys: Lessons Learned From the Population-Based HIV Impact Assessment Project.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  48. SACHATHEP K, Radin E, Hladik W, Hakim A, et al
    Population-Based HIV Impact Assessments Survey Methods, Response, and Quality in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  49. PORTER L, Bello G, Nkambule R, Justman J, et al
    HIV General Population Surveys: Shedding Light on the Status of HIV Epidemics and Informing Future Actions.
    J Acquir Immune Defic Syndr. 2021;87.
    >> Share

  50. HOQUE TMD, Cattin A, Whyte-Allman SK, Winchester L, et al
    Antiretroviral Drug Transporters and Metabolic Enzymes in Circulating Monocytes and Monocyte-Derived Macrophages of ART-Treated People Living With HIV and HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2021;87:1093-1101.
    >> Share

  51. TAIWO BO, Kuti KM, Kuhns LM, Omigbodun O, et al
    Effect of Text Messaging Plus Peer Navigation on Viral Suppression Among Youth With HIV in the iCARE Nigeria Pilot Study.
    J Acquir Immune Defic Syndr. 2021;87:1086-1092.
    >> Share

  52. SAMBOJU V, Cobigo Y, Paul R, Naasan G, et al
    Cerebrovascular Disease Correlates With Longitudinal Brain Atrophy in Virally Suppressed Older People Living With HIV.
    J Acquir Immune Defic Syndr. 2021;87:1079-1085.
    >> Share

  53. HERMANS LE, Nijhuis M, Tempelman HA, Houts T, et al
    Point-of-Care Detection of Nonadherence to Antiretroviral Treatment for HIV-1 in Resource-Limited Settings Using Drug Level Testing for Efavirenz, Lopinavir, and Dolutegravir: A Validation and Pharmacokinetic Simulation Study.
    J Acquir Immune Defic Syndr. 2021;87:1072-1078.
    >> Share

    July 2021
  54. SHRADER CH, Arroyo-Flores J, Stoler J, Skvoretz J, et al
    The association between social and spatial closeness with PrEP conversations among Latino men who have sex with men.
    J Acquir Immune Defic Syndr. 2021 Jul 31. pii: 00126334-900000000-95832.
    >> Share

  55. KAMIS KF, Barbera L, Abdo M, Rowan SE, et al
    Risk factors for hospitalization in people with HIV and COVID-19.
    J Acquir Immune Defic Syndr. 2021 Jul 30. pii: 00126334-900000000-95834.
    >> Share

  56. CHAISSON LH, Saraceni V, Cohn S, Cavalcante SC, et al
    Yield of repeat tuberculin skin testing for people living with HIV in Brazil.
    J Acquir Immune Defic Syndr. 2021 Jul 30. pii: 00126334-900000000-95833.
    >> Share

  57. SCHLENKER NW, Irvin NA, Galetto GG, Dashler GM, et al
    Identifying Missed Opportunities in the Prevention of Acute HIV Infection - The Need to Provide Pre-Exposure Prophylaxis Referrals to Emergency Department Patients with Increased Risk for Acquiring HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 27. pii: 00126334-900000000-95836.
    >> Share

  58. HAKIM AJ, Tippett Barr BA, Kinchen S, Musuka G, et al
    Progress toward the 90-90-90 HIV targets in Zimbabwe and identifying those left behind.
    J Acquir Immune Defic Syndr. 2021 Jul 24. pii: 00126334-900000000-95837.
    >> Share

  59. LYSS SB, Zhang T, Oster AM
    HIV Diagnoses Among Persons Who Inject Drugs, by Urban-Rural Classification - United States, 2010-2018.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95839.
    >> Share

  60. CHEN YT, Duncan DT, Del Vecchio N, Timmins L, et al
    COVID-19 related stressors, sex behaviors, and HIV status neutral care among Black men who have sex with men and transgender women in Chicago, USA.
    J Acquir Immune Defic Syndr. 2021 Jul 22. pii: 00126334-900000000-95838.
    >> Share

  61. JOHNSTON CD, Siegler EL, Rice MC, Derry HM, et al
    Urine Cell-Free Mitochondrial DNA as a Marker of Weight Loss and Body Composition in Older Adults with HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95842.
    >> Share

  62. MANZA-A AGOVI A, Anikpo I, Cvitanovich M, Fasanmi EO, et al
    Brief Report: HIV Pre-Exposure Prophylaxis Prescribing in an Urban Safety-Net Health System.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95841.
    >> Share

  63. SALAMA E, Hill L, Patel N, Best BM, et al
    Pharmacokinetics of bictegravir and tenofovir in combination with darunavir/cobicistat in treatment-experienced persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Jul 19. pii: 00126334-900000000-95840.
    >> Share

  64. COPELAND NK, Eller MA, Kim D, Creegan M, et al
    Increased Inflammation and Liver Disease in HIV/HBV-coinfected Individuals.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95846.
    >> Share

  65. CELERINO DA SILVA R, Pereira Alves NM, Gondim Silva ML, Agrelli A, et al
    Polymorphisms in TNF-alpha/TNFR1 pathway genes are associated with CD4+ T cells recovery in HIV-1-infected individuals on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95845.
    >> Share

  66. LARA-PAEZ G, Zuazo M, Blumenthal J, Coyne CJ, et al
    HIV and HCV Screening in the Emergency Department and Linkage to Care during COVID-19: Challenges and Solutions.
    J Acquir Immune Defic Syndr. 2021 Jul 14. pii: 00126334-900000000-95844.
    >> Share

  67. KALICHMAN SC, Kalichman MO, Eaton LA
    Undisclosed HIV Status to Sex Partners and Its Unintended Consequences in the Era of Undetectable = Untransmittable.
    J Acquir Immune Defic Syndr. 2021 Jul 13. pii: 00126334-900000000-95843.
    >> Share

  68. LELLOUCHE L, Gutierrez LA, Leclercq P, Zaegel-Faucher O, et al
    Frailty in Aging People Living With HIV: a matched controlled Study.
    J Acquir Immune Defic Syndr. 2021 Jul 6. pii: 00126334-900000000-95850.
    >> Share

  69. LUAN H, Song I, Fiellin DA, Ransome Y, et al
    HIV infection prevalence significantly intersects with COVID-19 infection at the area-level: a USA county-level analysis.
    J Acquir Immune Defic Syndr. 2021 Jul 6. pii: 00126334-900000000-95849.
    >> Share

  70. ELLSWORTH GB, Stier EA, Chiao EY, Lensing SY, et al
    Xpert HPV as a Screening Tool for Anal Histologic High-Grade Squamous Intraepithelial Lesions in Women Living With HIV.
    J Acquir Immune Defic Syndr. 2021;87:978-984.
    >> Share

  71. GRANDE M, Mawandia S, Bakae O, Tau L, et al
    Intensified Assisted Partner Notification Implementation in Botswana Increased Partner Identification but Not HIV Case-Finding: Findings Highlight the Need for Improved Data Monitoring.
    J Acquir Immune Defic Syndr. 2021;87:951-958.
    >> Share

    June 2021
  72. GIACOMELLI A, Cozzi-Lepri A, Cingolani A, Tavelli A, et al
    Does syphilis increase the risk of HIV-RNA elevation >200 copies/mL in HIV positive patients under effective antiretroviral treatment? Data from the ICONA cohort.
    J Acquir Immune Defic Syndr. 2021 Jun 15. pii: 00126334-900000000-95862.
    >> Share

  73. PANTAZIS N, Rosinska M, VAN Sighem A, Quinten C, et al
    Discriminating between pre-migration and post-migration HIV acquisition using surveillance data.
    J Acquir Immune Defic Syndr. 2021 Jun 15. pii: 00126334-900000000-95861.
    >> Share

  74. EL-FAR M, Hanna DB, Durand M, Larouche-Anctil E, et al
    Subclinical carotid artery atherosclerosis is associated with increased expression of peripheral blood IL-32 isoforms among women living with HIV.
    J Acquir Immune Defic Syndr. 2021 Jun 14. pii: 00126334-900000000-95860.
    >> Share

  75. SILHOL R, Coupland H, Baggaley RF, Miller L, et al
    What is the burden of heterosexually-acquired HIV due to HSV-2? Global and regional model-based estimates of the proportion and number of HIV infections attributable to HSV-2 infection.
    J Acquir Immune Defic Syndr. 2021 Jun 9. pii: 00126334-900000000-95864.
    >> Share

  76. FLYNN PM, Taha TE, Cababasay M, Butler K, et al
    Association of Maternal Viral Load and CD4 Count with Perinatal HIV-1 Transmission Risk during Breastfeeding in the PROMISE Postpartum Component.
    J Acquir Immune Defic Syndr. 2021 Jun 8. pii: 00126334-900000000-95865.
    >> Share

  77. CHAWANA TD, Nhachi CFB, Nathoo K, Ngara B, et al
    Ritonavir concentrations in hair predict virologic outcomes in HIV-infected adolescents with virologic failure on atazanavir/ritonavir-based second-line treatment.
    J Acquir Immune Defic Syndr. 2021 Jun 8. pii: 00126334-900000000-95863.
    >> Share

  78. JONES DL, Morgan KE, Martinez PC, Rodriguez VJ, et al
    COVID-19 Burden and Risk Among People With HIV.
    J Acquir Immune Defic Syndr. 2021;87:869-874.
    >> Share

  79. DZIVA CHIKWARI C, Simms V, Kranzer K, Dringus S, et al
    Feasibility and Accuracy of HIV Testing of Children by Caregivers Using Oral Mucosal Transudate HIV Tests.
    J Acquir Immune Defic Syndr. 2021;87:781-788.
    >> Share

    May 2021
  80. VUYLSTEKE B, Reyniers T, Noestlinger C, Smekens T, et al
    Can we predict incorrect PrEP use in high HIV risk situations among Men who have Sex with Men? An analysis of Be-PrEP-ared, the Belgian PrEP demonstration study .
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95868.
    >> Share

  81. BILLOCK RM, Samoff E, Lund JL, Pence BW, et al
    HIV VIRAL SUPPRESSION AND PRE-EXPOSURE PROPHYLAXIS IN HIV AND SYPHILIS CONTACT TRACING NETWORKS: AN ANALYSIS OF DISEASE SURVEILLANCE AND PRESCRIPTION CLAIMS DATA.
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95867.
    >> Share

  82. GUZMAN VA, Cham H, Gutierrez J, Byrd D, et al
    The Longitudinal Effects of Blood Pressure and Hypertension on Neurocognitive Performance in People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 31. pii: 00126334-900000000-95866.
    >> Share

  83. MCMILLAN JM, Gill MJ, Power C, Fujiwara E, et al
    Construct and Criterion-Related Validity of the Clinical Frailty Scale in Persons with HIV.
    J Acquir Immune Defic Syndr. 2021 May 28. pii: 00126334-900000000-95871.
    >> Share

  84. JASANTHA O, Kabanda S, Malaba TR, Lesosky M, et al
    Viral load monitoring in pregnancy to predict peripartum viraemia in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 28. pii: 00126334-900000000-95870.
    >> Share

  85. AMELIA DE SOUSA MASCENA VERAS , Roza Saggese GS, Gomez Junior JL, Silveira P, et al
    Young age and sex work are associated with HIV seroconversion among transgender women in Sao Paulo, Brazil.
    J Acquir Immune Defic Syndr. 2021 May 26. pii: 00126334-900000000-95872.
    >> Share

  86. GOENAGA SANCHEZ MA, Rodriguez IA, Equiza J, Echeverria CG, et al
    Prognosis of Stroke Among People Living with HIV and its relationship with admission to specialized Stroke Units.
    J Acquir Immune Defic Syndr. 2021 May 21. pii: 00126334-900000000-95876.
    >> Share

  87. HAZEN R, Halbur D, Mills B, Kirkham H, et al
    Evaluation of medication therapy issues, resolutions, and adherence among persons with HIV in the pharmacist-led Patient-centered HIV Care Model.
    J Acquir Immune Defic Syndr. 2021 May 20. pii: 00126334-900000000-95875.
    >> Share

  88. FOURMAN LT, Mueller SB, Boutin A, Zheng I, et al
    Placental Vascular Abnormalities in Association with Prenatal and Long-term Health Characteristics Among HIV-Exposed Uninfected Adolescents and Young Adults
    J Acquir Immune Defic Syndr. 2021 May 20. pii: 00126334-900000000-95874.
    >> Share

  89. HENSEN B, Machingura F, Busza J, Birdthistle I, et al
    How can we support the use of oral PrEP among young women who sell sex? A PrEP cascade analysis.
    J Acquir Immune Defic Syndr. 2021 May 19. pii: 00126334-900000000-95869.
    >> Share

  90. FOX MP, Pascoe S, Huber AN, Murphy J, et al
    Short-term Outcomes from a Cluster Randomized Evaluation of Adherence Clubs as Part of Differentiated HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95880.
    >> Share

  91. JOHNSON KA, Okochi H, Glidden DV, Gandhi M, et al
    Brief Report: No Difference in Urine Tenofovir Levels in Patients Living with HIV on Unboosted vs Dose-Adjusted Boosted Tenofovir Alafenamide.
    J Acquir Immune Defic Syndr. 2021 May 12. pii: 00126334-900000000-95879.
    >> Share

  92. GRAHAM SM, Maqungo S, Laubscher M, Ferreira N, et al
    Fracture healing in patients with human immunodeficiency virus in South Africa: a prospective cohort study.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95886.
    >> Share

  93. DRAIN PK, Galagan SR, Govere S, Krows M, et al
    Laboratory Reflex and Clinic-based Point-of-care Cryptococcal Antigen Screening for Preventing Meningitis and Mortality among People Living with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95885.
    >> Share

  94. DIAS JP, Haberlen SA, Dobs AS, Lake JE, et al
    Longitudinal changes in sex hormone-binding globulin in men with HIV.
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95884.
    >> Share

  95. JIAMSAKUL A, Boyd M, Choi JY, Edmiston N, et al
    Trends in follow-up visits among people living with HIV - results from the TREAT Asia and Australian HIV Observational Databases (TAHOD and AHOD).
    J Acquir Immune Defic Syndr. 2021 May 10. pii: 00126334-900000000-95883.
    >> Share

  96. HESELTINE T, Murray S, Ortega-Martorell S, Olier I, et al
    Associations of Hepatosteatosis with Cardiovascular Disease in HIV Positive and HIV Negative Patients: The Liverpool HIV-Heart Project.
    J Acquir Immune Defic Syndr. 2021 May 8. pii: 00126334-900000000-95882.
    >> Share

  97. SIRAJEE R, Conroy AL, Namasopo S, Opoka RO, et al
    Growth Faltering and Developmental Delay in HIV-Exposed Uninfected Ugandan Infants: A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2021;87:730-740.
    >> Share

  98. GAY CL, Bosch RJ, McKhann A, Moseley KF, et al
    Suspected Immune-Related Adverse Events with an Anti-PD-1 Inhibitor in Healthy People with HIV.
    J Acquir Immune Defic Syndr. 2021 May 1. pii: 00126334-900000000-95887.
    >> Share

    April 2021
  99. PITPITAN EV, MacKinnon DP, Eaton LA, Smith LR, et al
    Using novel approaches to evaluate behavioral interventions: Overlooked significant HIV prevention effects in HPTN 015 Project EXPLORE.
    J Acquir Immune Defic Syndr. 2021 Apr 20. pii: 00126334-900000000-95892.
    >> Share

  100. ANDERSON AM, Tang B, Vaida F, Mcclernon D, et al
    Low-Level HIV RNA in Cerebrospinal Fluid and Neurocognitive Performance: A Longitudinal Cohort Study.
    J Acquir Immune Defic Syndr. 2021 Apr 20. pii: 00126334-900000000-95891.
    >> Share

  101. SCHUMACHER CM, Tao X, Chandran A, Fields E, et al
    Reaching those most at risk for HIV acquisition: Evaluating Racial/Ethnic disparities in the PrEP Care Continuum in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2021 Apr 19. pii: 00126334-900000000-95894.
    >> Share

  102. HANS L, von Allmen N, Edelmann A, Hofmann J, et al
    Early diagnosis of HIV-1 and HIV-2 using cobas HIV-1/HIV-2 Qualitative, a novel qualitative nucleic acid amplification test for plasma, serum and dried blood spot specimens.
    J Acquir Immune Defic Syndr. 2021 Apr 19. pii: 00126334-900000000-95893.
    >> Share

  103. CRANE HM, Nance RM, Avoundjian T, Harding BN, et al
    Types of Stroke Among People Living With HIV in the United States.
    J Acquir Immune Defic Syndr. 2021;86:568-578.
    >> Share

  104. MEHROTRA ML, Westmoreland DA, Patel VV, Hojilla JC, et al
    Breaking Inertia: Movement Along the PrEP Cascade in a Longitudinal US National Cohort of Sexual Minority Individuals at Risk for HIV.
    J Acquir Immune Defic Syndr. 2021;86:e118-e125.
    >> Share

  105. VALENTE PK, Biello KB, Edeza A, Klasko-Foster L, et al
    Psychosocial Problems and Vulnerability to HIV in a Multi-City Prospective Cohort of Young Transgender Women in the United States: A Structural Equation Modeling Study.
    J Acquir Immune Defic Syndr. 2021;86:544-551.
    >> Share

  106. CHAS J, Bauer R, Larabi IA, Peytavin G, et al
    Evaluation of Drug Abuse by Hair Analysis and Self-Reported Use Among MSM Under PrEP: Results From a French Substudy of the ANRS-IPERGAY Trial.
    J Acquir Immune Defic Syndr. 2021;86:552-561.
    >> Share

  107. FREEMAN EE, Semeere A, McMahon DE, Byakwaga H, et al
    Beyond T Staging in the "Treat All" Era: Severity and Heterogeneity of Kaposi's Sarcoma in East Africa.
    J Acquir Immune Defic Syndr. 2021 Apr 14. pii: 00126334-900000000-95895.
    >> Share

  108. SUMARI-DE BOER M, Ngowi KM, Sonda T, Pima FM, et al
    Effect of Digital Adherence Tools on adherence to antiretroviral treatment among adults living with HIV in Kilimanjaro, Tanzania: a randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Apr 10. pii: 00126334-900000000-95898.
    >> Share

  109. MISHRA A, Mshweshwe-Pakela N, Kubeka G, Hansoti B, et al
    Systems analysis to increase HIV testing delivery and HIV diagnosis in primary care clinics in South Africa.
    J Acquir Immune Defic Syndr. 2021 Apr 5. pii: 00126334-900000000-95899.
    >> Share

  110. SINGHVI DG, Nouraie M, Kessinger C, McMahon DK, et al
    Association between Pain, Pulmonary Function, and Respiratory Symptoms in People with HIV.
    J Acquir Immune Defic Syndr. 2021 Apr 5. pii: 00126334-900000000-95897.
    >> Share

  111. HSIEH SM, Pan SC, Huang YS, Chang SC, et al
    Reversal of Viral Latency and Induction of Gag-Specific T-Cell Responses in HIV-1-Infected Adults Through Cyclic Treatment Interruption of Rosuvastatin: A Proof-of-Concept Study.
    J Acquir Immune Defic Syndr. 2021;86:500-508.
    >> Share

  112. YIGIT I, Bayramoglu Y, Weiser SD, Johnson MO, et al
    Disclosure Concerns and Viral Suppression in People Newly Initiating HIV Care: The Role of Internalized HIV Stigma.
    J Acquir Immune Defic Syndr. 2021;86:406-412.
    >> Share

  113. BOSSARD C, Schramm B, Wanjala S, Jain L, et al
    High prevalence of NRTI and NNRTI drug resistance among ART-experienced, hospitalized inpatients.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95902.
    >> Share

  114. BAVINTON BR, Vaccher S, Jin F, Prestage GP, et al
    High levels of prevention-effective adherence to HIV pre-exposure prophylaxis (PrEP): An analysis of sub-study data from the EPIC-NSW trial.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95901.
    >> Share

  115. PELUSO MJ, Dee L, Taylor J, Campbell DM, et al
    SARS-CoV-2 vaccination in the context of ongoing HIV cure-related research studies.
    J Acquir Immune Defic Syndr. 2021 Apr 1. pii: 00126334-900000000-95900.
    >> Share

    March 2021
  116. KHOSROPOUR CM, Dombrowski JC, Barbee LA, Kerani RP, et al
    Changing Patterns of Sexual Behavior and HIV/STI among Men who Have Sex with Men in Seattle, 2002 to 2018.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95906.
    >> Share

  117. JEWELL BL, Balzer LB, Clark TD, Charlebois ED, et al
    Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95905.
    >> Share

  118. CORNELISSE VJ, Traeger MW, Wright EJ, Murphy D, et al
    Low incidence of hepatitis C among a cohort of HIV-negative gay and bisexual men using HIV pre-exposure prophylaxis (PrEP) in Melbourne, Australia, and the contribution of sexual transmission.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95904.
    >> Share

  119. OKERE NE, Lennox L, Urlings L, Ford N, et al
    Exploring sustainability in the era of differentiated HIV service delivery in Sub-Saharan Africa: A systematic review.
    J Acquir Immune Defic Syndr. 2021 Mar 23. pii: 00126334-900000000-95903.
    >> Share

  120. SHIAU S, Cantos A, Ramon CV, Shen Y, et al
    Epigenetic age in young African American adults with perinatally-acquired HIV.
    J Acquir Immune Defic Syndr. 2021 Mar 18. pii: 00126334-900000000-95907.
    >> Share

  121. HINES JZ, Sachathep K, Pals S, Davis SM, et al
    HIV incidence by male circumcision status from the population-based HIV impact assessment (PHIA) surveys-eight sub-Saharan African countries, 2015-2017.
    J Acquir Immune Defic Syndr. 2021 Mar 16. pii: 00126334-900000000-95908.
    >> Share

  122. CHAN PA, Nunn A, Van Den Berg JJ, Cormier K, et al
    A randomized trial of a brief behavioral intervention for PrEP uptake among men who have sex with men at increased risk for HIV infection.
    J Acquir Immune Defic Syndr. 2021 Mar 15. pii: 00126334-900000000-95909.
    >> Share


  123. Bacterial Vaginosis and Risk of HIV Infection in the Context of CD101 Gene Variation: Erratum.
    J Acquir Immune Defic Syndr. 2021;86:387.
    >> Share

  124. PLUZNIK JA, Nijhawan AE, Spaulding AC
    Does Anything Work? Improving HIV Care Engagement for Individuals Transitioning out of Correctional Settings.
    J Acquir Immune Defic Syndr. 2021;86:286-287.
    >> Share

  125. COOLEY SA, Navid J, Wisch JK, Boerwinkle A, et al
    Relationships between Viral Load, Neuroimaging and Neuropsychological Performance in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95915.
    >> Share

  126. BAKER Z, Javanbacht M, Moore J, Brosnan H, et al
    A qualitative study on the acceptability of and adherence to a vaginal ring for HIV prophylaxis among adolescent girls.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95914.
    >> Share

  127. SILHOL R, Geidelberg L, Mitchell KM, Mishra S, et al
    Assessing the potential impact of disruptions due to COVID-19 on HIV among key and lower-risk populations in the largest cities of Cameroon and Benin.
    J Acquir Immune Defic Syndr. 2021 Mar 1. pii: 00126334-900000000-95920.
    >> Share

  128. LEVY ME, Agopian A, Magnus M, Rawls A, et al
    Is Long-Acting Injectable Cabotegravir Likely to Expand PrEP Coverage Among MSM in the District of Columbia?
    J Acquir Immune Defic Syndr. 2021;86:e80-e82.
    >> Share

    February 2021
  129. EDELMAN EJ, Gan G, Dziura J, Esserman D, et al
    Readiness to provide medications for opioid, alcohol and tobacco use disorder in HIV clinics: A multi-site mixed-methods formative evaluation.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95919.
    >> Share

  130. SOMERVILLE K, Jenkins CA, Carlucci JG, Person AK, et al
    Outcomes After Second-Line Antiretroviral Therapy in Children Living with HIV in Latin America.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95918.
    >> Share

  131. BATHER JR, Williams PL, Broadwell C, Smith R, et al
    Racial/Ethnic Disparities in Longitudinal Emotional-Behavioral Functioning Among Youth Born to Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95917.
    >> Share

  132. JANULIS P, Goodreau SM, Birkett M, Phillips G 2nd, et al
    Temporal variation in one-time partnership rates among young men who have sex with men and transgender women.
    J Acquir Immune Defic Syndr. 2021 Feb 26. pii: 00126334-900000000-95916.
    >> Share

  133. ERLY SJ, Naismith K, Kerani R, Buskin SE, et al
    Predictive Value of Time-Space Clusters for HIV Transmission in Washington State, 2017-2019.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95923.
    >> Share

  134. BHUSHAN NL, Stoner MCD, Twine R, Kahn K, et al
    Community Space, Community Groups, and Incident HIV Infection Among Adolescent Girls and Young Women in Rural South Africa: A Longitudinal Analysis of HIV Prevention Trials Network 068 Data.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95922.
    >> Share

  135. TAMARGO JA, Martin HR, Diaz-Martinez J, Trepka MJ, et al
    COVID-19 Testing and The Impact of The Pandemic on The Miami Adult Studies on HIV (MASH) Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 24. pii: 00126334-900000000-95921.
    >> Share

  136. BRUXVOORT KJ, Schumacher CM, Towner W, Jones J, et al
    Referral linkage to pre-exposure prophylaxis (PrEP) care and persistence on PrEP in an integrated healthcare system.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95928.
    >> Share

  137. NEARY J, Wagner AD, Omondi V, Otieno V, et al
    Male caregiver barriers to HIV index-case testing of untested children.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95927.
    >> Share

  138. TAGGART T, Mayer KH, Vermund SH, Huang S, et al
    Interaction of religion/spirituality with internalized HIV stigma, depression, alcohol use, and sexual risk among Black men who have sex with men: The six city HPTN 061 study.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95926.
    >> Share

  139. DRIVSHOLM N, Knudsen AD, Faurholt-Jepsen M, Midttun O, et al
    Alterations in the kynurenine pathway of tryptophan metabolism are associated with depression in people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 23. pii: 00126334-900000000-95925.
    >> Share

  140. MONTGOMERY ET, Browne E, Atujuna M, Boeri M, et al
    Long-acting injection and implant preferences and trade-offs for HIV prevention among South African male youth.
    J Acquir Immune Defic Syndr. 2021 Feb 22. pii: 00126334-900000000-95924.
    >> Share

  141. KUMAR P, Johnson M, Molina JM, Rizzardini G, et al
    Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through Week 144 in the DRIVE-SHIFT Trial.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95929.
    >> Share

  142. EJIMA K, Koizumi Y, Yamamoto N, Rosenberg M, et al
    HIV testing by public health centers and municipalities and new HIV cases during the COVID-19 pandemic in Japan.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95932.
    >> Share

  143. KELLY SG, Wu K, Tassiopoulos K, Erlandson KM, et al
    Incorporating frailty into the Pooled Cohort Equations to predict cardiovascular disease among persons with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95931.
    >> Share

  144. CINDI Z, Maartens G, Bradford Y, Venter F, et al
    Genetic Associations with Weight Gain among South Africans who Initiated Dolutegravir- and Tenofovir-containing Regimens.
    J Acquir Immune Defic Syndr. 2021 Feb 17. pii: 00126334-900000000-95930.
    >> Share

  145. NOWAK RG, Liska TA, Bentzen SM, Kim E, et al
    Herpes Simplex Virus Type-2 shedding and genital ulcers during early HIV in Zimbabwean women.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95936.
    >> Share

  146. TRUONG HM, Fatch R, McFarland W, Raymond HF, et al
    HIV Prevention Responsibility Beliefs Among Men Who Have Sex with Men in the PrEP Era.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95935.
    >> Share

  147. VAN WYK J, Ait-Khaled M, Santos J, Scholten S, et al
    Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95934.
    >> Share

  148. KOHN JN, Loop MS, Kim-Chang JJ, Garvie PA, et al
    Trajectories of depressive symptoms, neurocognitive function and viral suppression with antiretroviral therapy among youth with HIV over 36 months.
    J Acquir Immune Defic Syndr. 2021 Feb 12. pii: 00126334-900000000-95933.
    >> Share

  149. NIJHAWAN AE, Mathews WC, Raifman J, Fleming J, et al
    Hospitalization rates among persons with HIV who gained Medicaid or private insurance after the Affordable Care Act in 2014.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95945.
    >> Share

  150. MGODI NM, Takuva S, Edupuganti S, Karuna S, et al
    A phase 2b study to evaluate the safety and efficacy of VRC01 broadly neutralizing monoclonal antibody in reducing acquisition of HIV-1 infection in women in sub-Saharan Africa: baseline findings.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95944.
    >> Share

  151. PALEFSKY JM, Poongulali S, Lensing S, Lee J, et al
    AIDS Malignancy Consortium 054: Safety and Immunogenicity of the Quadrivalent vaccine in Indian Women Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95943.
    >> Share

  152. PRICE JT, Vwalika B, Edwards JK, Cole SR, et al
    Maternal HIV infection and spontaneous versus provider-initiated preterm birth in an urban Zambian cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95942.
    >> Share

  153. HUANG SH, Huang WC, Lin SW, Chuang YC, et al
    Impact of efavirenz mid-dose plasma concentration on long-term weight change among virologically suppressed people living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95941.
    >> Share

  154. PELCHEN-MATTHEWS A, Borges AH, Reekie J, Rasmussen LD, et al
    Prevalence and Outcomes for Heavily Treatment-Experienced (HTE) Individuals Living with Human Immunodeficiency Virus in a European Cohort.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95940.
    >> Share

  155. EDUPUGANTI S, Mgodi N, Karuna ST, Andrew P, et al
    Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95939.
    >> Share

  156. CACHAY ER, Torriani FJ, Hill L, Rajagopal A, et al
    HCV knowledge and Recent Diagnosis Affect HCV Treatment Willingness in Persons Living with HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95938.
    >> Share

  157. VERA JH, Eftychiou N, Schuerer M, Rullmann M, et al
    CLINICAL UTILITY OF beta-AMYLOID PET IMAGING IN PEOPLE LIVING WITH HIV WITH COGNITIVE SYMPTOMS.
    J Acquir Immune Defic Syndr. 2021 Feb 11. pii: 00126334-900000000-95937.
    >> Share

  158. FARAHANI M, Radin E, Saito S, Sachathep K, et al
    Population Viral Load, Viremia and Recent HIV-1 Infections: Findings from Population-based HIV Impact Assessments (PHIAs) in Zimbabwe, Malawi, and Zambia.
    J Acquir Immune Defic Syndr. 2021 Feb 5. pii: 00126334-900000000-95947.
    >> Share

  159. SHARMA A, Hoover DR, Shi Q, Gustafson DR, et al
    High Frequency of Recurrent Falls among Pre-frail and Frail Women with and without HIV.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95950.
    >> Share

  160. PAGKAS-BATHER J, Khosropour CM, Golden MR, Thibault C, et al
    Population-level Effectiveness of HIV pre-exposure prophylaxis among MSM and Transgender Persons with Bacterial Sexually Transmitted Infections.
    J Acquir Immune Defic Syndr. 2021 Feb 2. pii: 00126334-900000000-95949.
    >> Share

  161. PATEL VV, Felsen UR, Fisher M, Fazzari MJ, et al
    Clinical Outcomes and Inflammatory Markers by HIV Serostatus and Viral Suppression in a Large Cohort of Patients Hospitalized With COVID-19.
    J Acquir Immune Defic Syndr. 2021;86:224-230.
    >> Share

  162. MUCCINI C, Crowell TA, Pinyakorn S, Kroon E, et al
    Brief Report: Syphilis Incidence and Effect on Viral Load, CD4, and CD4/CD8 Ratio in a Thai Cohort of Predominantly Men Who Have Sex With Men Living With HIV.
    J Acquir Immune Defic Syndr. 2021;86:219-223.
    >> Share

  163. CRANE HM, Nance RM, Whitney BM, Heckbert SR, et al
    Brief Report: Differences in Types of Myocardial Infarctions Among People Aging With HIV.
    J Acquir Immune Defic Syndr. 2021;86:208-212.
    >> Share

  164. CHOW EPF, Hocking JS, Ong JJ, Phillips TR, et al
    Brief Report: Changes in PrEP Use, Sexual Practice, and Use of Face Mask During Sex Among MSM During the Second Wave of COVID-19 in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2021;86:153-156.
    >> Share

    January 2021
  165. SABERI P, Ming K, Hojilla JC, Scott HM, et al
    HIV pre-exposure prophylaxis in the time of COVID-19: How a robust and responsive HIV PrEP intervention can avert loss of HIV prevention coverage during a global pandemic.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95952.
    >> Share

  166. WAIRIMU F, Ward NC, Liu Y, Dwivedi G, et al
    Cardiac transplantation in HIV positive patients: a narrative review.
    J Acquir Immune Defic Syndr. 2021 Jan 29. pii: 00126334-900000000-95951.
    >> Share

  167. TIEN-HUAN L, Ismael FC, Suzue S, Rommel B, et al
    Evaluating Nonresponse Weighting Adjustment for the Population-Based HIV Impact Assessments Surveys: On Incorporating Survey Outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95955.
    >> Share

  168. JOHNSON KA, Chen MJ, Kohn R, Sachdev D, et al
    Acute HIV at the time of initiation of Pre or Post Exposure Prophylaxis: Impact on drug-resistance and clinical outcomes.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95954.
    >> Share

  169. PAMPATI S, Emrick K, Siegler AJ, Jones J, et al
    Changes in sexual behavior, PrEP adherence, and access to sexual health services due to the COVID-19 pandemic among a cohort of PrEP-using MSM in the South.
    J Acquir Immune Defic Syndr. 2021 Jan 28. pii: 00126334-900000000-95953.
    >> Share

  170. VAN DER HEIJDEN WA, Wan J, Van de Wijer L, Jaeger M, et al
    Plasmatic coagulation capacity correlates with inflammation and abacavir-use during chronic HIV-infection.
    J Acquir Immune Defic Syndr. 2021 Jan 26. pii: 00126334-900000000-95956.
    >> Share

  171. GOODRICH S, Siika A, Mwangi A, Nyambura M, et al
    Development, assessment and outcomes of a community-based model of anti-retroviral care in western Kenya through a cluster-randomized control trial.
    J Acquir Immune Defic Syndr. 2021 Jan 21. pii: 00126334-900000000-95957.
    >> Share

  172. ONGOLLY FK, Dolla A, Ngure K, Irungu EM, et al
    "I just decided to stop: " Understanding PrEP discontinuation among individuals initiating PrEP in HIV care centers in Kenya.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95963.
    >> Share

  173. COBURN SB, Shiels M, Silverberg M, Horberg M, et al
    Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95962.
    >> Share

  174. ZHANG L, Abohashem S, Osborne MT, Naddaf N, et al
    Lower Socioeconomic Status Associates with Greater Systemic and Arterial Inflammation in HIV.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95961.
    >> Share

  175. CHEN Y, Gao Y, Zhou Y, Li X, et al
    Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-analysis of Prospective Studies.
    J Acquir Immune Defic Syndr. 2021 Jan 20. pii: 00126334-900000000-95958.
    >> Share

  176. BUSZA J, Hensen B, Birdthistle I, Chabata ST, et al
    What's in a name? A mixed method study on how young women who sell sex characterise male partners and their use of condoms.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95964.
    >> Share

  177. CRABLE EL, Blue TR, McKenzie M, Rich JD, et al
    Effect of case management on HIV outcomes for community corrections population: Results of an 18-month randomized controlled trial.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95960.
    >> Share

  178. MUCCINI C, Galli L, Poli A, Chiurlo M, et al
    Changes in homeostatic model assessment for insulin resistance (HOMA-IR) index in treated HIV-1 infected people on virological suppression who switched to a different antiretroviral regimen.
    J Acquir Immune Defic Syndr. 2021 Jan 19. pii: 00126334-900000000-95959.
    >> Share

  179. RANA MN, Kim CH, Sullivan CE, Longenecker CT, et al
    Performance of Methods to Estimate Low-Density Lipoprotein Cholesterol in Women with and without HIV infection.
    J Acquir Immune Defic Syndr. 2021 Jan 18. pii: 00126334-900000000-95966.
    >> Share

  180. BIEN-GUND CH, Ho JI, Bair EF, Marcus N, et al
    Financial incentives and real-time adherence monitoring to promote daily adherence to HIV treatment and viral suppression among people living with HIV: a pilot study.
    J Acquir Immune Defic Syndr. 2021 Jan 15. pii: 00126334-900000000-95965.
    >> Share

  181. DIRAJLAL-FARGO S, Williams PL, Broadwell C, McFARLAND EJ, et al
    Youth living with perinatally-acquired HIV have lower physical activity levels as they age compared to HIV-exposed uninfected youth.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95968.
    >> Share

  182. RAO A, Rucinski K, Jarrett B, Ackerman B, et al
    Perceived interruptions to HIV prevention and treatment services associated with COVID-19 for gay, bisexual, and other men who have sex with men in 20 countries.
    J Acquir Immune Defic Syndr. 2021 Jan 13. pii: 00126334-900000000-95967.
    >> Share

  183. GATHE JC, Hardwicke RL, Garcia F, Weinheimer S, et al
    Efficacy, pharmacokinetics and safety over 48 weeks with ibalizumab-based therapy in treatment-experienced adults infected with HIV-1: A Phase 2a study.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  184. MEGGI B, Bollinger T, Zitha A, Mudenyanga C, et al
    Performance of a True Point-of-Care Assay for HIV-1/2 Viral Load Measurement at Antenatal and Postpartum Services.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  185. HENRY RT, Jiamsakul A, Law M, Losso M, et al
    Factors Associated With And Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants.
    J Acquir Immune Defic Syndr. 2021;Publish Ahead of Print.
    >> Share

  186. SPRING S, O'Bryan J, McMahon J, Woolley I, et al
    Acceptability of Injectable Antiretroviral Therapy in Australian Travelers With HIV.
    J Acquir Immune Defic Syndr. 2021;86:e13-e15.
    >> Share

  187. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    Integrase Inhibitors Use and Cytomegalovirus Infection Predict Immune Recovery in People Living With HIV Starting First-Line Therapy.
    J Acquir Immune Defic Syndr. 2021;86:119-127.
    >> Share

  188. DUNN D, Price H, Vudriko T, Kityo C, et al
    New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.
    J Acquir Immune Defic Syndr. 2021;86:98-103.
    >> Share

  189. ELLSWORTH GB, Burke LA, Wells MT, Mishra S, et al
    Randomized Pilot Study of an Advanced Smart-Pill Bottle as an Adherence Intervention in Patients With HIV on Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2021;86:73-80.
    >> Share

  190. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral Interventions can Mitigate Adverse Pregnancy Outcomes Among Women Conceiving on ART and Those Initiated on ART During Pregnancy: Findings From the MOTIVATE Trial in Southwestern Kenya.
    J Acquir Immune Defic Syndr. 2021;86:46-55.
    >> Share

  191. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase PrEP Uptake for HIV Prevention: 55-Week Results From PrEPChicago.
    J Acquir Immune Defic Syndr. 2021;86:31-37.
    >> Share

  192. PAHWA S, Deeks S, Zou S, Tomitch N, et al
    NIH Workshop on HIV-Associated Comorbidities, Coinfections, and Complications: Summary and Recommendation for Future Research.
    J Acquir Immune Defic Syndr. 2021;86:11-18.
    >> Share

    December 2020
  193. OLALI AZ, Sharma A, Shi Q, Hoover DR, et al
    Change in circulating undercarboxylated osteocalcin (ucOCN) is associated with fat accumulation in HIV-seropositive women.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  194. MCQUILLAN GM, Kruszon-Moran D, Gu Q, Masciotra S, et al
    Prevalence and trends in HIV infection and testing among adults in the United States: The National Health and Nutrition Examination Surveys, 1999-2018.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  195. MOSKOWITZ DA, Moran KO, Matson M, Alvarado-Avila A, et al
    The PrEP cascade in a national cohort of adolescent men who have sex with men.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  196. FELNER JK, Mittal ML, Hoenigl M, Amico KR, et al
    Constructions of HIV Risk Among a Diverse Sample of HIV-Negative Young Men who have Sex with Men who are Repeat Testers.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  197. MOHAREB AM, Patel AV, Laeyendecker OB, Toerper MF, et al
    The HIV screening cascade: current Emergency Department-based screening strategies leave many patients with HIV undiagnosed.
    J Acquir Immune Defic Syndr. 2020 Dec 28. doi: 10.1097/QAI.0000000000002609.
    >> Share

  198. MULATU MS, Wang G, Song W, Keatley J, et al
    HIV Testing, Diagnosis of HIV Infection, Linkage to Medical Care, and Interview for Partner Services among Transgender Persons - United States, 2012-2017.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  199. MOSHIRI N, Smith DM, Mirarab S
    HIV Care Prioritization using Phylogenetic Branch Length.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  200. O'HALLORAN JA, Wang K, Spence AB, Williams DW, et al
    Integrase Strand Transfer Inhibitor Start or Switch Impacts Learning in Women with HIV.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  201. LEDERMAN MM
    AIDS in the Heartland- Hemophilia was the Harbinger of Things to Come.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  202. BLAIR CS, Lake JE, Passaro RC, Chavez-Gomez S, et al
    HIV-1 Seroconversion is Not Associated with Prolonged Rectal Mucosal Inflammation.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  203. PETOUMENOS K, Kuwanda L, Ryom L, Mocroft A, et al
    Effect of changes in body mass index on the risk of cardiovascular disease and diabetes mellitus in HIV-positive individuals: results from the D: A: D study\.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  204. WEISER JK, Tie Y, Beer L, Fanfair RN, et al
    Racial/ethnic and Income Disparities in the Prevalence of Comorbidities that Are Associated With Risk for Severe COVID-19 Among Adults Receiving HIV Care, United States, 2014-2019.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  205. KATZ IT, Musinguzi N, Bell K, Cross A, et al
    The Impact of Disease Stage on Early Gaps in ART in the "Treatment for All" Era - A Multisite Cohort Study.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  206. SAMRI A, Chalouni M, Blanco J, Behrens G, et al
    Influence of the ARV regimen on the early changes in plasma HIV RNA and immune activation at initiation of antiretroviral therapy in naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  207. TOLENTINO A, Amaral S, Souza LS, Zeballos D, et al
    Frequency of falls and associated risk factors in people living with HIV: a systematic review with meta-analysis and meta-regression.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  208. STEK C, Buyze J, Menten J, Schutz C, et al
    Diagnostic accuracy of the INSHI consensus case definition for the diagnosis of paradoxical tuberculosis-IRIS.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  209. CHOW EPF, Ong JJ, Denham I, Fairley CK, et al
    HIV testing and diagnoses during the COVID-19 pandemic in Melbourne, Australia.
    J Acquir Immune Defic Syndr. 2020;Publish Ahead of Print.
    >> Share

  210. MALLARINO-HAEGER C, Abebe KZ, Jackson EK, Zyhowski A, et al
    Brief Report: Dipyridamole Decreases Gut Mucosal Regulatory T-Cell Frequencies Among People With HIV on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;85:665-669.
    >> Share

  211. GINGRICH D, Deitchman AN, Kantor A, Huang L, et al
    Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:651-658.
    >> Share

  212. HSIEH YL, Jahn A, Menzies NA, Yaesoubi R, et al
    Evaluation of 6-Month Versus Continuous Isoniazid Preventive Therapy for Mycobacterium tuberculosis in Adults Living With HIV/AIDS in Malawi.
    J Acquir Immune Defic Syndr. 2020;85:643-650.
    >> Share

  213. TORGERSEN J, Kallan MJ, Carbonari DM, Park LS, et al
    Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.
    J Acquir Immune Defic Syndr. 2020;85:530-534.
    >> Share

  214. LINNEMAYR S, Barreras JL, Izenberg M, Brooks RA, et al
    Longitudinal Assessment of Changes in Mental and Sexual Health Outcomes Due to COVID-19 Among Latinx SMM and TGW.
    J Acquir Immune Defic Syndr. 2020;85:e90-e92.
    >> Share

  215. PEREZ-VALERO I, Llibre JM, Castagna A, Pulido F, et al
    Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation.
    J Acquir Immune Defic Syndr. 2020 Dec 10. doi: 10.1097/QAI.0000000000002595.
    >> Share

  216. ELLIS RJ, Iudicello J, Sun-Suslow N, Grelotti D, et al
    Social isolation is linked to inflammation in aging people with HIV and uninfected individuals.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002596.
    >> Share

  217. ABRAMS EJ, Mofenson LM, Pozniak A, Lockman S, et al
    Enhanced and timely investigation of ARVs for use in pregnant women.
    J Acquir Immune Defic Syndr. 2020 Dec 8. doi: 10.1097/QAI.0000000000002597.
    >> Share

  218. NAIDOO K, Mansoor LE, Katz AW, Garcia M, et al
    Qualitative perceptions of dapivirine vaginal ring adherence and drug level feedback following an open-label extension trial.
    J Acquir Immune Defic Syndr. 2020 Dec 3. doi: 10.1097/QAI.0000000000002590.
    >> Share

  219. SINHA A, Mystakelis H, Rivera AS, Manion M, et al
    Association of Low CD4/CD8 Ratio With Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2020;85:e73-e76.
    >> Share

  220. MANSERGH G, Stephenson R, Hirshfield S, Sullivan P, et al
    Understanding HIV Sexual Protection and Its Association With Substance Use During Sex Among MSM in an Era of Multiple Primary Prevention Products.
    J Acquir Immune Defic Syndr. 2020;85:e67.
    >> Share

  221. POTEAT TC, Reisner SL, Miller M, Wirtz AL, et al
    Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.
    J Acquir Immune Defic Syndr. 2020;85:e67-e69.
    >> Share

  222. THORBALL CW, Borghesi A, Bachmann N, Von Siebenthal C, et al
    Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020;85:517-524.
    >> Share

  223. LUCAS GM, Atta MG, Zook K, Vaidya D, et al
    Cross-Sectional and Longitudinal Performance of Creatinine- and Cystatin C-Based Estimating Equations Relative to Exogenously Measured Glomerular Filtration Rate in HIV-Positive and HIV-Negative Persons.
    J Acquir Immune Defic Syndr. 2020;85:e58-e66.
    >> Share

  224. RODRIGUEZ VJ, Zegarac M, La Barrie DL, Parrish MS, et al
    Validation of the Bayley Infant Neurodevelopmental Screener Among HIV-Exposed Infants in Rural South Africa.
    J Acquir Immune Defic Syndr. 2020;85:507-516.
    >> Share

  225. RIZZARDINI G, Overton ET, Orkin C, Swindells S, et al
    Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials.
    J Acquir Immune Defic Syndr. 2020;85:498-506.
    >> Share

  226. HAN WM, Bijker R, Chandrasekaran E, Pujari S, et al
    Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
    J Acquir Immune Defic Syndr. 2020;85:489-497.
    >> Share

  227. MANN SC, Morrow M, Coyle RP, Coleman SS, et al
    Lower Cumulative Antiretroviral Exposure in People Living With HIV and Diabetes Mellitus.
    J Acquir Immune Defic Syndr. 2020;85:483-488.
    >> Share

  228. BALLIVIAN J, Alcaide ML, Cecchini D, Jones DL, et al
    Impact of COVID-19-Related Stress and Lockdown on Mental Health Among People Living With HIV in Argentina.
    J Acquir Immune Defic Syndr. 2020;85:475-482.
    >> Share

  229. BK K, Tiwari S, Chhapola V, Debnath E, et al
    Brief Report: Subclinical Kidney Dysfunction in HIV-Infected Children: A Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2020;85:470-474.
    >> Share

  230. MCCLEAN M, Buzkova P, Budoff M, Estrella M, et al
    Brief Report: Cystatin C-Based Estimation of Glomerular Filtration Rate and Association With Atherosclerosis Imaging Markers in People Living With HIV.
    J Acquir Immune Defic Syndr. 2020;85:466-469.
    >> Share

  231. MILLER L, Morar N, Kapiga S, Ramjee G, et al
    Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    J Acquir Immune Defic Syndr. 2020;85:458-465.
    >> Share

  232. HEBEL S, Kahn-Woods E, Malone-Thomas S, McNeese M, et al
    Brief Report: Discrepancies Between Self-Reported Adherence and a Biomarker of Adherence in Real-World Settings.
    J Acquir Immune Defic Syndr. 2020;85:454-457.
    >> Share

  233. BOYD AT, Odume B, Sidibe K, Onotu D, et al
    Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.
    J Acquir Immune Defic Syndr. 2020;85:450-453.
    >> Share

  234. CONTE M, Eshun-Wilson I, Geng E, Imbert E, et al
    Brief Report: Understanding Preferences for HIV Care Among Patients Experiencing Homelessness or Unstable Housing: A Discrete Choice Experiment.
    J Acquir Immune Defic Syndr. 2020;85:444-449.
    >> Share

  235. DEAN LT, Nonyane BAS, Ugoji C, Visvanathan K, et al
    Economic Burden Among Gay, Bisexual, and Other Men Who Have Sex With Men Living With HIV or Living Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020;85:436-443.
    >> Share

  236. CHAPIN-BARDALES J, Johnson Jones ML, Kirkcaldy RD, Bernstein KT, et al
    Pre-exposure Prophylaxis Use and Detected Sexually Transmitted Infections Among Men Who Have Sex With Men in the United States-National HIV Behavioral Surveillance, 5 US Cities, 2017.
    J Acquir Immune Defic Syndr. 2020;85:430-435.
    >> Share

  237. MOORE JR, Donnell DJ, Boily MC, Mitchell KM, et al
    Model-Based Predictions of HIV Incidence Among African Women Using HIV Risk Behaviors and Community-Level Data on Male HIV Prevalence and Viral Suppression.
    J Acquir Immune Defic Syndr. 2020;85:423-429.
    >> Share

  238. JEAN LOUIS F, Domercant JW, Ignacio C, Gianella S, et al
    High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    J Acquir Immune Defic Syndr. 2020;85:416-422.
    >> Share

  239. XIA Y, Greenwald ZR, Milwid RM, Trottier C, et al
    Pre-exposure Prophylaxis Uptake Among Men Who Have Sex With Men Who Used nPEP: A Longitudinal Analysis of Attendees at a Large Sexual Health Clinic in Montreal (Canada).
    J Acquir Immune Defic Syndr. 2020;85:408-415.
    >> Share

  240. DE ANDA S, Njoroge A, Njuguna I, Dunbar MD, et al
    Predictors of First-Time and Repeat HIV Testing Among HIV-Positive Individuals in Kenya.
    J Acquir Immune Defic Syndr. 2020;85:399-407.
    >> Share

  241. MOORE M, Boily MC, Mitchell KM, Donnell DD, et al
    Identifying Regions of Greatest Need for Ending the HIV Epidemic: A Plan for America.
    J Acquir Immune Defic Syndr. 2020;85:395-398.
    >> Share

  242. BRUMMEL SS, Taha TE, Angelidou KN, Saidi F, et al
    Impact of Antiretroviral Therapy on Maternal Health after Cessation of Breastfeeding.
    J Acquir Immune Defic Syndr. 2020 Dec 1. doi: 10.1097/QAI.0000000000002586.
    >> Share

  243. LEFEBVRE M, Walencik A, Allavena C, Billaud E, et al
    Rate of DRESS Syndrome With Raltegravir and Role of the HLA-B*53: 01 Allele.
    J Acquir Immune Defic Syndr. 2020;85:e77-e80.
    >> Share

    November 2020
  244. HUANG YS, Cheng CY, Liou BH, Lu PL, et al
    Efficacy and safety of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide as maintenance treatment in HIV/HBV-coinfected patients.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002589.
    >> Share

  245. MIN HAN W, Ueaphongsukkit T, Chattranukulchai P, Siwamogsatham S, et al
    Incident liver cirrhosis, associated factors and cardiovascular disease risks among people living with HIV: a longitudinal study.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002585.
    >> Share

  246. MAZAHERI-TEHRANI E, Mohraz M, Nasi M, Chester J, et al
    NLRP3 and IL-1beta gene expression is elevated in monocytes from HIV treated patients with neurocognitive disorders.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002588.
    >> Share

  247. PINTYE J, O'Malley G, Kinuthia J, Abuna F, et al
    Influences on early discontinuation and persistence of daily oral PrEP use among Kenyan adolescent girls and young women: a qualitative evaluation from a PrEP implementation program.
    J Acquir Immune Defic Syndr. 2020 Nov 30. doi: 10.1097/QAI.0000000000002587.
    >> Share

  248. CELERINO DA SILVA R, Segat L, Kuhn L, Bogo Chies JA, et al
    Association of single nucleotide polymorphisms in HLA-C and ZNRD1 genes with HIV-1 mother to child transmission in Zambia population.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002584.
    >> Share

  249. UNG MJ, Fairley CK, Martin SJ, Ong JJ, et al
    Pre-exposure Prophylaxis for HIV - an opportunity for the global control of sexually transmitted infections.
    J Acquir Immune Defic Syndr. 2020 Nov 23. doi: 10.1097/QAI.0000000000002582.
    >> Share

  250. PATHMANATHAN I, Nelson R, de Louvado A, Thompson R, et al
    High Coverage of Antiretroviral Treatment with Annual Home-Based HIV Testing, Follow-up Linkage Services, and Implementation of Test and Start: Findings from the Chokwe Health Demographic Surveillance System, Mozambique, 2014-2019.
    J Acquir Immune Defic Syndr. 2020 Nov 21. doi: 10.1097/QAI.0000000000002583.
    >> Share

  251. SILHOL R, Baral S, Bowring AL, Mukandavire C, et al
    Quantifying the evolving contribution of HIV interventions and key populations to the HIV epidemic in Yaounde, Cameroon.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002580.
    >> Share

  252. HAMILL MM, Hu F, Kokogho A, Shoyemi E, et al
    Factors Associated with Condom Failure in a Longitudinal Cohort of Men who have Sex with Men and Transgender Women in Abuja and Lagos, Nigeria.
    J Acquir Immune Defic Syndr. 2020 Nov 20. doi: 10.1097/QAI.0000000000002559.
    >> Share

  253. OLIVEIRA VH, Borsari AL, CArdenas JDG, Alves Junior CM, et al
    Low Agreement Between Initial and Revised European Consensus on Definition and Diagnosis of Sarcopenia Applied to People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002576.
    >> Share

  254. VAN BILSEN WPH, Zimmermann HML, Boyd A, Coyer L, et al
    Sexual behavior and its determinants during COVID-19 restrictions among men who have sex with men in Amsterdam.
    J Acquir Immune Defic Syndr. 2020 Nov 18. doi: 10.1097/QAI.0000000000002581.
    >> Share

  255. SEKIZIYIVU AB, Bancroft E, Rodriguez EM, Sendagala S, et al
    Task shifting for initiation and monitoring of antiretroviral therapy for HIV-infected adults in Uganda: The SHARE Trial.
    J Acquir Immune Defic Syndr. 2020 Nov 17. doi: 10.1097/QAI.0000000000002567.
    >> Share

  256. MACGIBBON J, Lea T, Ellard J, Murphy D, et al
    Access to subsidised healthcare affects HIV pre-exposure prophylaxis (PrEP) uptake among gay and bisexual men in Australia: results of national surveys 2013-19.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002572.
    >> Share

  257. ABDO M, Langan SJ, MaWhinney S, Sun J, et al
    The Effect of Statin Therapy on Age-Associated Changes in Physical Function Among Men With and Without HIV in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2020 Nov 16. doi: 10.1097/QAI.0000000000002579.
    >> Share

  258. BOGART LM, Ojikutu BO, Tyagi K, Klein DJ, et al
    COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002570.
    >> Share

  259. MULATO A, Acosta R, Chang S, Martin R, et al
    Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002562.
    >> Share

  260. SCHNITTMAN SR, Zepf R, Cocohoba J, Sears D, et al
    Heplisav-B Seroprotection in People with HIV: A Single-Center Experience.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002573.
    >> Share

  261. ATKINS K, Rucinski K, Mudavanhu M, Holmes L, et al
    Sexual Relationship Types, Partner HIV Self-Testing, and Pre-Exposure Prophylaxis Among South African Adolescent Girls and Young Women: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002569.
    >> Share

  262. GOSWAMI S, Hu X, Chen Q, Qiu J, et al
    Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T cells: Identification of a Novel Anti-Viral MicroRNA.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002565.
    >> Share

  263. CASALE M, Cluver L, Boyes M, Toska E, et al
    Bullying and ART non-adherence among South African adolescents living with HIV: effects, risk and protective factors.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002574.
    >> Share

  264. JOHNSON LM, Green HD Jr, Koch B, Stockman JK, et al
    Role of social networks and social norms in future PrEP use in a racially-diverse sample of at-risk women and members of their social networks.
    J Acquir Immune Defic Syndr. 2020 Nov 9. doi: 10.1097/QAI.0000000000002571.
    >> Share

  265. BERES LK, Schwartz S, Simbeza S, McGready J, et al
    Patterns and Predictors of Incident Return to HIV Care Among Traced, Disengaged Patients in Zambia: Analysis of a prospective cohort.
    J Acquir Immune Defic Syndr. 2020 Nov 4. doi: 10.1097/QAI.0000000000002554.
    >> Share

  266. BULTERYS MA, Sharma M, Mugwanya K, Stein G, et al
    Correlates of HIV status non-disclosure by pregnant women living with HIV to their male partners in Uganda: a cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002566.
    >> Share

  267. PIZZIRUSSO M, Carrion-Park C, Clark US, Gonzalez J, et al
    Physical and mental health screening in a New York City HIV cohort during the COVID-19 pandemic: A preliminary report.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002564.
    >> Share

  268. MAYER ME, White E, Montano MA, Lama JR, et al
    Sexual Behavior among Men Who Have Sex with Men: the Need for More Targeted Outreach to Men Who Also Have Sex with Cisgender Women.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002568.
    >> Share

  269. MIMIAGA MJ, Hughto JMW, Klasko-Foster L, Jin H, et al
    Substance use, mental health problems, and physical and sexual violence additively increase HIV risk between male sex workers and their male clients in Northeastern United States.
    J Acquir Immune Defic Syndr. 2020 Nov 2. doi: 10.1097/QAI.0000000000002563.
    >> Share

  270. SUMMERS NA, Lahiri CD, Angert CD, Aldredge A, et al
    Metabolic Changes Associated With the Use of Integrase Strand Transfer Inhibitors Among Virally Controlled Women.
    J Acquir Immune Defic Syndr. 2020;85:355-362.
    >> Share

  271. BEBELL LM, Siedner MJ, Ngonzi J, Le MH, et al
    Brief Report: Chronic Placental Inflammation Among Women Living With HIV in Uganda.
    J Acquir Immune Defic Syndr. 2020;85:320-324.
    >> Share

    October 2020
  272. ZHAO H, Li J, Li S, Wang Y, et al
    Comparative analysis of presentation and outcome after liver resection of patients with hepatocellular carcinoma with and without HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002561.
    >> Share

  273. CHAHINE A, Koru-Sengul T, Feaster DJ, Dilworth SE, et al
    Blue Monday: Co-Occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
    J Acquir Immune Defic Syndr. 2020 Oct 30. doi: 10.1097/QAI.0000000000002560.
    >> Share

  274. KUNIHOLM MH, Bramah-Lawani M, Fitzpatrick M, Nouraie M, et al
    Association of monocyte migration marker CD11b with pulmonary function in people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002544.
    >> Share

  275. ROTH AM, Tran NK, Felsher MA, Gadegbeku AB, et al
    Integrating HIV pre-exposure prophylaxis with community-based syringe services for women who inject drugs: Results from the Project SHE demonstration study.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002558.
    >> Share

  276. RUDERMAN SA, Crane HM, Nance RM, Whitney BM, et al
    Weight gain following antiretroviral therapy (ART) initiation in ART-naive people living with HIV in the current treatment era.
    J Acquir Immune Defic Syndr. 2020 Oct 28. doi: 10.1097/QAI.0000000000002556.
    >> Share

  277. SCHNEIDER JA, Young L, Ramachandran A, Michaels S, et al
    A Pragmatic Randomized Controlled Trial to Increase Pre-Exposure Prophylaxis Uptake for HIV prevention: 55-week results from PrEPChicago.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002518.
    >> Share

  278. EHRENKRANZ P, Grimsrud A, Holmes CB, Preko P, et al
    Expanding the vision for differentiated service delivery: a call for more inclusive and truly patient-centered care for people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002549.
    >> Share

  279. DAVIS SM, Habel MA, Pretorius C, Yu T, et al
    Modeling the Impact of Voluntary Medical Male Circumcision (VMMC) on Cervical Cancer in Uganda.
    J Acquir Immune Defic Syndr. 2020 Oct 23. doi: 10.1097/QAI.0000000000002552.
    >> Share

  280. TEIXEIRA DA SILVA D, Bouris A, Ramachandran A, Blocker O, et al
    Embedding a Linkage to Pre-Exposure Prophylaxis (PrEP) Care Intervention in Social Network Strategy and Partner Notification Services: Results from a Pilot Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002548.
    >> Share

  281. GOYAL R, Hu C, Klein PW, Hotchkiss J, et al
    DEVELOPMENT OF A MATHEMATICAL MODEL TO ESTIMATE THE COST-EFFECTIVENESS OF THE RYAN WHITE HIV/AIDS PROGRAM.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002546.
    >> Share

  282. SRINIVASAN K, Heylen E, Raj T, Nyblade L, et al
    Reduction in stigma drivers partially mediates the effect of a stigma reduction intervention among nursing students in India: The DriSti cluster randomized controlled trial.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002543.
    >> Share

  283. HOOVER KW, Khalil GM, Cadwell BL, Rose CE, et al
    Benchmarks for HIV Testing: What is Needed to Achieve Universal Testing Coverage at U.S. Ambulatory Healthcare Facilities.
    J Acquir Immune Defic Syndr. 2020 Oct 22. doi: 10.1097/QAI.0000000000002553.
    >> Share

  284. GANESH P, Heller T, Chione B, Gumulira J, et al
    NEAR POINT OF CARE HIV VIRAL LOAD: TARGETED TESTING AT LARGE FACILITIES.
    J Acquir Immune Defic Syndr. 2020 Oct 21. doi: 10.1097/QAI.0000000000002555.
    >> Share

  285. GHARE SS, Chilton PM, Rao AV, Joshi-Barve S, et al
    Epigenetic mechanisms underlying HIV-Infection induced susceptibility of CD4+ T cells to enhanced activation-induced FasL expression and cell death.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002526.
    >> Share

  286. BRAUNSTEIN SL, Robbins RS, Ramaswamy C, Daskalakis D, et al
    DRUG OVERDOSE DEATHS AMONG PEOPLE WITH HIV IN NEW YORK CITY, 2007-2017.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002545.
    >> Share

  287. PHILLIPS TR, Fairley CK, Bradshaw FAChSHM CS, Hocking JS, et al
    Group sex among men who have sex with men in the era of PrEP: A cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002550.
    >> Share

  288. TRUONG HM, Mehrotra ML, Grant RM
    Seroadaptive Behaviors Varied among Geographically-Diverse iPrEx Participants.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002551.
    >> Share

  289. GOYAL R, Luca D, Klein P, Morris E, et al
    Cost-Effectiveness of the Health Resources and Services Administration's Ryan White HIV/AIDS Program.
    J Acquir Immune Defic Syndr. 2020 Oct 19. doi: 10.1097/QAI.0000000000002547.
    >> Share

  290. GEIDELBERG L, Mitchell KM, Alary M, Mboup A, et al
    A mathematical model impact analysis of a real-life pre-exposure prophylaxis and treatment-as-prevention study among female sex workers in Cotonou, Benin.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002535.
    >> Share

  291. MODY A, Sikombe K, Beres LK, Simbeza S, et al
    Profiles of HIV Care Disruptions Among Adult Patients Lost to Follow-up in Zambia: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002530.
    >> Share

  292. VERHEIJ E, Wit FW, Verboeket SO, Schim van der Loeff MF, et al
    Frequency, risk factors and mediators of frailty transitions during long-term follow-up among people with HIV and HIV-negative AGEhIV Cohort participants.
    J Acquir Immune Defic Syndr. 2020 Oct 16. doi: 10.1097/QAI.0000000000002532.
    >> Share

  293. HU R, Yan H, Liu M, Tang L, et al
    Virologic and immunologic outcomes for HIV patients with coronavirus disease 2019.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002540.
    >> Share

  294. WOZNICA DM, Fernando NB, Bonomo EJ, Owczarzak J, et al
    Interventions to improve HIV care continuum outcomes among individuals released from prison or jail: Systematic literature review.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002523.
    >> Share

  295. AMELE S, Peters L, Rodger A, Lundgren J, et al
    Effectiveness and safety of IFN-free DAA HCV therapy in HIV/HCV co-infected persons: Results from a pan-European study.
    J Acquir Immune Defic Syndr. 2020 Oct 15. doi: 10.1097/QAI.0000000000002541.
    >> Share

  296. AFFI R, Gabillard D, Dunyach-Remy C, Ntakpe JB, et al
    0.1. Association of plasma sVCAM-1 and sCD14 with mortality in HIV-1 infected West African adults with high CD4 counts.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002533.
    >> Share

  297. MCLAUGHLIN TA, Nizam A, Hayara FO, Ouma GS, et al
    Schistosoma mansoni infection is associated with a higher probability of tuberculosis disease in HIV-infected adults in Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002536.
    >> Share

  298. AGUILERA-ALONSO D, Sainz T, Jimenez DE Ory S, Bernardino I, et al
    Clinical, Immunological and Virological Outcomes among youths with perinatal HIV after Transition to Adult Units in Spain from 1997 to 2016.
    J Acquir Immune Defic Syndr. 2020 Oct 14. doi: 10.1097/QAI.0000000000002539.
    >> Share

  299. CALZA L, Bon I, Borderi M, Colangeli V, et al
    COVID-19 OUTCOMES IN PATIENTS WITH UNCONTROLLED HIV-1 INFECTION.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002537.
    >> Share

  300. ECKARD AR, Hughes HY, Hagood NL, O'Riordan MA, et al
    Fecal Calprotectin is Elevated in HIV and Related to Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 13. doi: 10.1097/QAI.0000000000002538.
    >> Share

  301. SACHDEV D, Mara E, Hsu L, Scheer S, et al
    COVID-19 Susceptibility and Outcomes among People Living with HIV in San Francisco.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002531.
    >> Share

  302. SHARMA M, Kariithi E, Kemunto E, Otieno G, et al
    High acceptability of assisted partner notification services among HIV-positive females in Kenya: Results from an ongoing implementation study.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002527.
    >> Share

  303. PETERS M, Margevicius S, Kityo C, Mirembe G, et al
    The Association of Kidney Disease with Abnormal Cardiac Structure and Function among Ugandans with HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Oct 8. doi: 10.1097/QAI.0000000000002529.
    >> Share

  304. ALBAUGH NW, Nonyane BAS, Mmolawa L, Siwelana T, et al
    Proportion and predictors of adult TB contacts accepting HIV testing during an active TB case finding intervention in South Africa.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002509.
    >> Share

  305. HAMMOUD MA, Grulich A, Holt M, Maher L, et al
    Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia: Results from a prospective observational study of gay and bisexual men.
    J Acquir Immune Defic Syndr. 2020 Oct 7. doi: 10.1097/QAI.0000000000002514.
    >> Share

  306. DE BAETSELIER I, Tsoumanis A, Florence E, Van den Berghe W, et al
    Did pre-exposure prophylaxis roll-out influence the epidemic of rectal lymphogranuloma venereum in Belgium? Results from the national surveillance system.
    J Acquir Immune Defic Syndr. 2020 Oct 6. doi: 10.1097/QAI.0000000000002524.
    >> Share

  307. ONONO M, Odwar T, Wahome S, Helova A, et al
    Behavioral interventions can mitigate adverse pregnancy outcomes among women conceiving on antiretroviral therapy (ART) and those initiated on ART during pregnancy: Findings from the MOTIVATE trial in southwestern Kenya.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002521.
    >> Share

  308. JIN H, Biello K, Garofalo R, Lurie M, et al
    Examining the longitudinal predictive relationship between HIV treatment outcomes and pre-exposure prophylaxis use by serodiscordant male couples.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002522.
    >> Share

  309. FABBIANI M, Borghetti A, Squillace N, Colafigli M, et al
    INTEGRASE INHIBITORS USE AND CMV INFECTION PREDICT IMMUNE RECOVERY IN PEOPLE LIVING WITH HIV STARTING FIRST-LINE THERAPY.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002525.
    >> Share

  310. KAPITO-TEMBO AP, Bauleni A, Wesevich A, Ongubo D, et al
    Growth and neurodevelopment outcomes in HIV, tenofovir and efavirenz exposed breastfed infants in PMTCT Option B+ program in Malawi.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002515.
    >> Share

  311. STRATHDEE SA, Martin NK, Pitpitan EV, Stockman JK, et al
    What the HIV Pandemic Experience can Teach the U.S. about the COVID-19 Response.
    J Acquir Immune Defic Syndr. 2020 Oct 5. doi: 10.1097/QAI.0000000000002520.
    >> Share

  312. RAJU S, McCormack MC, Drummond MB, Ramamurthi HC, et al
    Association of Lung Function With HIV-Related Quality of Life and Health Care Utilization in a High-Risk Cohort.
    J Acquir Immune Defic Syndr. 2020;85:219-226.
    >> Share

  313. MACCARTHY S, Wagner Z, Barreras JL, Kim A, et al
    Brief Report: Using Behavioral Economics to Increase HIV Knowledge and Testing Among Latinx Sexual Minority Men and Transgender Women: A Quasi-Experimental Pilot Study.
    J Acquir Immune Defic Syndr. 2020;85:189-194.
    >> Share

  314. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Reclassification of Statin Indication Among People Living With HIV Using Coronary Artery Calcium Scoring.
    J Acquir Immune Defic Syndr. 2020;85:e26-e29.
    >> Share

  315. SURIAL B, Beguelin C, Chave JP, Stockle M, et al
    Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
    J Acquir Immune Defic Syndr. 2020;85:227-232.
    >> Share

  316. BHARTI AR, McCutchan JA, Umlauf A, Okwuegbuna OK, et al
    Asymptomatic Malaria Co-infection of HIV-infected Adults in Nigeria: Prevalence of and Impact on Cognition, Mood and Biomarkers of Systemic Inflammation.
    J Acquir Immune Defic Syndr. 2020 Oct 1. doi: 10.1097/QAI.0000000000002516.
    >> Share

    September 2020
  317. HICKEY MD, Ayieko J, Kwarisiima D, Opel FJ, et al
    Improved Viral Suppression with Streamlined Care in the SEARCH Study.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002508.
    >> Share

  318. HARGREAVES JR, Pliakas T, Hoddinott G, Mainga T, et al
    HIV stigma and viral suppression among people living with HIV in the context of universal test and treat: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.
    J Acquir Immune Defic Syndr. 2020 Sep 24. doi: 10.1097/QAI.0000000000002504.
    >> Share

  319. WANGA V, Mackelprang RD, Thomas KK, Donnell D, et al
    Bacterial vaginosis and risk of HIV infection in the context of CD101 gene variation.
    J Acquir Immune Defic Syndr. 2020 Sep 18. doi: 10.1097/QAI.0000000000002505.
    >> Share

  320. WU L, Schumacher C, Chandran A, Fields E, et al
    Patterns of PrEP Retention among HIV Pre-Exposure Prophylaxis Users in Baltimore City, Maryland.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002506.
    >> Share

  321. THIVALAPILL N, Jasumback CL, Perry SH, Dlamini L, et al
    Predicting Sexually Transmitted Infections Among HIV+ Adolescents and Young Adults: A Novel Risk Score to Augment Syndromic Management in Eswatini.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002512.
    >> Share

  322. AHRENSTORF G, Jablonka A, Ernst D, Bange FC, et al
    Improved prognosis of infection with M. genavense in immune compromized HIV patients after introduction of combined antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Sep 15. doi: 10.1097/QAI.0000000000002513.
    >> Share

  323. VITELLI M, Mazelle H, Joncour AL, Amelot A, et al
    A Diagnosis Can Hide Another: The Value of Brain Biopsy in Neurological Lesion of HIV Patients.
    J Acquir Immune Defic Syndr. 2020 Sep 14. doi: 10.1097/QAI.0000000000002511.
    >> Share

  324. ANDERSON AM, Jang JH, Easley KA, Fuchs D, et al
    Cognitive and neuronal link with inflammation: a longitudinal study in people with and without HIV infection.
    J Acquir Immune Defic Syndr. 2020 Sep 11. doi: 10.1097/QAI.0000000000002484.
    >> Share

  325. MUGO C, Wang J, Begnel ER, Njuguna IN, et al
    Home- and clinic-based pediatric HIV index case testing in Kenya: Uptake, HIV prevalence, linkage to care, and missed opportunities.
    J Acquir Immune Defic Syndr. 2020 Sep 11. doi: 10.1097/QAI.0000000000002500.
    >> Share

  326. JIMENEZ-SOUSA MA, Jimenez JL, Bellon JM, Fernandez-Rodriguez A, et al
    CYP27B1 rs10877012 T allele was linked to non-AIDS progression in ART-naive HIV-infected patients: a retrospective study.
    J Acquir Immune Defic Syndr. 2020 Sep 11. doi: 10.1097/QAI.0000000000002485.
    >> Share

  327. HSIEH YL, Jahn A, Menzies NA, Yaesoubi R, et al
    An evaluation of 6-month versus continuous isoniazid preventive therapy for M. tuberculosis in adults living with HIV/AIDS in Malawi.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002497.
    >> Share

  328. CLARKE DF, Lommerse J, Acosta EP, Cababasay MP, et al
    IMPACT OF LOW BIRTH WEIGHT AND PREMATURITY ON NEONATAL RALTEGRAVIR PHARMACOKINETICS: IMPAACT P1097.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002492.
    >> Share

  329. SPRING S, O'Bryan J, McMahon J, Woolley I, et al
    Acceptability of injectable anti-retroviral therapy in Australian travellers with HIV.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002501.
    >> Share

  330. MARTIN EA, Lai MT, Ngo W, Feng M, et al
    Review of Doravirine Resistance Patterns Identified in Participants During Clinical Development.
    J Acquir Immune Defic Syndr. 2020 Sep 9. doi: 10.1097/QAI.0000000000002496.
    >> Share

  331. YANUAR SAFRI A, Gaff J, Octaviana F, Dewanto Setiawan D, et al
    Demographic and genetic associations with markers of small and large fibre sensory neuropathy in HIV patients treated without stavudine.
    J Acquir Immune Defic Syndr. 2020 Sep 7. doi: 10.1097/QAI.0000000000002503.
    >> Share

  332. GATECHOMPOL S, Teeratakulpisarn N, Wittawatmongkol O, Teeraananchai S, et al
    Incidence, persistence, and factors associated with HPV infection among male adolescents with and without perinatally acquired HIV infection.
    J Acquir Immune Defic Syndr. 2020 Sep 4. doi: 10.1097/QAI.0000000000002499.
    >> Share

  333. MCCREE DH, Chesson HW, Eppink ST, Beer L, et al
    Changes in Racial and Ethnic Disparities in Estimated Diagnosis Rates of Heterosexually-acquired HIV Infection among Heterosexual Males in the United States, 2014-2018.
    J Acquir Immune Defic Syndr. 2020 Sep 4. doi: 10.1097/QAI.0000000000002495.
    >> Share

  334. BALLIVIAN J, Alcaide ML, Cecchini D, Jones DL, et al
    Impact of COVID-19-related stress and lockdown on mental health among people living with HIV in Argentina.
    J Acquir Immune Defic Syndr. 2020 Sep 3. doi: 10.1097/QAI.0000000000002493.
    >> Share

  335. CYRUS M, Katherine W, Alvin O, Irene NN, et al
    Time to repeat viral load testing among unsuppressed adolescents and young adults living with HIV in Kenya.
    J Acquir Immune Defic Syndr. 2020 Sep 3. doi: 10.1097/QAI.0000000000002498.
    >> Share

  336. ANSARI AW, Ahmad F, Shankar EM, Yong YK, et al
    Brief Report: Diminished Coinhibitory Molecule 2B4 Expression Is Associated With Preserved iNKT Cell Phenotype in HIV Long-Term Nonprogressors.
    J Acquir Immune Defic Syndr. 2020;85:73-78.
    >> Share

  337. SHEKHAR R, Barton A, Sheikh AB, Upadhyay S, et al
    Coronavirus Disease of 2019 in Patients With Well-Controlled Human Immunodeficiency Virus on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;85:e1-e4.
    >> Share

    August 2020
  338. DIAZ P, Ferketich A, Wewers ME, Browning K, et al
    INCREASED COTININE CONCENTRATIONS ARE ASSOCIATED WITH REDUCED EXPRESSION OF CATHELICIDIN (LL-37) AND NOD-2 in ALVEOLAR MACROPHAGES OF PLWH WHO SMOKE.
    J Acquir Immune Defic Syndr. 2020 Aug 25. doi: 10.1097/QAI.0000000000002491.
    >> Share

  339. POTEAT TC, Reisner SL, Miller M, Wirtz AL, et al
    Letter to the Editor: Vulnerability to COVID-19-related Harms Among Transgender Women With and Without HIV Infection in the Eastern and Southern U.S.
    J Acquir Immune Defic Syndr. 2020 Aug 25. doi: 10.1097/QAI.0000000000002490.
    >> Share

  340. FRANCIS F, Gough EK, Edens TJ, Berejena C, et al
    Cessation of long-term cotrimoxazole prophylaxis in HIV-infected children does not alter the carriage of antimicrobial resistance genes.
    J Acquir Immune Defic Syndr. 2020 Aug 25. doi: 10.1097/QAI.0000000000002489.
    >> Share

  341. MOORE JR, Donnell DJ, Boily MC, Mitchell KM, et al
    Model-based predictions of HIV incidence among African women using HIV risk behaviors and community-level data on male HIV prevalence and viral suppression.
    J Acquir Immune Defic Syndr. 2020 Aug 24. doi: 10.1097/QAI.0000000000002481.
    >> Share

  342. DANIELA K VS, Paul A A, Joseph S, Christopher FK, et al
    The impact of markers of HIV infection on change in liver stiffness in people with HIV and hepatitis C virus co-infection after treatment and cure of hepatitis C.
    J Acquir Immune Defic Syndr. 2020 Aug 24. doi: 10.1097/QAI.0000000000002487.
    >> Share

  343. JEAN LOUIS F, Domercant JW, Ignacio C, Gianella S, et al
    High Prevalence of HIV-1 Drug Resistance and Dynamics of Transmission Among High-Risk Populations in Port-au-Prince, Haiti.
    J Acquir Immune Defic Syndr. 2020 Aug 24. doi: 10.1097/QAI.0000000000002475.
    >> Share

  344. HEBEL S, Kahn-Woods E, Malone-Thomas S, McNeese M, et al
    Discrepancies between self-reported adherence and a biomarker of adherence in real-world settings.
    J Acquir Immune Defic Syndr. 2020 Aug 20. doi: 10.1097/QAI.0000000000002486.
    >> Share

  345. XIA Y, Greenwald ZR, Milwid RM, Claire T, et al
    Pre-exposure prophylaxis uptake among men who have sex with men who used non-occupational post-exposure prophylaxis: a longitudinal analysis of attendees at a large sexual health clinic in Montreal (Canada).
    J Acquir Immune Defic Syndr. 2020 Aug 19. doi: 10.1097/QAI.0000000000002472.
    >> Share

  346. BOYD AT, Odume B, Sidibe K, Onotu D, et al
    Programmatic scale-up of tuberculosis preventive treatment among people living with HIV through targeted technical assistance to high-volume antiretroviral treatment sites-Nigeria, 2018-2019.
    J Acquir Immune Defic Syndr. 2020 Aug 19. doi: 10.1097/QAI.0000000000002483.
    >> Share

  347. MANSERGH G, Stephenson R, Hirshfield S, Sullivan P, et al
    Understanding HIV Sexual Protection and Its Association with Substance Use During Sex among MSM in an Era of Multiple Primary Prevention Products.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002480.
    >> Share

  348. LUCAS GM, Atta MG, Zook K, Vaidya D, et al
    Cross-sectional and longitudinal performance of creatinine- and cystatin C-based estimating equations relative to exogenously measured glomerular filtration rate in HIV-positive and HIV-negative persons.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002471.
    >> Share

  349. RODRIGUEZ VJ, Zegarac M, La Barrie DL, Parrish MS, et al
    Validation of the Bayley Infant Neurodevelopmental Screener among HIV-exposed infants in rural South Africa.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002479.
    >> Share

  350. CONTE M, Eshun-Wilson I, Geng E, Imbert E, et al
    Understanding preferences for HIV care among patients experiencing homelessness or unstable-housing: A discrete choice experiment.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002476.
    >> Share

  351. SIEWE FODJO JN, Faria de Moura Villela E, Van Hees S, Tiberio Dos Santos T, et al
    Impact of the COVID-19 pandemic on the medical follow-up and psychosocial well-being of people living with HIV: A cross-sectional survey.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002468.
    >> Share

  352. ANDA S, Njoroge A, Njuguna R, Dunbar MD, et al
    Predictors of first-time and repeat HIV testing among HIV positive individuals in Kenya.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002469.
    >> Share

  353. THORBALL CW, Borghesi A, Bachmann N, Von Siebenthal C, et al
    Host genomics of the HIV-1 reservoir size and its decay rate during suppressive antiretroviral treatment.
    J Acquir Immune Defic Syndr. 2020 Aug 18. doi: 10.1097/QAI.0000000000002473.
    >> Share

  354. CALON M, Menon K, Carr A, Henry RG, et al
    Additive and Synergistic Cardiovascular Disease Risk Factors and HIV Disease Markers' Effects on White Matter Microstructure in Virally Suppressed HIV.
    J Acquir Immune Defic Syndr. 2020;84:543-551.
    >> Share

  355. VECCHIO A, Robertson K, Saylor D, Nakigozi G, et al
    Neurocognitive Effects of Antiretroviral Initiation Among People Living With HIV in Rural Uganda.
    J Acquir Immune Defic Syndr. 2020;84:534-542.
    >> Share

  356. AUDSLEY J, Avihingsanon A, Littlejohn M, Bowden S, et al
    Long-Term TDF-Inclusive ART and Progressive Rates of HBsAg Loss in HIV-HBV Coinfection-Lessons for Functional HBV Cure?
    J Acquir Immune Defic Syndr. 2020;84:527-533.
    >> Share

  357. SUN-SUSLOW N, Paolillo EW, Morgan EE, Letendre S, et al
    Brief Report: Frailty and HIV Disease Severity Synergistically Increase Risk of HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2020;84:522-526.
    >> Share

  358. DE ALMEIDA SM, Ribeiro CE, Tang B, de Pereira AP, et al
    Neurocytoskeleton Proteins in Cerebrospinal Fluid of People With HIV-1 Subtypes B and C.
    J Acquir Immune Defic Syndr. 2020;84:514-521.
    >> Share

  359. EGAN JE, Ho K, Stall R, Drucker MT, et al
    Feasibility of Short-Term PrEP Uptake for Men Who Have Sex With Men With Episodic Periods of Increased HIV Risk.
    J Acquir Immune Defic Syndr. 2020;84:508-513.
    >> Share

  360. HIRSCHHORN LR, Brown RN, Friedman EE, Greene GJ, et al
    Black Cisgender Women's PrEP Knowledge, Attitudes, Preferences, and Experience in Chicago.
    J Acquir Immune Defic Syndr. 2020;84:497-507.
    >> Share

  361. ANDRASIK MP, Sesay FA, Isaacs A, Oseso L, et al
    Social Impacts Among Participants in HIV Vaccine Trial Network (HVTN) Preventive HIV Vaccine Trials.
    J Acquir Immune Defic Syndr. 2020;84:488-496.
    >> Share

  362. NAUGLE DA, Dosso A, Tibbels NJ, Van Lith LM, et al
    Addressing Uptake of HIV Testing and Linkage to Care Among Men in Cote d'Ivoire: An Evaluation of the Brothers for Life Program Implementation.
    J Acquir Immune Defic Syndr. 2020;84:480-487.
    >> Share

  363. MA H, Wang L, Gichangi P, Mochache V, et al
    Venue-Based HIV Testing at Sex Work Hotspots to Reach Adolescent Girls and Young Women Living With HIV: A Cross-sectional Study in Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2020;84:470-479.
    >> Share

  364. MURENZI G, Kim HY, Munyaneza A, Tuyisenge P, et al
    Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men.
    J Acquir Immune Defic Syndr. 2020;84:463-469.
    >> Share

  365. ZHANG W, Hu Q, Tang W, Jin X, et al
    HIV Self-Testing Programs to Men Who Have Sex With Men Delivered by Social Media Key Opinion Leaders and Community-Based Organizations are Both Effective and Complementary: A National Pragmatic Study in China.
    J Acquir Immune Defic Syndr. 2020;84:453-462.
    >> Share

  366. DASGUPTA S, Tie Y, Bradley H, Beer L, et al
    Characteristics of Sexual Partnerships Among Men With Diagnosed HIV Who Have Sex With Men, United States and Puerto Rico-2015-2019.
    J Acquir Immune Defic Syndr. 2020;84:443-452.
    >> Share

  367. SEVELIUS JM, Poteat T, Luhur WE, Reisner SL, et al
    HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    J Acquir Immune Defic Syndr. 2020;84:437-442.
    >> Share

  368. BK K, Tiwari S, Chhapola V, Debnath E, et al
    Subclinical kidney dysfunction in HIV infected children: a cross-sectional study.
    J Acquir Immune Defic Syndr. 2020 Aug 5. doi: 10.1097/QAI.0000000000002470.
    >> Share

  369. CANETTI D, Galli L, Gianotti N, Celotti A, et al
    Simplification to High Genetic Barrier 2-Drug Regimens in People Living With HIV Harboring 4-Class Resistance Enrolled in the PRESTIGIO Registry.
    J Acquir Immune Defic Syndr. 2020;84:e24-e28.
    >> Share

  370. LI MJ, Su E, Garland WH, Oksuzyan S, et al
    Trajectories of Viral Suppression in People Living With HIV Receiving Coordinated Care: Differences by Comorbidities.
    J Acquir Immune Defic Syndr. 2020;84:387-395.
    >> Share

  371. NERLANDER LM, Handanagic S, Hess KL, Lutnick A, et al
    HIV Prevalence Among Women Who Exchange Sex for Money or Drugs-4 U.S. Cities.
    J Acquir Immune Defic Syndr. 2020;84:345-354.
    >> Share

  372. HARRIS M, Brouillette MJ, Scott SC, Smaill F, et al
    Impact of Loneliness on Brain Health and Quality of Life Among Adults Living With HIV in Canada.
    J Acquir Immune Defic Syndr. 2020;84:336-344.
    >> Share

  373. WANG L, Tan DHS, Mishra S
    Evidence of Nonrandom Mixing by Pre-exposure Prophylaxis Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2016 to 2018.
    J Acquir Immune Defic Syndr. 2020;84:e22-e23.
    >> Share

    July 2020
  374. HAMMOUD MA, Maher L, Holt M, Degenhardt L, et al
    Physical distancing due to COVID-19 disrupts sexual behaviours among gay and bisexual men in Australia: Implications for trends in HIV and other sexually transmissible infections.
    J Acquir Immune Defic Syndr. 2020 Jul 29. doi: 10.1097/QAI.0000000000002462.
    >> Share

  375. MCCLEAN M, Buzkova P, Budoff M, Estrella M, et al
    Cystatin C based estimation of glomerular filtration rate and association with atherosclerosis imaging markers in people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jul 27. doi: 10.1097/QAI.0000000000002467.
    >> Share

  376. BOARD AR, Oster AM, Song R, Gant Z, et al
    Geographic distribution of HIV transmission networks in the United States.
    J Acquir Immune Defic Syndr. 2020 Jul 27. doi: 10.1097/QAI.0000000000002448.
    >> Share

  377. VALLABHAJOSYULA S, Subramaniam AV, Sundaragiri PR, Cheungpasitporn W, et al
    Influence of Human Immunodeficiency Virus Infection on the Management and Outcomes of Acute Myocardial Infarction with Cardiogenic Shock.
    J Acquir Immune Defic Syndr. 2020 Jul 27. doi: 10.1097/QAI.0000000000002442.
    >> Share

  378. SINHA A, Mystakelis H, Rivera AS, Manion M, et al
    Association of low CD4/CD8 ratio with Adverse Cardiac Mechanics in Lymphopenic HIV-Infected Adults.
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002465.
    >> Share

  379. PELLOQUIN R, Abdo M, MaWhinney S, Jankowski CM, et al
    Physical Function and Frailty Tools in Mortality Prediction of Middle-Aged Adults with HIV.
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002455.
    >> Share

  380. EUBANKS A, Dembele Keita B, Anoma C, Dah E, et al
    Reaching a different population of MSM in West Africa with the integration of PrEP into a comprehensive prevention package. (CohMSM-PrEP ANRS 12369 - Expertise France).
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002453.
    >> Share

  381. SHRESTHA RK, Schommer JC, Taitel MS, Garza OW, et al
    Costs and cost-effectiveness of the Patient-centered HIV Care Model: A collaboration between community-based pharmacists and primary medical providers.
    J Acquir Immune Defic Syndr. 2020 Jul 23. doi: 10.1097/QAI.0000000000002458.
    >> Share

  382. GROV C, Westmoreland D, Morrison C, Carrico AW, et al
    The crisis we are not talking about: One-in-three annual HIV seroconversions among sexual and gender minorities were persistent methamphetamine users.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002461.
    >> Share

  383. HAN WM, Bijker R, Chandrasekaran E, Pujari S, et al
    Validation of the D: A: D Chronic Kidney Disease Risk Score Model among people living with HIV in the Asia-Pacific.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002464.
    >> Share

  384. MILLER L, Morar N, Kapiga S, Ramjee G, et al
    Prevention, Partners, and Power Imbalances: Women's views on how male partners affected their adherence to vaginal microbicide gels during HIV prevention trials in Africa.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002463.
    >> Share

  385. MANN SC, Morrow M, Coyle RP, Coleman SS, et al
    Lower Cumulative Antiretroviral Exposure in People Living with Hiv and Diabetes Mellitus.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002460.
    >> Share

  386. GAO G, Wang A, Wang S, Qian F, et al
    A retrospective evaluation on the efficacy of Lopinavir/ritonavir and chloroquine to treat non-severe COVID-19 patients.
    J Acquir Immune Defic Syndr. 2020 Jul 22. doi: 10.1097/QAI.0000000000002452.
    >> Share

  387. NARSI K, Tomita A, Ramlall S
    Cognitive reserve and its determinants in newly HIV diagnosed antiretroviral-naive adults from peri-urban and informal settlements: Evidence from an HIV hyperendemic South African setting.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002457.
    >> Share

  388. ACOSTA RK, Willkom M, Andreatta K, Liu H, et al
    Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from Dolutegravir (DTG)+F/TAF or DTG+F/Tenofovir Disoproxil Fumarate (TDF) in the Presence of Pre-Existing NRTI Resistance.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002454.
    >> Share

  389. JOHN SA, Petroll AE, Walsh JL, Quinn KG, et al
    Reducing the discussion divide by digital questionnaires in healthcare settings: Disruptive innovation for HIV testing and pre-exposure prophylaxis (PrEP) screening.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002459.
    >> Share

  390. PAIROJ C, Weerayut T, Sarawut S, Sudarat S, et al
    Echocardiographic findings among virally suppressed HIV-infected Aging Asians compared to HIV-negative individuals.
    J Acquir Immune Defic Syndr. 2020 Jul 21. doi: 10.1097/QAI.0000000000002456.
    >> Share

  391. PEEBLES K, Palanee-Phillips T, Balkus JE, Beesham I, et al
    Age-specific risk scores do not improve HIV-1 prediction among women in South Africa.
    J Acquir Immune Defic Syndr. 2020 Jul 17. doi: 10.1097/QAI.0000000000002436.
    >> Share

  392. KEEN P, Lee E, Grulich AE, Prestage G, et al
    Sustained, low prevalence of undiagnosed HIV among gay and bisexual men in Sydney, Australia coincident with increased testing and pre-exposure prophylaxis use: results from repeated, bio-behavioural studies 2014-2018.
    J Acquir Immune Defic Syndr. 2020 Jul 17. doi: 10.1097/QAI.0000000000002451.
    >> Share

  393. JANKOWSKI CM, Mawhinney S, Wilson MP, Campbell TB, et al
    Body Composition Changes in Response to Moderate or High-Intensity Exercise Among Older Adults with or without HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jul 16. doi: 10.1097/QAI.0000000000002443.
    >> Share

  394. O'BRIEN BE, Williams PL, Huo Y, Kacanek D, et al
    Repeat Pregnancies Among US Women Living with HIV in the SMARTT Study: Temporal Changes in HIV Disease Status and Predictors of Preterm Birth.
    J Acquir Immune Defic Syndr. 2020 Jul 16. doi: 10.1097/QAI.0000000000002445.
    >> Share

  395. VAN WYK J, Orkin C, Rubio R, Bogner J, et al
    Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and -2 Randomized Clinical Trials.
    J Acquir Immune Defic Syndr. 2020 Jul 13. doi: 10.1097/QAI.0000000000002449.
    >> Share

  396. GUDIPATI S, Brar I, Murray S, McKinnon JE, et al
    Descriptive Analysis of Patients Living with HIV Affected By COVID-19.
    J Acquir Immune Defic Syndr. 2020 Jul 13. doi: 10.1097/QAI.0000000000002450.
    >> Share

  397. TORDOFF DM, Barbee LA, Khosropour CM, Hughes JP, et al
    Derivation and Validation of an HIV Risk Prediction Score Among Gay, Bisexual and Other Men Who Have Sex With Men to Inform PrEP Initiation in an STD Clinic Setting.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002438.
    >> Share

  398. STALTER R, Mugwanya K, Thomas K, Donnell D, et al
    Sexual behaviors following PrEP discontinuation among HIV serodiscordant couples in Kenya and Uganda.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002434.
    >> Share

  399. BOERWINKLE AH, Strain JF, Burdo T, Doyle J, et al
    Comparison of [11C]-PBR28 binding between persons living with HIV and HIV uninfected individuals.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002435.
    >> Share

  400. BRUMFIELD S, Dube A, Reniers G, Helleringer S, et al
    Comparing approaches to collecting self-reported data on HIV status in population-based surveys.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002441.
    >> Share

  401. VALLEJO A, Molina-Pinelo S, De Felipe B, Abad-Fernandez M, et al
    Toll-like receptor 9 1635A/G polymorphism is associated with HIV-1 rebound after four weeks of interruption of antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Jul 8. doi: 10.1097/QAI.0000000000002437.
    >> Share

  402. TUKEI BB, Fatti G, Tiam A, Ngorima-Mabhena N, et al
    Twelve-month outcomes of community-based differentiated models of multi-month dispensing of antiretroviral treatment among stable HIV-infected adults in Lesotho: a cluster randomized non-inferiority trial.
    J Acquir Immune Defic Syndr. 2020 Jul 7. doi: 10.1097/QAI.0000000000002439.
    >> Share

  403. BALMACEDA JB, Abd-Elmoniem KZ, Liu CY, Purdy JB, et al
    Adiponectin Levels Linked to Subclinical Myocardial Fibrosis in HIV.
    J Acquir Immune Defic Syndr. 2020 Jul 6. doi: 10.1097/QAI.0000000000002440.
    >> Share

  404. RUCINSKI KB, Schwartz SR, Mishra S, Phaswana-Mafuya N, et al
    High HIV prevalence and low HIV-service engagement among young women who sell sex: A pooled analysis across nine sub-Saharan African countries.
    J Acquir Immune Defic Syndr. 2020 Jul 3. doi: 10.1097/QAI.0000000000002432.
    >> Share

  405. SURIAL B, Beguelin C, Chave JP, Stockle M, et al
    Switching from TDF to TAF in HIV/HBV co-infected individuals with renal dysfunction - a prospective cohort study.
    J Acquir Immune Defic Syndr. 2020 Jul 2. doi: 10.1097/QAI.0000000000002429.
    >> Share


  406. Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials: Erratum.
    J Acquir Immune Defic Syndr. 2020;84:e21.
    >> Share

  407. RAMIREZ-MARRERO FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, et al
    Brief Report: Effects of Low-Volume High-Intensity Interval Training in Hispanic HIV+ Women: A Nonrandomized Study.
    J Acquir Immune Defic Syndr. 2020;84:285-289.
    >> Share

  408. PHILBIN MM, Parish CL, Kinnard EN, Reed SE, et al
    Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;84:263-270.
    >> Share

  409. MACNEAL K, Tukei V, Sacks E, Mokone M, et al
    Use of Point-of-Care Nucleic Acid Tests Beyond Early Infant Diagnosis of HIV: A Retrospective Case Review in Lesotho.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S78-S83.
    >> Share

  410. ADETUNJI O, Mukherjee S, Sacks E, Ciaranello A, et al
    Front-Line Human Resource Time-Use for Early Infant HIV Diagnosis: A Comparative Time-Motion Study at Centralized and Point-of-Care Health Facilities in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S70-S77.
    >> Share

  411. MUKHERJEE S, Cohn J, Ciaranello AL, Sacks E, et al
    Estimating the Cost of Point-of-Care Early Infant Diagnosis in a Program Setting: A Case Study Using Abbott m-PIMA and Cepheid GeneXpert IV in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S63-S69.
    >> Share

  412. ALEMNJI G, Peter T, Vojnov L, Alexander H, et al
    Building and Sustaining Optimized Diagnostic Networks to Scale-up HIV Viral Load and Early Infant Diagnosis.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S56-S62.
    >> Share

  413. KATIRAYI L, Ochuka B, Mafaune H, Chadambuka A, et al
    "We Need it the Same Day": A Qualitative Study of Caregivers and Community Members' Perspectives Toward the Use of Point-of-Care Early Infant Diagnosis.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S49-S55.
    >> Share

  414. BIANCHI F, Clemens S, Arif Z, Sacks E, et al
    Acceptability of Routine Point-of-Care Early Infant Diagnosis in Eight African Countries: Findings From a Qualitative Assessment of Clinical and Laboratory Personnel.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S41-S48.
    >> Share

  415. TCHENDJOU P, Nzima V, Lekeumo S, Sacks E, et al
    HIV Mother-to-Child Transmission in Cameroon: EID Positivity Yields and Key Risk Factors by Health Service Points After Usage of POC EID Systems.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S34-S40.
    >> Share

  416. MAFAUNE HW, Sacks E, Chadambuka A, Musarandega R, et al
    Effectiveness of Maternal Transmission Risk Stratification in Identification of Infants for HIV Birth Testing: Lessons From Zimbabwe.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S28-S33.
    >> Share

  417. KHUMALO PN, Sacks E, Chouraya C, Tsabedze B, et al
    The Cascade of Care From Routine Point-of-Care HIV Testing at Birth: Results From an 18-Months Pilot Program in Eswatini.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S22-S27.
    >> Share

  418. MCCANN NC, Cohn J, Flanagan C, Sacks E, et al
    Strengthening Existing Laboratory-Based Systems vs. Investing in Point-of-Care Assays for Early Infant Diagnosis of HIV: A Model-Based Cost-Effectiveness Analysis.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S12-S21.
    >> Share

  419. SACKS E, Cohn J, Ochuka B, Mafaune H, et al
    Impact of Routine Point-of-Care Versus Laboratory Testing for Early Infant Diagnosis of HIV: Results From a Multicountry Stepped-Wedge Cluster-Randomized Controlled Trial.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S5-S11.
    >> Share

  420. MOFENSON LM, Cohn J, Sacks E
    Challenges in the Early Infant HIV Diagnosis and Treatment Cascade.
    J Acquir Immune Defic Syndr. 2020;84 Suppl 1:S1-S4.
    >> Share

  421. YAGER J, Castillo-Mancilla J, Ibrahim ME, Brooks KM, et al
    Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.
    J Acquir Immune Defic Syndr. 2020;84:323-330.
    >> Share

  422. BOFFA JM, Fisher DA, Mayan MJ, Sauve RS, et al
    Effectiveness of Isoniazid Preventive Therapy to Reduce Tuberculosis Incidence in the Context of Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2020;84:e14-e17.
    >> Share

  423. KASPER P, Phiri S, Chaweza T, Tweya H, et al
    Ambulatory Blood Pressure Monitoring in PLHIV in Malawi: Preliminary Findings.
    J Acquir Immune Defic Syndr. 2020;84:e11-e14.
    >> Share

    June 2020
  424. LANE CE, Widen EM, Collins SM, Young SL, et al
    HIV-exposed, uninfected infants in Uganda experience poorer growth and body composition trajectories than HIV-unexposed infants.
    J Acquir Immune Defic Syndr. 2020 Jun 24. doi: 10.1097/QAI.0000000000002428.
    >> Share

  425. BOETTIGER DC, Kerr S, Chattranukulchai P, Siwamogsatham S, et al
    Re-classification of statin indication among people living with HIV using coronary artery calcium scoring.
    J Acquir Immune Defic Syndr. 2020 Jun 22. doi: 10.1097/QAI.0000000000002430.
    >> Share

  426. MORRIS SE, Dziobek-Garrett L, Strehlau R, Schroter J, et al
    Quantifying the dynamics of HIV decline in perinatally-infected neonates on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Jun 22. doi: 10.1097/QAI.0000000000002425.
    >> Share

  427. CALZA L, Bon I, Borderi M, Colangeli V, et al
    NO SIGNIFICANT EFFECT OF COVID-19 ON IMMUNOLOGICAL AND VIROLOGICAL PARAMETERS IN PATIENTS WITH HIV-1 INFECTION.
    J Acquir Immune Defic Syndr. 2020 Jun 19. doi: 10.1097/QAI.0000000000002427.
    >> Share

  428. TARLETON J, Chen BA, Meyn LA, Hendrix CW, et al
    Pharmacokinetic and pharmacodynamic impacts of depot medroxyprogesterone acetate use on HIV pre-exposure prophylaxis in women.
    J Acquir Immune Defic Syndr. 2020 Jun 18. doi: 10.1097/QAI.0000000000002421.
    >> Share

  429. WEISER JK, Vu QM, Dasgupta S, Nelson NP, et al
    Estimated Additional Number of Adults in HIV Care Who have an Indication for Hepatitis A Vaccination Following 2020 US Guideline Update.
    J Acquir Immune Defic Syndr. 2020 Jun 15. doi: 10.1097/QAI.0000000000002426.
    >> Share

  430. HU Y, Ma J, Huang H, Vermund SH, et al
    Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series.
    J Acquir Immune Defic Syndr. 2020 Jun 12. doi: 10.1097/QAI.0000000000002424.
    >> Share

  431. KARMEN-TUOHY S, Carlucci PM, Zervou FN, Zacharioudakis IM, et al
    Outcomes among HIV-positive patients hospitalized with COVID-19.
    J Acquir Immune Defic Syndr. 2020 Jun 12. doi: 10.1097/QAI.0000000000002423.
    >> Share

  432. GROVER S, Mehta P, Wang Q, Bhatia R, et al
    Association between CD4 count and chemoradiation therapy outcomes among cervical cancer patients with HIV.
    J Acquir Immune Defic Syndr. 2020 Jun 12. doi: 10.1097/QAI.0000000000002420.
    >> Share

  433. SALONER R, Cherner M, Iudicello JE, Heaton RK, et al
    Cerebrospinal Fluid Norepinephrine and Neurocognition in HIV and Methamphetamine Dependence.
    J Acquir Immune Defic Syndr. 2020 Jun 10. doi: 10.1097/QAI.0000000000002422.
    >> Share

  434. TORIBIO M, Awadalla M, Cetlin M, Fulda ES, et al
    Vascular Dysfunction and Monocyte Activation among Women with HIV.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002419.
    >> Share

  435. OBERMAIER B, Ananth S, Tibroni N, Pierini V, et al
    Patient-derived HIV-1 Nef alleles reveal uncoupling of CD4 downregulation and SERINC5 antagonism functions of the viral pathogenesis factor.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002418.
    >> Share

  436. HAPP LP, Monroe AK, Young HA, Ma Y, et al
    Individual- and clinic-level factors associated with achieving glycemic control in a large cohort of people with HIV in care-Washington, D.C.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002416.
    >> Share

  437. WULANDARI EAT, Wijaya IP, Karim B, Ariyanto I, et al
    Periodontitis and cytomegalovirus associate with atherosclerosis among HIV patients after 5 years on ART.
    J Acquir Immune Defic Syndr. 2020 Jun 8. doi: 10.1097/QAI.0000000000002417.
    >> Share

  438. KALICHMAN SC, Eaton LA, Berman M, Kalichman MO, et al
    Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living with HIV, Atlanta, Georgia.
    J Acquir Immune Defic Syndr. 2020 Jun 5. doi: 10.1097/QAI.0000000000002414.
    >> Share

  439. ETOORI D, Gomez-Olive FX, Reniers G, Rice B, et al
    Outcomes after being lost to follow-up differ for pregnant and postpartum women when compared to the general HIV treatment population in rural South Africa.
    J Acquir Immune Defic Syndr. 2020 Jun 4. doi: 10.1097/QAI.0000000000002413.
    >> Share

  440. GOMEZ-OLIVE FX, Houle B, Rosenberg M, Kabudula C, et al
    HIV incidence among older adults in a rural South African setting: 2010-2015.
    J Acquir Immune Defic Syndr. 2020 Jun 2. doi: 10.1097/QAI.0000000000002404.
    >> Share

  441. INDRAVUDH PP, Hensen B, Nzawa R, Chilongosi R, et al
    Who is reached by HIV self-testing? Individual factors associated with self-testing within a community-based programme in rural Malawi.
    J Acquir Immune Defic Syndr. 2020 Jun 1. doi: 10.1097/QAI.0000000000002412.
    >> Share

    May 2020
  442. OKOH AK, Bishburg E, Grinberg S, Nagarakanti S, et al
    COVID-19 pneumonia in patients with HIV - A Case Series.
    J Acquir Immune Defic Syndr. 2020 May 28. doi: 10.1097/QAI.0000000000002411.
    >> Share

  443. BLAIR CS, Li S, Chau G, Cottle L, et al
    Hormonal Contraception Use and Cabotegravir Pharmacokinetics in HIV-Uninfected Women Enrolled in HPTN 077.
    J Acquir Immune Defic Syndr. 2020 May 21. doi: 10.1097/QAI.0000000000002409.
    >> Share

  444. SABIN CA, Harding R, Doyle N, Redline S, et al
    Associations between widespread pain and sleep quality in people with HIV.
    J Acquir Immune Defic Syndr. 2020 May 21. doi: 10.1097/QAI.0000000000002410.
    >> Share

  445. OKAFOR CN, Hucks-Ortiz C, Hightow-Weidman LB, Magnus M, et al
    Associations between Self-Reported Substance Use Behaviors and PrEP Acceptance and Adherence among Black MSM in the HPTN 073 Study.
    J Acquir Immune Defic Syndr. 2020 May 21. doi: 10.1097/QAI.0000000000002407.
    >> Share

  446. NEL A, Malherbe M, van Niekerk N, Beksinska M, et al
    Performance and Acceptability of the FC2 Female Condom(R) when Used With and Without a Silicone Placebo Vaginal Ring - A Randomized, Crossover Trial.
    J Acquir Immune Defic Syndr. 2020 May 20. doi: 10.1097/QAI.0000000000002408.
    >> Share

  447. SIVRO A, Mwatelah R, Kambaran C, Gebrebrhan H, et al
    Sex work is associated with increased vaginal microbiome diversity in young women from Mombasa, Kenya.
    J Acquir Immune Defic Syndr. 2020 May 18. doi: 10.1097/QAI.0000000000002406.
    >> Share

  448. EL KAMARI V, Hileman CO, Kosco J, Mccomsey GA, et al
    Sleeve Gastrectomy compared to Roux-en-Y Gastric Bypass in individuals living with HIV.
    J Acquir Immune Defic Syndr. 2020 May 15. doi: 10.1097/QAI.0000000000002392.
    >> Share

  449. SEAMAN SM, Van Pilsum Rasmussen SE, Nguyen AQ, Halpern SE, et al
    Willingness to Accept HIV-infected and Increased Infectious Risk Donor Organs among Transplant Candidates Living with HIV.
    J Acquir Immune Defic Syndr. 2020 May 14. doi: 10.1097/QAI.0000000000002405.
    >> Share

  450. LOKKEN EM, Wanje G, Richardson BA, Mutunga E, et al
    Incidence and correlates of pregnancy in HIV-positive Kenyan sex workers.
    J Acquir Immune Defic Syndr. 2020 May 14. doi: 10.1097/QAI.0000000000002402.
    >> Share

  451. GRYAZNOV D, Chammartin F, Stoeckle M, Anagnostopoulos A, et al
    Smartphone app and carbon monoxide self-monitoring support for smoking cessation: A randomised controlled trial nested into the Swiss HIV Cohort Study.
    J Acquir Immune Defic Syndr. 2020 May 13. doi: 10.1097/QAI.0000000000002396.
    >> Share

  452. SEVELIUS JM, Poteat T, Luhur WE, Reisner SL, et al
    HIV Testing and PrEP Use in a National Probability Sample of Sexually Active Transgender People in the United States.
    J Acquir Immune Defic Syndr. 2020 May 13. doi: 10.1097/QAI.0000000000002403.
    >> Share

  453. LOUISA SJ, Lin Serene WX, Gollamudi S
    A case of HIV and SARS-CoV-2 co-infection in Singapore.
    J Acquir Immune Defic Syndr. 2020 May 11. doi: 10.1097/QAI.0000000000002401.
    >> Share

  454. PEREIRA B, Mazzitelli M, Milinkovic A, Moyle G, et al
    Use of Coronary Artery Calcium Scoring to improve cardiovascular risk stratification and guide decisions to start statin therapy in People living with HIV.
    J Acquir Immune Defic Syndr. 2020 May 7. doi: 10.1097/QAI.0000000000002400.
    >> Share

  455. ANSARI AW, Ahmad F, Shankar EM, Kong YY, et al
    Diminished Co-inhibitory Molecule 2B4 expression is Associated with Preserved iNKT cell Phenotype in HIV Long-term Non-progressors.
    J Acquir Immune Defic Syndr. 2020 May 7. doi: 10.1097/QAI.0000000000002399.
    >> Share

  456. HATZENBUEHLER ML, McKetta S, Goldberg N, Sheldon A, et al
    Trends in State Policy Support for Sexual Minorities and HIV-Related Outcomes among Men Who Have Sex with Men in the United States, 2008-2014.
    J Acquir Immune Defic Syndr. 2020 May 7. doi: 10.1097/QAI.0000000000002395.
    >> Share

  457. CREPAZ N, Song R, Lyss S, Hall HI, et al
    Trends in time from HIV diagnosis to first viral suppression following revised U.S. HIV treatment guidelines, 2012-2017.
    J Acquir Immune Defic Syndr. 2020 May 5. doi: 10.1097/QAI.0000000000002398.
    >> Share

  458. FEARON E, Chabata ST, Magutshwa S, Ndori-Mharadze T, et al
    Estimating the population size of female sex workers in Zimbabwe: comparison of estimates obtained using different methods in twenty sites and development of a national-level estimate.
    J Acquir Immune Defic Syndr. 2020 May 5. doi: 10.1097/QAI.0000000000002393.
    >> Share

  459. NEL A, Malherbe M, van Niekerk N, Beksinska M, et al
    Performance of Male Condoms when Used With and Without a Silicone Placebo Vaginal Ring - A Randomized, Crossover Trial.
    J Acquir Immune Defic Syndr. 2020 May 4. doi: 10.1097/QAI.0000000000002397.
    >> Share

  460. KAPOGIANNIS BG, Koenig LJ, Xu J, Mayer KH, et al
    The HIV Continuum of Care for Adolescents and Young Adults Attending 13 Urban US HIV Care Centers of the NICHD-ATN-CDC-HRSA SMILE Collaborative.
    J Acquir Immune Defic Syndr. 2020;84:92-100.
    >> Share

  461. EDELMAN EJ, Li Y, Barry D, Brennan Braden J, et al
    Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.
    J Acquir Immune Defic Syndr. 2020;84:26-36.
    >> Share

  462. CLARK E, Royse KE, Dong Y, Chang E, et al
    Stable Incidence and Poor Survival for HIV-Related Burkitt Lymphoma Among the US Veteran Population During the Antiretroviral Era.
    J Acquir Immune Defic Syndr. 2020;84:18-25.
    >> Share

    April 2020
  463. DE ALMEIDA SM, Ribeiro CE, Tang B, de Pereira AP, et al
    Neurocytoskeleton proteins in cerebrospinal fluid of people with HIV-1 subtypes B and C.
    J Acquir Immune Defic Syndr. 2020 Apr 27. doi: 10.1097/QAI.0000000000002389.
    >> Share

  464. SUN-SUSLOW N, Paolillo EW, Morgan EE, Letendre S, et al
    Frailty and HIV disease severity synergistically increase risk of HIV-associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2020 Apr 27. doi: 10.1097/QAI.0000000000002391.
    >> Share

  465. LEE SA, Telwatte S, Hatano H, Kashuba ADM, et al
    Antiretroviral Therapy Concentrations Differ in Gut vs. Lymph Node Tissues and Are Associated With HIV Viral Transcription by a Novel RT-ddPCR Assay.
    J Acquir Immune Defic Syndr. 2020;83:530-537.
    >> Share

  466. ANDRASIK MP, Sesay FA, Isaacs A, Oseso L, et al
    Social Impacts among Participants in HIV Vaccine Trial Network (HVTN) preventive HIV vaccine trials.
    J Acquir Immune Defic Syndr. 2020 Apr 15. doi: 10.1097/QAI.0000000000002369.
    >> Share

  467. ZHANG W, Hu Q, Tang W, Jin X, et al
    HIV self-testing programs to men who have sex with men delivered by social media key opinion leaders and community-based organizations are both effective and complementary: a national pragmatic study in China.
    J Acquir Immune Defic Syndr. 2020 Apr 14. doi: 10.1097/QAI.0000000000002375.
    >> Share

  468. NAUGLE DA, Dosso A, Tibbels NJ, Van Lith LM, et al
    Addressing uptake of HIV testing and linkage to care among men in Cote d'Ivoire: An evaluation of the Brothers for Life program implementation.
    J Acquir Immune Defic Syndr. 2020 Apr 14. doi: 10.1097/QAI.0000000000002379.
    >> Share

  469. WANSOM T, Pinyakorn S, Kolsteeg CJ, Kroon ED, et al
    Group sex and methamphetamine use fuel an explosive epidemic of Hepatitis C among HIV-infected men who have sex with men in Bangkok, Thailand.
    J Acquir Immune Defic Syndr. 2020 Apr 9. doi: 10.1097/QAI.0000000000002356.
    >> Share

  470. LAVERGNE S, Umlauf A, McCutchan A, Heaton R, et al
    Impact of Latent Tuberculosis Infection on Neurocognitive Functioning and Inflammation in HIV-Infected and Uninfected South Indians.
    J Acquir Immune Defic Syndr. 2020 Apr 9. doi: 10.1097/QAI.0000000000002368.
    >> Share

  471. NYIRENDA M, Ngongondo M, Kang M, Umbleja T, et al
    Early progression and immune reconstitution inflammatory syndrome during treatment of mild-to-moderate Kaposi sarcoma in sub-Saharan Africa and South America: Incidence, long-term outcomes and effects of early chemotherapy.
    J Acquir Immune Defic Syndr. 2020 Apr 4. doi: 10.1097/QAI.0000000000002361.
    >> Share


  472. Characteristics and Care Outcomes Among Persons Living With Perinatally Acquired HIV Infection in the United States, 2015: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e28.
    >> Share


  473. Should Urine-LAM Tests Be Used in TB Symptomatic HIV-Positive Patients When No CD4 Count Is Available? A Prospective Observational Cohort Study From Malawi: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e28.
    >> Share

  474. CASTILHO JL, Rebeiro PF, Shepherd BE, Nash R, et al
    Mood Disorders and Increased Risk of Noncommunicable Disease in Adults With HIV.
    J Acquir Immune Defic Syndr. 2020;83:397-404.
    >> Share

  475. VAUGHAN J, Perner Y, McAlpine E, Wiggill T, et al
    Brief Report: HIV-Associated Hodgkin Lymphoma Involving the Bone Marrow Identifies a Very High-Risk Subpopulation in the Era of Widescale Antiretroviral Therapy Use in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020;83:345-349.
    >> Share

  476. CROCKETT KB, Entler KJ, Brodie E, Kempf MC, et al
    Brief Report: Linking Depressive Symptoms to Viral Nonsuppression Among Women With HIV Through Adherence Self-Efficacy and ART Adherence.
    J Acquir Immune Defic Syndr. 2020;83:340-344.
    >> Share

  477. PAUL RH, Cho KS, Luckett PM, Strain JF, et al
    Machine learning analysis reveals novel neuroimaging and clinical signatures of frailty in HIV.
    J Acquir Immune Defic Syndr. 2020 Apr 1. doi: 10.1097/QAI.0000000000002360.
    >> Share

    March 2020
  478. KAPLAN A, Simon TG, Henson JB, Wang T, et al
    Relationship between Non-Alcoholic Fatty Liver Disease and Cardiovascular Disease in Persons with HIV.
    J Acquir Immune Defic Syndr. 2020 Mar 31. doi: 10.1097/QAI.0000000000002359.
    >> Share

  479. KAPETANOVIC S, Norato G, Nair G, Julnes PS, et al
    Effect of HIV and Interpersonal Trauma on Cortical Thickness, Cognition, and Daily Functioning.
    J Acquir Immune Defic Syndr. 2020 Mar 30. doi: 10.1097/QAI.0000000000002358.
    >> Share

  480. O'HALLORAN JA, Sahrmann J, Butler AM, Olsen MA, et al
    Integrase Strand Transfer Inhibitors are associated with lower risk of incident Cardiovascular Disease in People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Mar 25. doi: 10.1097/QAI.0000000000002357.
    >> Share

  481. RAMIREZ-MARRERO FA, Perez-Frontera S, Amalbert-Birriel MA, Matos M, et al
    Effects of low volume high intensity interval training in Hispanic HIV+ Women: a non-randomized study.
    J Acquir Immune Defic Syndr. 2020 Mar 20. doi: 10.1097/QAI.0000000000002353.
    >> Share

  482. CATTANEO D, Riva A, Columpsi P, Lapadula G, et al
    Dosing of dolutegravir in TB/HIV co-infected patients on rifampicin: twice is (always) better than once.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002352.
    >> Share

  483. KAMITANI E, Johnson WD, Wichser ME, Adegbite AH, et al
    Growth in proportion and disparities of HIV PrEP use among key populations identified in the United States national goals: systematic review & meta-analysis of published surveys.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002345.
    >> Share

  484. LALLEMANT M, Amzal B, Sripan P, Urien S, et al
    Perinatal antiretroviral intensification to prevent intrapartum HIV transmission when antenatal antiretroviral therapy is initiated less than 8 weeks prior to delivery.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002350.
    >> Share

  485. DAS S, Allston A, Kharfen M
    Detecting spatial cores and temporal trends of repeat STIs to plan Pre-Exposure Prophylaxis (PrEP) scale-up in DC.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002348.
    >> Share

  486. KOSTEV K
    Sex Differences in People Aging with HIV in Germany.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002349.
    >> Share

  487. OYARO P, Kwena Z, Bukusi EA, Baeten JM, et al
    Is HIV self-testing a strategy to increase repeat testing among pregnant and postpartum women? A pilot mixed methods study.
    J Acquir Immune Defic Syndr. 2020 Mar 19. doi: 10.1097/QAI.0000000000002347.
    >> Share

  488. PAOLILLO EW, Pasipanodya EC, Moore RC, Pence BW, et al
    Cumulative Burden of Depression and Neurocognitive Decline among Persons with HIV: A Longitudinal Study.
    J Acquir Immune Defic Syndr. 2020 Mar 16. doi: 10.1097/QAI.0000000000002346.
    >> Share

  489. DAVEY S, Ajibola G, Maswabi K, Sakoi M, et al
    Mother-to-Child HIV Transmission with in utero Dolutegravir vs. Efavirenz in Botswana.
    J Acquir Immune Defic Syndr. 2020 Mar 16. doi: 10.1097/QAI.0000000000002338.
    >> Share

  490. HENSEN B, Schaap AJ, Mulubwa C, Floyd S, et al
    Who accepts and who uses community-based secondary distribution HIV self-testing (HIVST) kits? Findings from the intervention arm of a cluster-randomised trial of HIVST distribution nested in four HPTN 071 (PopART) communities in Zambia.
    J Acquir Immune Defic Syndr. 2020 Mar 13. doi: 10.1097/QAI.0000000000002344.
    >> Share

  491. SPINELLI MA, Rodrigues WC, Wang G, Vincent M, et al
    HIGH ACCURACY OF A REAL-TIME URINE ANTIBODY-BASED TENOFOVIR POINT-OF-CARE TEST COMPARED TO LABORATORY-BASED ELISA IN DIVERSE POPULATIONS.
    J Acquir Immune Defic Syndr. 2020 Mar 10. doi: 10.1097/QAI.0000000000002322.
    >> Share

  492. SEWELL WC, Powell VE, Mayer KH, Ochoa A, et al
    Non-Daily Use of HIV Preexposure Prophylaxis in a Large Online Survey of Primarily Men Who Have Sex with Men in the U.S.
    J Acquir Immune Defic Syndr. 2020 Mar 9. doi: 10.1097/QAI.0000000000002332.
    >> Share

  493. KORTE JE, Kisa R, Vrana-Diaz CJ, Malek AM, et al
    HIV oral self-testing for male partners of women attending antenatal care in central Uganda: uptake and linkage to care post-test in a randomized trial.
    J Acquir Immune Defic Syndr. 2020 Mar 9. doi: 10.1097/QAI.0000000000002341.
    >> Share

  494. NELSON KM, Perry NS, Stout CD, Carey MP, et al
    Sexual debut among 14-17-year-old sexual minority males: A preliminary investigation of early HIV risk and sexual health needs.
    J Acquir Immune Defic Syndr. 2020 Mar 6. doi: 10.1097/QAI.0000000000002342.
    >> Share

  495. SILHOL R, Boily MC, Dimitrov D, German D, et al
    Understanding the HIV epidemic among MSM in Baltimore: a modelling study estimating the impact of past HIV interventions and who acquired and contributed to infections.
    J Acquir Immune Defic Syndr. 2020 Mar 3. doi: 10.1097/QAI.0000000000002340.
    >> Share

  496. PHILBIN MM, Parish C, Kinnard EN, Reed SE, et al
    A multi-site study of women living with HIV's perceived barriers to, and interest in, long-acting injectable anti-retroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Mar 2. doi: 10.1097/QAI.0000000000002337.
    >> Share

  497. SHIAU S, Yin MT, Strehlau R, Burke M, et al
    Deficits in bone architecture and strength in children living with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Mar 2. doi: 10.1097/QAI.0000000000002309.
    >> Share

  498. VOGELZANG M, Terris-Prestholt F, Vickerman P, Delany-Moretlwe S, et al
    The cost-effectiveness of HIV pre-exposure prophylaxis among heterosexual men in South Africa: a cost-utility modelling analysis.
    J Acquir Immune Defic Syndr. 2020 Mar 2. doi: 10.1097/QAI.0000000000002327.
    >> Share

  499. SAJDEYA R, Cook RL
    Need to Improve Dose Measurements in Studies of Marijuana Use for Pain.
    J Acquir Immune Defic Syndr. 2020;83:e23.
    >> Share

  500. BRANAS F, Sanchez-Conde M, Carli F, Menozzi M, et al
    Sex Differences in People Aging With HIV.
    J Acquir Immune Defic Syndr. 2020;83:284-291.
    >> Share

  501. MOLINARO M, Sacktor N, Nakigozi G, Anok A, et al
    Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Disorder.
    J Acquir Immune Defic Syndr. 2020;83:278-283.
    >> Share

  502. ATTIA EF, Bhatraju PK, Triplette M, Kosamo S, et al
    Endothelial Activation, Innate Immune Activation, and Inflammation Are Associated With Postbronchodilator Airflow Limitation and Obstruction Among Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2020;83:267-277.
    >> Share

    February 2020
  503. GORI A, Antinori A, Vergori A, Cossu MV, et al
    Effectiveness of switching to darunavir/cobicistat in virologically-suppressed HIV-positive patients receiving ritonavir-boosted protease inhibitor-based regimen: the "STORE" Study.
    J Acquir Immune Defic Syndr. 2020 Feb 24. doi: 10.1097/QAI.0000000000002331.
    >> Share

  504. FATTI G, Ngorima-Mabhena N, Mothibi E, Muzenda T, et al
    Outcomes of Three versus Six-Monthly Dispensing of Antiretroviral Treatment (ART) for Stable HIV Patients in Community ART Refill Groups: A Cluster-Randomized Trial in Zimbabwe.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002333.
    >> Share

  505. GILLIS JL, Grennan T, Grewal R, Ogilvie G, et al
    Racial disparities in anal cancer screening among men living with HIV: findings from a clinical cohort study.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002335.
    >> Share

  506. HERSBERGER M, Schlaepfer E, Buehler M, Bochud PY, et al
    Polymorphisms of SOCS-1 are associated with rapid HIV progression rate.
    J Acquir Immune Defic Syndr. 2020 Feb 21. doi: 10.1097/QAI.0000000000002319.
    >> Share

  507. STABELL AC, Wilson M, Jankowski CM, MaWhinney S, et al
    The Impact of a Structured, Supervised Exercise Program on Daily Step Count in Sedentary Older Adults With and Without HIV.
    J Acquir Immune Defic Syndr. 2020 Feb 20. doi: 10.1097/QAI.0000000000002326.
    >> Share

  508. TAYLOR K, Lamb M, Lahuerta M, Ahoua L, et al
    Patterns and Predictors of HIV Status Disclosure in the 12 Months Following Diagnosis in Mozambique.
    J Acquir Immune Defic Syndr. 2020 Feb 20. doi: 10.1097/QAI.0000000000002334.
    >> Share

  509. SHUTER J, Kim RS, Durant S, Stanton CA, et al
    Long-term follow-up of smokers living with HIV after an intensive behavioral tobacco treatment intervention.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002330.
    >> Share

  510. PUTTKAMMER N, Parrish C, Desir Y, Hyppolite N, et al
    Toward Universal HIV Treatment in Haiti: Time Trends in ART Retention Following Expanded ART Eligibility in a National Cohort from 2011-17.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002329.
    >> Share

  511. CHIKANDIWA A, Faust H, Chersich MF, Mayaud P, et al
    Human papillomavirus seroprevalence and seroconversion among men living with HIV: Cohort study in South Africa.
    J Acquir Immune Defic Syndr. 2020 Feb 14. doi: 10.1097/QAI.0000000000002328.
    >> Share

  512. WELTY S, Motoku J, Muriithi C, Rice B, et al
    RECENT HIV INFECTION SURVEILLANCE IN ROUTINE HIV TESTING IN NAIROBI, KENYA: A FEASIBILITY STUDY.
    J Acquir Immune Defic Syndr. 2020 Feb 13. doi: 10.1097/QAI.0000000000002317.
    >> Share

  513. ATKINS D, Wagner AD, Zhang J, Njuguna IN, et al
    Use of the Consolidated Framework for Implementation Research (CFIR) to Characterize Healthcare Workers' Perspectives on Financial Incentives to Increase Pediatric HIV Testing.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002323.
    >> Share

  514. GODFREY C, Hughes MD, Ritz J, Coelho L, et al
    SEX DIFFERENCES IN OUTCOMES FOR INDIVIDUALS PRESENTING FOR THIRD-LINE ANTIRETROVIRAL THERAPY.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002324.
    >> Share

  515. PAINTSIL E, Kyriakides TC, Antwi S, Renner L, et al
    Clinic-Based Pediatric Disclosure Intervention Trial Improves Pediatric HIV Status Disclosure in Ghana.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002316.
    >> Share

  516. HAWKS LC, McGinnis KA, Howell BA, Khan MR, et al
    Frequency and duration of incarceration and mortality among US Veterans with and without HIV.
    J Acquir Immune Defic Syndr. 2020 Feb 10. doi: 10.1097/QAI.0000000000002325.
    >> Share

  517. JUMARE J, Akolo C, Ndembi N, Bwala S, et al
    Elevated Plasma Levels of sCD14 and MCP-1 are associated with HIV Associated Neurocognitive Disorders among Antiretroviral Naive Individuals in Nigeria.
    J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002320.
    >> Share

  518. CRAW JA, Beer L, Tie Y, Jaenicke T, et al
    Viral rebound among persons with diagnosed HIV who achieved viral suppression, United States.
    J Acquir Immune Defic Syndr. 2020 Feb 7. doi: 10.1097/QAI.0000000000002321.
    >> Share

  519. JAO J, Kacanek D, Yu W, Williams PL, et al
    Neurodevelopment of HIV-Exposed Uninfected Infants Born to Women with Perinatally-Acquired HIV in the United States.
    J Acquir Immune Defic Syndr. 2020 Feb 5. doi: 10.1097/QAI.0000000000002318.
    >> Share

  520. KEEN P, Hammoud MA, Bourne A, Bavinton BR, et al
    Use of HIV Pre-exposure Prophylaxis (PrEP) Associated With Lower HIV Anxiety Among Gay and Bisexual Men in Australia Who Are at High Risk of HIV Infection: Results From the Flux Study.
    J Acquir Immune Defic Syndr. 2020;83:119-125.
    >> Share


  521. A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e13-e14.
    >> Share


  522. Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia: Erratum.
    J Acquir Immune Defic Syndr. 2020;83:e12.
    >> Share

  523. LIPPMAN SA, West R, Gomez-Olive FX, Leslie HH, et al
    Treatment as Prevention-Provider Knowledge and Counseling Lag Behind Global Campaigns.
    J Acquir Immune Defic Syndr. 2020;83:e9-e12.
    >> Share

  524. ARYA M, Marren RE, Marek HG, Pasalar S, et al
    Success of Supplementing National HIV Testing Recommendations With a Local Initiative in a Large Health Care System in the U.S. South.
    J Acquir Immune Defic Syndr. 2020;83:e6-e9.
    >> Share

  525. QIN S, Vodovotz L, Zamora R, Fitzpatrick M, et al
    Association Between Inflammatory Pathways and Phenotypes of Pulmonary Dysfunction Using Cluster Analysis in Persons Living With HIV and HIV-Uninfected Individuals.
    J Acquir Immune Defic Syndr. 2020;83:189-196.
    >> Share

  526. WADLEY AL, Lazarus E, Gray GE, Mitchell D, et al
    Pain in Clients Attending a South African Voluntary Counseling and Testing Center Was Frequent and Extensive But Did Not Depend on HIV Status.
    J Acquir Immune Defic Syndr. 2020;83:181-188.
    >> Share

  527. AIZIRE J, Brooks KM, Mirochnick M, Flynn PM, et al
    Antenatal Intracellular Concentrations of Tenofovir Diphosphate and Emtricitabine Triphosphate and Associations Between Tenofovir Diphosphate and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial.
    J Acquir Immune Defic Syndr. 2020;83:173-180.
    >> Share

  528. THOMSEN MT, Wiegandt YL, Gelpi M, Knudsen AD, et al
    Prevalence of and Risk Factors for Low Bone Mineral Density Assessed by Quantitative Computed Tomography in People Living With HIV and Uninfected Controls.
    J Acquir Immune Defic Syndr. 2020;83:165-172.
    >> Share

  529. MILLHAM LRI, Scott JA, Sax PE, Shebl FM, et al
    Clinical and Economic Impact of Ibalizumab for People With Multidrug-Resistant HIV in the United States.
    J Acquir Immune Defic Syndr. 2020;83:148-156.
    >> Share

  530. HUGHES E, Mwebaza N, Huang L, Kajubi R, et al
    Efavirenz-Based Antiretroviral Therapy Reduces Artemether-Lumefantrine Exposure for Malaria Treatment in HIV-Infected Pregnant Women.
    J Acquir Immune Defic Syndr. 2020;83:140-147.
    >> Share

  531. BUNGE KE, Levy L, Szydlo DW, Zhang J, et al
    Brief Report: Phase IIa Safety Study of a Vaginal Ring Containing Dapivirine in Adolescent Young Women.
    J Acquir Immune Defic Syndr. 2020;83:135-139.
    >> Share

  532. BIELLO KB, Goedel WC, Edeza A, Safren SA, et al
    Network-Level Correlates of Sexual Risk Among Male Sex Workers in the United States: A Dyadic Analysis.
    J Acquir Immune Defic Syndr. 2020;83:111-118.
    >> Share

  533. CHOW EPF, Phillips TR, Bradshaw CS, Chen MY, et al
    Brief Report: Sexual Mixing Patterns by HIV Status and PrEP Use Among Men Who Have Sex With Men Partnerships in Melbourne, 2011-2018.
    J Acquir Immune Defic Syndr. 2020;83:99-102.
    >> Share

    January 2020
  534. MCFARLAND W, Wesson P, Turner C, Lin J, et al
    High HIV incidence among young and racial/ethnic minority transgender women in San Francisco: results of a longitudinal cohort study.
    J Acquir Immune Defic Syndr. 2020 Jan 31. doi: 10.1097/QAI.0000000000002315.
    >> Share

  535. GORROD HB, Court R, Schomaker M, Maartens G, et al
    Increased Mortality with Delayed and Missed Switch to Second-Line Antiretroviral Therapy in South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 31. doi: 10.1097/QAI.0000000000002313.
    >> Share

  536. JACQUELINE H, Landon M, Sarah H, Jean-Paul F, et al
    Cognition, structural brain changes and systemic inflammation in adolescents living with HIV on antiretroviral therapy.
    J Acquir Immune Defic Syndr. 2020 Jan 31. doi: 10.1097/QAI.0000000000002314.
    >> Share

  537. MERCURIO V, Fitzgerald W, Molodtsov I, Margolis L, et al
    Persistent immune activation in HIV-1 infected ex vivo model tissues subjected to antiretroviral therapy: Soluble and extracellular vesicle-associated cytokines.
    J Acquir Immune Defic Syndr. 2020 Jan 30. doi: 10.1097/QAI.0000000000002301.
    >> Share

  538. CLARK E, Royse KE, Dong Y, Chang E, et al
    Stable Incidence and Poor Survival for HIV-Related Burkitt Lymphoma Among the U.S. Veteran Population During the Anti-Retroviral Era.
    J Acquir Immune Defic Syndr. 2020 Jan 27. doi: 10.1097/QAI.0000000000002303.
    >> Share

  539. FISK RJ
    Expanding HIV Continuum of Care Analyses: Impacts in the American South and the Roles of Health Insurance and Multiple Substance Use.
    J Acquir Immune Defic Syndr. 2020 Jan 24. doi: 10.1097/QAI.0000000000002307.
    >> Share

  540. STAFFORD KA, Mayer BT, Fulp W, Chua J, et al
    Variability of CD4+ cell counts in HIV-1 uninfected volunteers who are eligible for a Phase I HIV vaccine study.
    J Acquir Immune Defic Syndr. 2020 Jan 24. doi: 10.1097/QAI.0000000000002306.
    >> Share

  541. MORRISON CS, Chen PL, Yamamoto H, Gao X, et al
    Concomitant Imbalances of Systemic and Mucosal Immunity Increase HIV Acquisition Risk.
    J Acquir Immune Defic Syndr. 2020 Jan 23. doi: 10.1097/QAI.0000000000002299.
    >> Share

  542. PANNEER N, France AM, Whiteside YO, Zhang T, et al
    Temporal Changes in HIV Transmission Patterns among Young Men Who Have Sex with Men, United States, 2009-2016.
    J Acquir Immune Defic Syndr. 2020 Jan 17. doi: 10.1097/QAI.0000000000002305.
    >> Share

  543. STIER EA, Abbasi W, Agyemang AF, Valle Alvarez EA, et al
    Recurrence of Anal High-Grade Squamous Intraepithelial Lesions among Women Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 16. doi: 10.1097/QAI.0000000000002304.
    >> Share

  544. ERON J, Hung CC, Baril JG, Slim J, et al
    Virologic Response by Baseline Viral Load With Dolutegravir Plus Lamivudine vs Dolutegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Analysis.
    J Acquir Immune Defic Syndr. 2020 Jan 16. doi: 10.1097/QAI.0000000000002302.
    >> Share

  545. TURNER D, Lockhart E, Wang W, Shore R, et al
    PrEP implementation behaviors of community-based HIV testing staff: A mixed methods approach using latent class analysis.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002289.
    >> Share

  546. PHILLIPS G 2ND, Raman AB, Felt D, McCuskey DJ, et al
    PrEP4Love: The Role of Messaging and Prevention Advocacy in PrEP Attitudes, Perceptions, and Uptake Among YMSM and Transgender Women.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002297.
    >> Share

  547. WEISS KM, Prasad P, Ramaraju R, Zlotorzynska M, et al
    Estimated Number of Men who have Sex with Men with Indications for HIV Pre-Exposure Prophylaxis in a National Sexual Network Study.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002300.
    >> Share

  548. FLAX VL, Kasasa S, Ssendagire S, Lane C, et al
    Using a quality improvement approach in the prevention of mother-to-child HIV transmission program in Uganda improves key outcomes and is sustainable in demonstration facilities: Partnership for HIV-Free Survival.
    J Acquir Immune Defic Syndr. 2020 Jan 13. doi: 10.1097/QAI.0000000000002298.
    >> Share

  549. KAPELIOS CJ, Argyris AA, Protogerou AD, Katsarolis I, et al
    Progression of subclinical vascular damage in people living with HIV is not predicted by current cardiovascular risk scores: a prospective 3-year study.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002286.
    >> Share

  550. GREENBERG L, Ryom L, Wandeler G, Grabmeier-Pfistershammer K, et al
    Uptake and discontinuation of integrase inhibitors (INSTIs) in a large cohort setting.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002250.
    >> Share

  551. EKE AC, Stek AM, Wang J, Kreitchmann R, et al
    Darunavir pharmacokinetics with an increased dose during pregnancy.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002261.
    >> Share

  552. GILLIAMS EA, Ammirati RJ, Nguyen ML, Shahane AA, et al
    Increased Retention in Care after a Palliative Care Referral among People Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002296.
    >> Share

  553. MCCLYMONT E, Coutlee F, Lee M, Albert A, et al
    Persistence of Non-Vaccine Oncogenic HPV Genotypes in Quadrivalent HPV-Vaccinated Women Living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 8. doi: 10.1097/QAI.0000000000002258.
    >> Share

  554. REEPALU A, Arimide DA, Balcha TT, Bjorkman P, et al
    Interferon-gamma-inducible protein 10 - a potential marker for targeted viral load monitoring of antiretroviral treatment?
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002292.
    >> Share

  555. SCHROTER J, Anelone AJN, Yates AJ, de Boer RJ, et al
    Time to viral suppression in perinatally HIV-infected infants depends on the viral load and CD4 T-cell percentage at the start of treatment.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002291.
    >> Share

  556. PUTHANAKIT T, Ananworanich J, Akapirat S, Pattanachaiwit S, et al
    Pattern and Frequency of Seroreactivity to Routinely Used Serologic Tests in Early Treated Infants with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002254.
    >> Share

  557. ATTIA EF, Bhatraju PK, Triplette M, Kosamo S, et al
    Endothelial activation, innate immune activation, and inflammation are associated with post-bronchodilator airflow limitation and obstruction among adolescents living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002255.
    >> Share

  558. STEPHENSON R, Bratcher A, Mimiaga MJ, Garofalo R, et al
    Accuracy in self-report of viral suppression among HIV-positive men with HIV-negative male partners.
    J Acquir Immune Defic Syndr. 2020 Jan 7. doi: 10.1097/QAI.0000000000002240.
    >> Share

  559. MANTOVANI E, Lugoboni F, Federico A, Zipeto D, et al
    Benzodiazepine use and HIV-associated neurocognitive impairment: which comes first?
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002278.
    >> Share

  560. FAZELI PL, Waldrop-Valverde D, Yigit I, Turan B, et al
    An exploratory study of correlates of allostatic load in older people living with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002293.
    >> Share

  561. KING EM, Nesbitt A, Albert AYK, Pick N, et al
    Prolonged Amenorrhea and Low Hip Bone Mineral Density in Women Living with HIV-a Controlled, Cross-Sectional Study.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002282.
    >> Share

  562. KAMKWALALA AR, Wang X, Maki PM, Williams DW, et al
    Higher peripheral monocyte activation markers are associated with smaller frontal and temporal cortical volumes in women with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002283.
    >> Share

  563. WEBEL A, Davey CH, Schexnayder J, Currie J, et al
    The Impact of Perceived Cardiovascular Risk on Cardiovascular Disease Prevention Behaviors in People With and Without HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002290.
    >> Share

  564. MOYO F, Mazanderani AH, Murray T, Technau KG, et al
    Characterizing viral load burden among HIV-infected women around the time of delivery: Findings from four tertiary obstetric units in Gauteng, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002267.
    >> Share

  565. SAJDEYA R, Cook RL
    Letter to the editors.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002238.
    >> Share

  566. DE SOCIO GV, Ricci E, Maggi P, Orofino G, et al
    Is it feasible to impact on smoking habits in HIV-Infected patients? Mission impossible from the STOPSHIV Project cohort.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002284.
    >> Share

  567. SUN X, Wang C, Zhao K, Zhang L, et al
    HIV seroconversion and types of relationships among men who have sex with men: A cohort study in China.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002264.
    >> Share

  568. ECKARD AR, Hughes HY, Hagood NL, O'riordan MA, et al
    Fibroblast Growth Factor 21 is Elevated in HIV and Associated with Interleukin-6.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002285.
    >> Share

  569. PATEL F, Thurman C, Liberty A, Burke M, et al
    Negative diagnostic PCR tests in school-aged, HIV-infected children on antiretroviral therapy since early life in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002265.
    >> Share

  570. CARRERO A, Berenguer J, Hontanon V, Navarro J, et al
    Effects of eradication of HCV on cardiovascular risk and preclinical atherosclerosis in HIV/HCV-coinfected patients.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002260.
    >> Share

  571. CLARKE DF, Acosta EP, Cababasay M, Wang J, et al
    Raltegravir (RAL) in neonates: Dosing, pharmacokinetics (PK), and safety in HIV-1 exposed neonates at risk of infection (IMPAACT P1110).
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002294.
    >> Share

  572. KALICHMAN S, Mathews C, Banas E, Kalichman M, et al
    HIV Status Disclosure and Sexual Transmission Risks among People who are Living with HIV and Receiving Treatment for Non-HIV Sexually Transmitted Infections, Cape Town, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002256.
    >> Share

  573. HOLT M, Lee E, Lea T, Bavinton B, et al
    HIV pre-exposure prophylaxis cascades to assess implementation in Australia: results from repeated, national behavioural surveillance of gay and bisexual men, 2014-18.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002243.
    >> Share

  574. MAY PE, Heithoff AJ, Wichman CS, Phatak VS, et al
    Assessing Cognitive Functioning in People Living with HIV (PLWH): Factor Analytic Results from CHARTER and NNTC Cohorts.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002252.
    >> Share

  575. ZHANG Q, Yu X, Wu T, Shang H, et al
    Immunological and Virological Responses in Older HIV-Infected Adults Receiving Antiretroviral Therapy: An Evidence-Based Meta-Analysis.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002266.
    >> Share

  576. SHARMA A, Vance DE, Hoover DR, Shi Q, et al
    Impaired Cognition Predicts Falls Among Women with and Without HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002262.
    >> Share

  577. WEBB K, Chitiyo V, Mahachi N, Mukungunugwa SH, et al
    Improving Early Infant Diagnosis Observations: Estimates of timely HIV testing and mortality among HIV-exposed infants.
    J Acquir Immune Defic Syndr. 2020 Jan 6. doi: 10.1097/QAI.0000000000002263.
    >> Share

  578. FATIMA B, Matilde SC, Federica C, Marianna M, et al
    Sex Difference In People Aging With Hiv.
    J Acquir Immune Defic Syndr. 2020 Jan 4. doi: 10.1097/QAI.0000000000002259.
    >> Share

  579. VAUGHAN J, Perner Y, McAlpine E, Wiggill T, et al
    HIV-associated Hodgkin lymphoma involving the bone marrow identifies a very high risk sub-population in the era of widescale Anti-retroviral therapy use in Johannesburg, South Africa.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002276.
    >> Share

  580. TOPAZIAN HM, Stoner MCD, Edwards JK, Kahn K, et al
    Variations in HIV risk by young women's age and partner age-disparity in rural South Africa (HPTN 068).
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002270.
    >> Share

  581. STANTON CA, Kumar PN, Moadel AB, Cunningham CO, et al
    A multicenter randomized controlled trial of intensive group therapy for tobacco treatment in HIV-infected cigarette smokers.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002271.
    >> Share

  582. NEILAN AM, Lu F, Gebo KA, Diaz-Reyes R, et al
    Higher acuity resource utilization with older age and poorer HIV control in adolescents and young adults in the HIV Research Network.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002280.
    >> Share

  583. JANUS SE, Sullivan C, Morrison J, McComsey GA, et al
    Positron Emission Tomography to Characterize Dorsocervical Fat Pad Hypertrophy in People with Treated HIV Infection.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002273.
    >> Share

  584. CREPAZ N, Dong X, Hess KL, Bosh K, et al
    Racial and ethnic disparities in sustained viral suppression and transmission risk potential among persons aged 13-29 years living with diagnosed HIV infection, United States, 2016.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002277.
    >> Share

  585. FEHER C, Plana M, Guardo AC, Climent N, et al
    A classifier to predict viral control after antiretroviral treatment interruption in chronic HIV-1 infected patients.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002281.
    >> Share

  586. CROCKETT KB, Entler KJ, Brodie E, Kempf MC, et al
    Linking Depressive Symptoms to Viral Non-suppression among Women with HIV through Adherence Self-Efficacy and ART Adherence.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002268.
    >> Share

  587. CASTILHO JL, Rebeiro PF, Shepherd BE, Nash R, et al
    Mood disorders and increased risk of non-communicable disease in adults with HIV.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002269.
    >> Share

  588. PATHELA P, Jamison K, Blank S, Daskalakis D, et al
    The HIV Pre-exposure Prophylaxis (PrEP) cascade at NYC Sexual Health Clinics: Navigation is the Key to Uptake.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002274.
    >> Share

  589. DANIEL JACOBUS VH, Andre P K, Gary M, Graeme M, et al
    Point-of-care ultrasound predictors for the diagnosis of tuberculosis in HIV-positive patients presenting to an emergency center.
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002279.
    >> Share

  590. MILANINI B, Allen I, Paul R, Bahemana E, et al
    Frequency and Predictors of HIV-related Cognitive Impairment in East Africa: The Africa Cohort Study (AFRICOS).
    J Acquir Immune Defic Syndr. 2020 Jan 3. doi: 10.1097/QAI.0000000000002242.
    >> Share

  591. LANG R, Krentz HB, Gill MJ
    In Defense of Baseline Genotypic Antiretroviral Resistance Testing.
    J Acquir Immune Defic Syndr. 2020;83:e1-e2.
    >> Share

  592. WELCH JL, Kaddour H, Winchester L, Fletcher CV, et al
    Semen Extracellular Vesicles From HIV-1-Infected Individuals Inhibit HIV-1 Replication In Vitro, and Extracellular Vesicles Carry Antiretroviral Drugs In Vivo.
    J Acquir Immune Defic Syndr. 2020;83:90-98.
    >> Share

  593. GOGOKHIA L, Taur Y, Juluru K, Yagan N, et al
    Intestinal Dysbiosis and Markers of Systemic Inflammation in Viscerally and Generally Obese Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2020;83:81-89.
    >> Share

  594. NORTHROP AJ, Pomeroy LW
    Forecasting Prevalence of HIV-1 Integrase Strand Transfer Inhibitor (INSTI) Drug Resistance: A Modeling Study.
    J Acquir Immune Defic Syndr. 2020;83:65-71.
    >> Share

  595. WATSON CW, Paolillo EW, Morgan EE, Umlauf A, et al
    Cannabis Exposure is Associated With a Lower Likelihood of Neurocognitive Impairment in People Living With HIV.
    J Acquir Immune Defic Syndr. 2020;83:56-64.
    >> Share

  596. SMITH JP, Gandhi NR, Shah NS, Mlisana K, et al
    The Impact of Concurrent Antiretroviral Therapy and MDR-TB Treatment on Adverse Events.
    J Acquir Immune Defic Syndr. 2020;83:47-55.
    >> Share

  597. FRYE V, Nandi V, Hirshfield S, Chiasson MA, et al
    Brief Report: Randomized Controlled Trial of an Intervention to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options in New York City (All About Me).
    J Acquir Immune Defic Syndr. 2020;83:31-36.
    >> Share

  598. BROWN LB, Balzer LB, Kabami J, Kwarisiima D, et al
    The Influence of Social Networks on Antiretroviral Therapy Initiation Among HIV-Infected Antiretroviral Therapy-Naive Youth in Rural Kenya and Uganda.
    J Acquir Immune Defic Syndr. 2020;83:9-15.
    >> Share

  599. STARUP-LINDE J, Rosendahl SB, Storgaard M, Langdahl B, et al
    Management of Osteoporosis in Patients Living With HIV-A Systematic Review and Meta-analysis.
    J Acquir Immune Defic Syndr. 2020;83:1-8.
    >> Share

  600. CRAWFORD M, van Wyk J, Aboud M, Vannappagari V, et al
    Postmarketing Surveillance of Pregnancy Outcomes With Dolutegravir Use.
    J Acquir Immune Defic Syndr. 2020;83:e2-e5.
    >> Share

  601. FELDACKER C, Murenje V, Holeman I, Xaba S, et al
    Reducing Provider Workload While Preserving Patient Safety: A Randomized Control Trial Using 2-Way Texting for Postoperative Follow-up in Zimbabwe's Voluntary Medical Male Circumcision Program.
    J Acquir Immune Defic Syndr. 2020;83:16-23.
    >> Share

    December 2019
  602. HUANG Y, Zhang Y, Bailer R, Grunenberg N, et al
    Prediction of Serum HIV-1 Neutralization Titers After Passive Administration of VRC01.
    J Acquir Immune Defic Syndr. 2019 Dec 17. doi: 10.1097/QAI.0000000000002272.
    >> Share

  603. DA RESSUREICAO SGNOTTO F, Souza Santos L, Rodrigues de Sousa T, Feitosa de Lima J, et al
    IgG From HIV-1-Exposed Seronegative and HIV-1-Infected Subjects Differently Modulates IFN-gamma Production by Thymic T and B Cells.
    J Acquir Immune Defic Syndr. 2019;82:e56-e60.
    >> Share

  604. REZAHOSSEINI O, Knudsen AD, Gelpi M, Ronit A, et al
    Plasma Cotinine Cutoff for Distinguishing Smokers From Nonsmokers Among Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82:e54-e56.
    >> Share

  605. O'MEARA T, Kong Y, Chiarella J, Price RW, et al
    Exosomal MicroRNAs Associate With Neuropsychological Performance in Individuals With HIV Infection on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2019;82:514-522.
    >> Share

  606. ZAIDAN SM, Leyre L, Bunet R, Larouche-Anctil E, et al
    Upregulation of IL-32 Isoforms in Virologically Suppressed HIV-Infected Individuals: Potential Role in Persistent Inflammation and Transcription From Stable HIV-1 Reservoirs.
    J Acquir Immune Defic Syndr. 2019;82:503-513.
    >> Share

  607. LUCKETT P, Paul RH, Navid J, Cooley SA, et al
    Deep Learning Analysis of Cerebral Blood Flow to Identify Cognitive Impairment and Frailty in Persons Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82:496-502.
    >> Share

  608. SRINIVASA S, Torriani M, Fitch KV, Maehler P, et al
    Brief Report: Adipogenic Expression of Brown Fat Genes in HIV and HIV-Related Parameters.
    J Acquir Immune Defic Syndr. 2019;82:491-495.
    >> Share

  609. DOMINGUEZ-RODRIGUEZ S, Tagarro A, Palma P, Foster C, et al
    Reduced Time to Suppression Among Neonates With HIV Initiating Antiretroviral Therapy Within 7 Days After Birth.
    J Acquir Immune Defic Syndr. 2019;82:483-490.
    >> Share

  610. SALONER R, Grelotti DJ, Tyree G, Sundermann EE, et al
    Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82:475-482.
    >> Share

  611. YEN YF, Lai YJ, Chen YY, Lai HH, et al
    Association of HIV Infection and Antiretroviral Therapy With Sudden Cardiac Death.
    J Acquir Immune Defic Syndr. 2019;82:468-474.
    >> Share

  612. MARSICO F, Lo Vecchio A, Paolillo S, D'Andrea C, et al
    Left Ventricular Function, Epicardial Adipose Tissue, and Carotid Intima-Media Thickness in Children and Adolescents With Vertical HIV Infection.
    J Acquir Immune Defic Syndr. 2019;82:462-467.
    >> Share

  613. VAN WELZEN BJ, Yesilay S, Arends JE, Hoepelman AIM, et al
    Brief Report: Low Sensitivity of the Fracture Risk Assessment Tool in Young HIV-Infected Patients: Time to Revise Our Screening Strategy.
    J Acquir Immune Defic Syndr. 2019;82:439-442.
    >> Share

  614. BARTLETT AW, Lumbiganon P, Jamal Mohamed TA, Lapphra K, et al
    Dual Analysis of Loss to Follow-up for Perinatally HIV-Infected Adolescents Receiving Combination Antiretroviral Therapy in Asia.
    J Acquir Immune Defic Syndr. 2019;82:431-438.
    >> Share

  615. VAN EPPS P, Wilson BM, Garner W, Beste LA, et al
    Brief Report: Incidence of HIV in a Nationwide Cohort Receiving Pre-exposure Prophylaxis for HIV Prevention.
    J Acquir Immune Defic Syndr. 2019;82:427-430.
    >> Share

  616. CAHN P, Madero JS, Arribas JR, Antinori A, et al
    Durable Efficacy of Dolutegravir Plus Lamivudine in Antiretroviral Treatment-Naive Adults With HIV-1 Infection: 96-Week Results From the GEMINI-1 and GEMINI-2 Randomized Clinical Trials.
    J Acquir Immune Defic Syndr. 2019 Dec 10. doi: 10.1097/QAI.0000000000002275.
    >> Share

  617. RENDINA HJ, Cienfuegos-Szalay J, Talan A, Jones SS, et al
    Growing acceptability of Undetectable = Untransmittable but widespread misunderstanding of transmission risk: Findings from a very large sample of sexual minority men in the United States.
    J Acquir Immune Defic Syndr. 2019 Dec 5. doi: 10.1097/QAI.0000000000002239.
    >> Share

  618. PEEBLES K, van der Straten A, Palanee-Phillips T, Reddy K, et al
    Anal intercourse, HIV-1 risk, and efficacy in a trial of a dapivirine-containing vaginal ring for HIV-1 prevention.
    J Acquir Immune Defic Syndr. 2019 Dec 3. doi: 10.1097/QAI.0000000000002253.
    >> Share

  619. RUBTSOVA AA, Wingood GM, Ofotokun I, Gustafson D, et al
    Prevalence and Correlates of Self-Rated Successful Aging Among Older Women Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S162-S169.
    >> Share

  620. CAPASSO A, DiClemente RJ, Wingood GM
    Pregnancy Coercion as a Risk Factor for HIV and Other Sexually Transmitted Infections Among Young African American Women.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S155-S161.
    >> Share

  621. RUIZ MS, O'Rourke A, Allen ST, Holtgrave DR, et al
    Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and Philadelphia.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S148-S154.
    >> Share

  622. DENIS CM, Morales KH, Wu Q, Metzger DS, et al
    Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S142-S147.
    >> Share

  623. BAUERMEISTER JA, Golinkoff JM, Lin WY, Claude KF, et al
    Testing the Testers: Are Young Men Who Have Sex With Men Receiving Adequate HIV Testing and Counseling Services?
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S133-S141.
    >> Share

  624. BROWN LA, Dangerfield DT 2nd, Meanley S, Hickson D, et al
    Increasing Diversity and Capacity in HIV Behavioral and Social Science Research: Reflections and Recommendations From the Inaugural Cohort of the Mid-Atlantic CFAR Consortium (MACC) Scholars Program.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S128-S132.
    >> Share

  625. LIMAYE RJ, Magnus M, Metzger D, Blank MB, et al
    The Mid-Atlantic Center for AIDS Research Consortium Scholars Program: A Multi-Institutional Approach to Mentoring the Next Generation of Underrepresented Scientists.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S124-S127.
    >> Share

  626. VINCENT W, Sevelius J, Lippman SA, Linnemayr S, et al
    Identifying Opportunities for Collaboration Across the Social Sciences to Reach the 10-10-10: A Multilevel Approach.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S118-S123.
    >> Share

  627. MAYER KH, Allan-Blitz LT
    PrEP 1.0 and Beyond: Optimizing a Biobehavioral Intervention.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S113-S117.
    >> Share

  628. BRAULT MA, Spiegelman D, Hargreaves J, Nash D, et al
    Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S104-S112.
    >> Share

  629. AUERBACH JD
    Getting to Zero Begins With Getting to Ten.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S99-S103.
    >> Share

  630. KELLY JA
    Ten Things We Need to Do to Achieve the Goals of the End the HIV Epidemic Plan for America.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S94-S98.
    >> Share

  631. COATES TJ
    The Fight Against HIV Is a Fight for Human Rights: A Personal Reflection.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S91-S93.
    >> Share

  632. NEWCOMER SF
    Response to the HIV Epidemic: Perspectives From a Retired NIH Project Officer.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S88-S90.
    >> Share

  633. GOODENOW MM, Gaist P
    Importance of HIV/AIDS-Related Behavioral and Social Sciences Research at the NIH and Beyond.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S84-S87.
    >> Share

  634. BLANK MB, Metzger DS, Wingood GM, DiClemente RJ, et al
    The Social and Behavioral Sciences Research Network: Shaping a Contemporary Agenda for Research in HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 2:S81-S83.
    >> Share

  635. SEMITALA FC, Cattamanchi A, Andama A, Atuhumuza E, et al
    Brief Report: Yield and Efficiency of Intensified Tuberculosis Case-Finding Algorithms in 2 High-Risk HIV Subgroups in Uganda.
    J Acquir Immune Defic Syndr. 2019;82:416-420.
    >> Share

  636. MCCARTHY SDS, Leontyev D, Nicoletti P, Binnington B, et al
    Targeting ABL1 or ARG Tyrosine Kinases to Restrict HIV-1 Infection in Primary CD4+ T-Cells or in Humanized NSG Mice.
    J Acquir Immune Defic Syndr. 2019;82:407-415.
    >> Share

  637. OSETINSKY B, Genberg BL, Bloomfield GS, Hogan J, et al
    Hypertension Control and Retention in Care Among HIV-Infected Patients: The Effects of Co-located HIV and Chronic Noncommunicable Disease Care.
    J Acquir Immune Defic Syndr. 2019;82:399-406.
    >> Share

  638. CLARKE DF, Mirochnick M, Acosta EP, Capparelli E, et al
    Use of Modeling and Simulations to Determine Raltegravir Dosing in Neonates: A Model for Safely and Efficiently Determining Appropriate Neonatal Dosing Regimens: IMPAACT P1110.
    J Acquir Immune Defic Syndr. 2019;82:392-398.
    >> Share

  639. MUSINGUZI N, Castillo-Mancilla J, Morrow M, Byakwaga H, et al
    Antiretroviral Therapy Adherence Interruptions Are Associated With Systemic Inflammation Among Ugandans Who Achieved Viral Suppression.
    J Acquir Immune Defic Syndr. 2019;82:386-391.
    >> Share

  640. MUCCINI C, Galli L, Spagnuolo V, Poli A, et al
    Brief Report: Association Between Low HIV-1 DNA and Western Blot Reactivity to HIV-1 Pol in Chronically Infected Individuals.
    J Acquir Immune Defic Syndr. 2019;82:373-376.
    >> Share

  641. TRUONG HM, Akama E, Guze MA, Otieno F, et al
    Implementation of a Community-Based Hybrid HIV Testing Services Program as a Strategy to Saturate Testing Coverage in Western Kenya.
    J Acquir Immune Defic Syndr. 2019;82:362-367.
    >> Share

  642. KASAMBA I, Nash S, Shahmanesh M, Baisley K, et al
    Missed Study Visits and Subsequent HIV Incidence Among Women in a Predominantly Sex Worker Cohort Attending a Dedicated Clinic Service in Kampala, Uganda.
    J Acquir Immune Defic Syndr. 2019;82:343-354.
    >> Share

  643. CASTOR D, Kimmel AL, McFall A, Padian N, et al
    Employing the Payback Framework to Assess Implementation Science Research Utilization: Lessons From the USAID's PEPFAR HIV/AIDS Implementation Science Awards.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S348-S356.
    >> Share

  644. ROBERTS DA, Tan N, Limaye N, Irungu E, et al
    Cost of Differentiated HIV Antiretroviral Therapy Delivery Strategies in Sub-Saharan Africa: A Systematic Review.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S339-S347.
    >> Share

  645. PACKEL L, Fahey C, Njau P, McCoy SI, et al
    Implementation Science Using Proctor's Framework and an Adaptation of the Multiphase Optimization Strategy: Optimizing a Financial Incentive Intervention for HIV Treatment Adherence in Tanzania.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S332-S338.
    >> Share

  646. WAGNER AD, Gimbel S, Asbjornsdottir KH, Cherutich P, et al
    Cascade Analysis: An Adaptable Implementation Strategy Across HIV and Non-HIV Delivery Platforms.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S322-S331.
    >> Share

  647. SALOMON JA
    Integrating Economic Evaluation and Implementation Science to Advance the Global HIV Response.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S314-S321.
    >> Share

  648. STEWART J, Salas-Brooks J, Kelly B
    Implementation of HIV Interventions Into Faith-Based Organizations: Models and Methodological Considerations.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S305-S313.
    >> Share

  649. HARGREAVES J, Dalal S, Rice B, Anderegg N, et al
    Repositioning Implementation Science in the HIV Response: Looking Ahead From AIDS 2018.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S299-S304.
    >> Share

  650. DONENBERG GR, Cohen MH, Ingabire C, Fabri M, et al
    Applying the Exploration Preparation Implementation Sustainment (EPIS) Framework to the Kigali Imbereheza Project for Rwandan Adolescents Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S289-S298.
    >> Share

  651. CZARNOGORSKI M
    Using Implementation Science to Better Integrate Novel Long-Acting Injectable Therapy Into Routine HIV Care.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S286-S288.
    >> Share

  652. DOMBROWSKI JC, Irvine M, Nash D, Harriman G, et al
    Public Health Practice-Driven Research to Improve HIV Prevention in the United States.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S279-S285.
    >> Share

  653. WU D, Ong JJ, Tang W, Ritchwood TD, et al
    Crowdsourcing Methods to Enhance HIV and Sexual Health Services: A Scoping Review and Qualitative Synthesis.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S271-S278.
    >> Share

  654. HARGREAVES JR, Hassan S, Schellenberg J, Hayes R, et al
    Five Challenges in the Design and Conduct of IS Trials for HIV Prevention and Treatment.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S261-S270.
    >> Share

  655. GROV C, Westmoreland D, Rendina HJ, Nash D, et al
    Seeing Is Believing? Unique Capabilities of Internet-Only Studies as a Tool for Implementation Research on HIV Prevention for Men Who Have Sex With Men: A Review of Studies and Methodological Considerations.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S253-S260.
    >> Share

  656. HARLING G, Tsai AC
    Using Social Networks to Understand and Overcome Implementation Barriers in the Global HIV Response.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S244-S252.
    >> Share

  657. BERES LK, Simbeza S, Holmes CB, Mwamba C, et al
    Human-Centered Design Lessons for Implementation Science: Improving the Implementation of a Patient-Centered Care Intervention.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S230-S243.
    >> Share

  658. MINNIS AM, Montgomery ET, Napierala S, Browne EN, et al
    Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S222-S229.
    >> Share

  659. WARE NC
    Qualitative Contributions to Implementation Research on HIV Prevention and Treatment.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S217-S221.
    >> Share

  660. SCHWARTZ SR, Rao A, Rucinski KB, Lyons C, et al
    HIV-Related Implementation Research for Key Populations: Designing for Individuals, Evaluating Across Populations, and Integrating Context.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S206-S216.
    >> Share

  661. MEHROTRA ML, Petersen ML, Geng EH
    Understanding HIV Program Effects: A Structural Approach to Context Using the Transportability Framework.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S199-S205.
    >> Share

  662. SOHAIL M, Rastegar J, Long D, Rana A, et al
    Data for Care (D4C) Alabama: Clinic-Wide Risk Stratification With Enhanced Personal Contacts for Retention in HIV Care via the Alabama Quality Management Group.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S192-S198.
    >> Share

  663. BOR J, Thirumurthy H
    Bridging the Efficacy-Effectiveness Gap in HIV Programs: Lessons From Economics.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S183-S191.
    >> Share

  664. BUCHBINDER SP, Havlir DV
    Getting to Zero San Francisco: A Collective Impact Approach.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S176-S182.
    >> Share

  665. GENG E, Hargreaves J, Peterson M, Baral S, et al
    Implementation Research to Advance the Global HIV Response: Introduction to the JAIDS Supplement.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S173-S175.
    >> Share

  666. EISINGER RW, Dieffenbach CW, Fauci AS
    Role of Implementation Science: Linking Fundamental Discovery Science and Innovation Science to Ending the HIV Epidemic at the Community Level.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 3:S171-S172.
    >> Share

    November 2019
  667. FOURMAN LT, Pan CS, Zheng I, Gerard ME, et al
    Association of In Utero HIV Exposure with Obesity and Reactive Airway Disease in HIV-Negative Adolescents and Young Adults.
    J Acquir Immune Defic Syndr. 2019 Nov 14. doi: 10.1097/QAI.0000000000002235.
    >> Share

  668. PHILLIPS TK, Mogoba P, Brittain K, Gomba Y, et al
    Long-term outcomes of HIV-infected women receiving antiretroviral therapy after transferring out of an integrated maternal and child health service in South Africa.
    J Acquir Immune Defic Syndr. 2019 Nov 8. doi: 10.1097/QAI.0000000000002236.
    >> Share

  669. YAMAGUCHI J, McArthur C, Vallari A, Sthreshley L, et al
    Complete genome sequence of CG-0018a-01 establishes HIV-1 subtype L.
    J Acquir Immune Defic Syndr. 2019 Nov 6. doi: 10.1097/QAI.0000000000002246.
    >> Share

  670. RANGANATHAN M, Kilburn K, Stoner MCD, Hughes JP, et al
    The mediating role of partner selection in the association between transactional sex and HIV incidence among young women.
    J Acquir Immune Defic Syndr. 2019 Nov 6. doi: 10.1097/QAI.0000000000002225.
    >> Share

  671. KITYO C, Hagins D, Koenig E, Avihingsanon A, et al
    Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial.
    J Acquir Immune Defic Syndr. 2019;82:321-328.
    >> Share

  672. LODI S, Gunthard HF, Gill J, Phillips AN, et al
    Effectiveness of Transmitted Drug Resistance Testing Before Initiation of Antiretroviral Therapy in HIV-Positive Individuals.
    J Acquir Immune Defic Syndr. 2019;82:314-320.
    >> Share

  673. SALVATORE P, Johnson K, Vojnov L, Doherty M, et al
    Clinical Consequences of Using an Indeterminate Range for Early Infant Diagnosis of HIV: A Decision Model.
    J Acquir Immune Defic Syndr. 2019;82:287-296.
    >> Share

  674. LUO R, Boeras D, Broyles LN, Fong Y, et al
    Use of an Indeterminate Range in HIV Early Infant Diagnosis: A Systematic Review and Meta-Analysis.
    J Acquir Immune Defic Syndr. 2019;82:281-286.
    >> Share

  675. DIRAJLAL-FARGO S, Yu J, Kulkarni M, Sattar A, et al
    Brief Report: Zinc Supplementation and Inflammation in Treated HIV.
    J Acquir Immune Defic Syndr. 2019;82:275-280.
    >> Share

  676. GILBERT HN, Wyatt MA, Pisarski EE, Muwonge TR, et al
    PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    J Acquir Immune Defic Syndr. 2019;82:265-274.
    >> Share

    October 2019
  677. HOFFMAN RM, Warshaw MG, Amico KR, Pilotto J, et al
    Predictors of Viremia in Postpartum Women on Antiretroviral Therapy.
    J Acquir Immune Defic Syndr. 2019 Oct 22. doi: 10.1097/QAI.0000000000002228.
    >> Share

  678. HUERGA H, Mathabire Rucker SC, Bastard M, Dimba A, et al
    Should urine-LAM tests be used in TB symptomatic HIV-positive patients when no CD4 count is available? A prospective observational cohort study from Malawi.
    J Acquir Immune Defic Syndr. 2019 Oct 16. doi: 10.1097/QAI.0000000000002206.
    >> Share

  679. ORTBLAD KF, Musoke DK, Chanda MM, Ngabirano T, et al
    Knowledge of HIV status is associated with a decrease in the severity of depressive symptoms among female sex workers in Uganda and Zambia.
    J Acquir Immune Defic Syndr. 2019 Oct 16. doi: 10.1097/QAI.0000000000002224.
    >> Share

  680. RB-SILVA R, Goios A, Kelly C, Teixeira P, et al
    Definition of Immunological Non-Response to Antiretroviral Therapy: a Systematic Review.
    J Acquir Immune Defic Syndr. 2019 Oct 4. doi: 10.1097/QAI.0000000000002157.
    >> Share

  681. DEGUIT CDT, Hough M, Hoh R, Krone M, et al
    Some Aspects of CD8+ T Cell Exhaustion are Associated with Altered T Cell Mitochondrial Features and ROS content in HIV Infection.
    J Acquir Immune Defic Syndr. 2019 Oct 3. doi: 10.1097/QAI.0000000000002121.
    >> Share

  682. MERLIN JS, Samet JH, Cheng DM, Lira MC, et al
    Marijuana Use and Its Associations With Pain, Opioid Dose, and HIV Viral Suppression Among Persons Living With HIV on Chronic Opioid Therapy.
    J Acquir Immune Defic Syndr. 2019;82:195-201.
    >> Share

  683. MADDALI MV, Mehtani NJ, Converse C, Kapoor S, et al
    Development and Validation of HIV-ASSIST, an Online, Educational, Clinical Decision Support Tool to Guide Patient-Centered ARV Regimen Selection.
    J Acquir Immune Defic Syndr. 2019;82:188-194.
    >> Share

  684. KERRIGAN D, Mbwambo J, Likindikoki S, Davis W, et al
    Project Shikamana: Community Empowerment-Based Combination HIV Prevention Significantly Impacts HIV Incidence and Care Continuum Outcomes Among Female Sex Workers in Iringa, Tanzania.
    J Acquir Immune Defic Syndr. 2019;82:141-148.
    >> Share

  685. CHRISTOPOULOS KA, Neilands TB, Hartogensis W, Geng EH, et al
    Internalized HIV Stigma Is Associated With Concurrent Viremia and Poor Retention in a Cohort of US Patients in HIV Care.
    J Acquir Immune Defic Syndr. 2019;82:116-123.
    >> Share


  686. Chronic Distal Sensory Polyneuropathy Is a Major Contributor to Balance Disturbances in Persons Living With HIV: Erratum.
    J Acquir Immune Defic Syndr. 2019;82:e43.
    >> Share


  687. "Impact of HIV Self-Test Distribution to Male Partners of ANC Clients: Results of a Randomized Controlled Trial in Kenya: Erratum".
    J Acquir Immune Defic Syndr. 2019;82:e42.
    >> Share


  688. Detecting Disengagement From HIV Care Before It Is Too Late: Development and Preliminary Validation of a Novel Index of Engagement in HIV Care: Erratum.
    J Acquir Immune Defic Syndr. 2019;82:e42.
    >> Share

  689. TAN CS, Ghofrani J, Geiger E, Koralnik IJ, et al
    Brief Report: Decreased JC Virus-Specific Antibody-Dependent Cellular Cytotoxicity in HIV-Seropositive PML Survivors.
    J Acquir Immune Defic Syndr. 2019;82:220-224.
    >> Share

  690. DEGUIT CDT, Hough M, Hoh R, Krone M, et al
    Some Aspects of CD8+ T-Cell Exhaustion Are Associated With Altered T-Cell Mitochondrial Features and ROS Content in HIV Infection.
    J Acquir Immune Defic Syndr. 2019;82:211-219.
    >> Share

  691. WEINBERG A, Huo Y, Kacanek D, Patel K, et al
    Brief Report: Markers of Spontaneous Preterm Delivery in Women Living With HIV: Relationship With Protease Inhibitors and Vitamin D.
    J Acquir Immune Defic Syndr. 2019;82:181-187.
    >> Share

  692. STEPHENS F, Gandhi NR, Brust JCM, Mlisana K, et al
    Treatment Adherence Among Persons Receiving Concurrent Multidrug-Resistant Tuberculosis and HIV Treatment in KwaZulu-Natal, South Africa.
    J Acquir Immune Defic Syndr. 2019;82:124-130.
    >> Share

    September 2019
  693. RAGGIO GA, Psaros C, Fatch R, Goodman G, et al
    High Rates of Biomarker-Confirmed Alcohol Use among Pregnant Women Living with HIV in South Africa and Uganda.
    J Acquir Immune Defic Syndr. 2019 Sep 18. doi: 10.1097/QAI.0000000000002156.
    >> Share

  694. ONYANGO-MAKUMBI C, Owora AH, Mwiru RS, Mwatha A, et al
    EXTENDED PROPHYLAXIS WITH NEVIRAPINE DOES NOT AFFECT GROWTH IN HIV-EXPOSED INFANTS.
    J Acquir Immune Defic Syndr. 2019 Sep 13. doi: 10.1097/QAI.0000000000002145.
    >> Share

  695. DODGE B, Ford J, Bo N, Tu W, et al
    HIV Risk and Prevention Outcomes in a Probability-Based Sample of Gay and Bisexual Men in the United States.
    J Acquir Immune Defic Syndr. 2019 Sep 11. doi: 10.1097/QAI.0000000000002151.
    >> Share

  696. KERSCHBERGER B, Ntshalintshali N, Mpala Q, Diaz Uribe PA, et al
    Field Suitability and Diagnostic Accuracy of the Biocentric Open Real-Time PCR Platform for Dried Blood Spot-Based HIV Viral Load Quantification in Eswatini.
    J Acquir Immune Defic Syndr. 2019;82:96-104.
    >> Share

  697. HEVEY MA, Presti RM, O'Halloran JA, Larson L, et al
    Mortality After Cryptococcal Infection in the Modern Antiretroviral Therapy Era.
    J Acquir Immune Defic Syndr. 2019;82:81-87.
    >> Share

  698. BRENNAN AT, Bonawitz R, Gill CJ, Thea DM, et al
    A Meta-analysis Assessing Diarrhea and Pneumonia in HIV-Exposed Uninfected Compared With HIV-Unexposed Uninfected Infants and Children.
    J Acquir Immune Defic Syndr. 2019;82:1-8.
    >> Share

  699. BRAHME R, Godbole S, Sonawale S, Kadu C, et al
    Declining Trends in HIV Prevalence Among Women Attending Antenatal Care Clinics Obfuscate the Continued Vulnerability of Adolescent Girls in Maharashtra, India (2005-2017).
    J Acquir Immune Defic Syndr. 2019;82:e13-e17.
    >> Share

  700. LACOURSE SM, Wagner AD, Cranmer LM, Copeland A, et al
    Brief Report: High Programmatic Isoniazid Preventive Therapy (IPT) Use in Pregnancy Among HIV-Infected Women.
    J Acquir Immune Defic Syndr. 2019;82:41-45.
    >> Share

  701. MOKOTOFF ED, Green Ruth K, Benbow N, Sweeney P, et al
    Data to Care: Lessons Learned From Delivering Technical Assistance to 20 Health Departments.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S74-S79.
    >> Share

  702. MACOMBER KE, Viall A, Ramakrishnan V, Wilson J, et al
    Operationalizing a Data to Care Strategy in Michigan Through Cross-Agency Collaborations.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S69-S73.
    >> Share

  703. DAVIES C, Klein PW, Okoye ID, Heitgerd J, et al
    Short-Term Outcomes and Lessons Learned From the Federal HIV Health Improvement Affinity Group for State Medicaid/Children's Health Insurance Program Agencies and State Health Departments.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S62-S68.
    >> Share

  704. NEBLETT FANFAIR R, Shrestha RK, Randall L, Lucas C, et al
    Implementing Data to Care-What Are the Costs for the Health Department?
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S57-S61.
    >> Share

  705. BYRD KK, Camp NM, Iqbal K, Weidle PJ, et al
    Pharmacy Data as an Alternative Data Source for Implementation of a Data to Care Strategy.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S53-S56.
    >> Share

  706. LEWIS S, Morrison M, Randall LM, Roosevelt K, et al
    The Partnerships for Care Project in Massachusetts: Developing Partnerships and Data Systems to Increase Linkage and Engagement in Care for Individuals Living With HIV.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S47-S52.
    >> Share

  707. HART-MALLOY R, Rajulu DT, Johnson MC, Shrestha T, et al
    Cross-Jurisdictional Data to Care: Lessons Learned in New York State and Florida.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S42-S46.
    >> Share

  708. KUNZWEILER C, Kishore N, John B, Roosevelt K, et al
    Using HIV Surveillance and Clinic Data to Optimize Data to Care Efforts in Community Health Centers in Massachusetts: The Massachusetts Partnerships for Care Project.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S33-S41.
    >> Share

  709. AREY AL, Cassidy-Stewart H, Kurowski PL, Hitt JC, et al
    Evaluating HIV Surveillance Completeness Along the Continuum of Care: Supplementing Surveillance With Health Center Data to Increase HIV Data to Care Efficiency.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S26-S32.
    >> Share

  710. HART-MALLOY R, Shrestha T, Pezzulo MC, Patterson W, et al
    Data to Care Opportunities: An Evaluation of Persons Living With HIV Reported to Be "Current to Care" Without Current HIV-Related Labs.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S20-S25.
    >> Share

  711. OCAMPO JMF, Hamp A, Rhodes A, Smart JC, et al
    Improving HIV Surveillance Data by Using the ATra Black Box System to Assist Regional Deduplication Activities.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S13-S19.
    >> Share

  712. BEER L, Bosh KA, Chowdhury PP, Craw J, et al
    Informing Data to Care: Contacting Persons Sampled for the Medical Monitoring Project.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S6-S12.
    >> Share

  713. SWEENEY P, DiNenno EA, Flores SA, Dooley S, et al
    HIV Data to Care-Using Public Health Data to Improve HIV Care and Prevention.
    J Acquir Immune Defic Syndr. 2019;82 Suppl 1:S1-S5.
    >> Share

    August 2019
  714. HOLTZ TH, Chitwarakorn A, Hughes JP, Curlin ME, et al
    HPTN 067/ADAPT: Correlates of sex-related pre-exposure prophylaxis adherence, Thai men who have sex with men, and transgender women, 2012-2013.
    J Acquir Immune Defic Syndr. 2019 Aug 30. doi: 10.1097/QAI.0000000000002131.
    >> Share

  715. CHIKWARI CD, Njuguna IN, Neary J, Rainer C, et al
    Diagnostic accuracy of oral mucosal transudate tests compared to blood-based rapid tests for HIV among children ages 18 months to 18 years in Kenya and Zimbabwe.
    J Acquir Immune Defic Syndr. 2019 Aug 16. doi: 10.1097/QAI.0000000000002146.
    >> Share

  716. WONG A, Goldstein D, Mallolas J, DeJesus E, et al
    Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) in Treatment-Naive HIV-1 Infected Adults with Transmitted Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance Mutations.
    J Acquir Immune Defic Syndr. 2019 Aug 16. doi: 10.1097/QAI.0000000000002153.
    >> Share

  717. LIU AY, Norwood A, Gundacker H, Carballo-Dieguez A, et al
    Brief Report: Routine Use of Oral PrEP in a Phase 2 Rectal Microbicide Study of Tenofovir Reduced-Glycerin 1% Gel (MTN-017).
    J Acquir Immune Defic Syndr. 2019;81:516-520.
    >> Share

  718. BECKER ML, Bhattacharjee P, Blanchard JF, Cheuk E, et al
    Reply.
    J Acquir Immune Defic Syndr. 2019;81:e163-e165.
    >> Share

  719. SEBIKARI D, Farhad M, Fenton T, Owor M, et al
    Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.
    J Acquir Immune Defic Syndr. 2019;81:521-532.
    >> Share

  720. SHAVA E, Moyo S, Zash R, Diseko M, et al
    Brief Report: High Rates of Adverse Birth Outcomes in HIV and Syphilis Coinfected Women in Botswana.
    J Acquir Immune Defic Syndr. 2019;81:e135-e140.
    >> Share

  721. MAHEU-GIROUX M, Diabate S, Boily MC, Jean-Paul N, et al
    Cost-Effectiveness of Accelerated HIV Response Scenarios in Cote d'Ivoire.
    J Acquir Immune Defic Syndr. 2019 Aug 1. doi: 10.1097/QAI.0000000000001956.
    >> Share

  722. ERLANDSON KM, Zhang L, Ng DK, Althoff KN, et al
    Risk Factors for Falls, Falls With Injury, and Falls With Fracture Among Older Men With or at Risk of HIV Infection.
    J Acquir Immune Defic Syndr. 2019;81:e117-e126.
    >> Share

  723. HAAS AD, Johnson LF, Grimsrud A, Ford N, et al
    Extending Visit Intervals for Clinically Stable Patients on Antiretroviral Therapy: Multicohort Analysis of HIV Programs in Southern Africa.
    J Acquir Immune Defic Syndr. 2019;81:439-447.
    >> Share

  724. WHITE DL, Oluyomi A, Royse K, Dong Y, et al
    Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014.
    J Acquir Immune Defic Syndr. 2019;81:387-394.
    >> Share

  725. HOARE J, Phillips N, Brittain K, Myer L, et al
    Mental Health and Functional Competence in the Cape Town Adolescent Antiretroviral Cohort.
    J Acquir Immune Defic Syndr. 2019;81:e109-e116.
    >> Share

  726. BWAKURA DANGAREMBIZI M, Samson P, Capparelli EV, Moore CB, et al
    Establishing Dosing Recommendations for Efavirenz in HIV/TB-Coinfected Children Younger Than 3 Years.
    J Acquir Immune Defic Syndr. 2019;81:473-480.
    >> Share

  727. SERETI I, Gulick RM, Krishnan S, Migueles SA, et al
    ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial.
    J Acquir Immune Defic Syndr. 2019;81:456-462.
    >> Share

    July 2019
  728. ASCHER SB, Scherzer R, Nishtala A, Jotwani V, et al
    Association of Statin Use with Kidney Damage and Function Among HIV-infected Men.
    J Acquir Immune Defic Syndr. 2019 Jul 24. doi: 10.1097/QAI.0000000000002122.
    >> Share

  729. LEVY ME, Monroe AK, Horberg MA, Benator DA, et al
    Pharmacologic Treatment of Psychiatric Disorders and Time with Unsuppressed HIV Viral Load in a Clinical HIV Cohort.
    J Acquir Immune Defic Syndr. 2019 Jul 24. doi: 10.1097/QAI.0000000000002138.
    >> Share

  730. GIGUERE K, Behanzin L, Guedou FA, Talbot D, et al
    PrEP Use Among Female Sex Workers: No Evidence for Risk Compensation.
    J Acquir Immune Defic Syndr. 2019 Jul 23. doi: 10.1097/QAI.0000000000002134.
    >> Share

  731. BYRD KK, Hou JG, Hazen R, Kirkham H, et al
    Antiretroviral Adherence Level Necessary for HIV Viral Suppression using Real-World Data.
    J Acquir Immune Defic Syndr. 2019 Jul 18. doi: 10.1097/QAI.0000000000002142.
    >> Share

  732. MILLS JC, Pence BW, Edmonds A, Adedimeji A, et al
    The Impact of Cumulative Depression along the HIV Care Continuum in Women Living with HIV during the Era of Universal Antiretroviral Treatment.
    J Acquir Immune Defic Syndr. 2019 Jul 16. doi: 10.1097/QAI.0000000000002140.
    >> Share

  733. SHORT WR, Sutton MY, Luo Q, Frazier EL, et al
    Use of recommended preventive health care services and variations in HIV care among women with HIV in the United States, 2013-2014: Opportunities for expanded partnerships in support of ending the HIV epidemic.
    J Acquir Immune Defic Syndr. 2019 Jul 16. doi: 10.1097/QAI.0000000000002141.
    >> Share

  734. MODONGO C, Wang Q, Dima M, Matsiri O, et al
    Clinical and virological outcomes of TB/HIV co-infected patients treated with dolutegravir-based HIV antiretroviral regimens: Programmatic experience from Botswana.
    J Acquir Immune Defic Syndr. 2019 Jul 10. doi: 10.1097/QAI.0000000000002126.
    >> Share

  735. WOMACK JA, Murphy TE, Rentsch CT, Tate JP, et al
    Polypharmacy, hazardous alcohol and illicit substance use and serious falls among PLWH and uninfected comparators.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002130.
    >> Share

  736. HAALAND RE, Martin A, Livermont T, Fountain J, et al
    Urine emtricitabine and tenofovir concentrations provide markers of recent antiretroviral drug exposure among HIV-negative men who have sex with men.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002133.
    >> Share

  737. KERR SJ, Puthanakit T, Malee KM, Thongpibul K, et al
    Increased risk of executive function and emotional-behavioural problems among virologically well-controlled perinatally HIV-infected adolescents in Thailand and Cambodia.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002132.
    >> Share

  738. VELLOZA J, Bacchetti P, Hendrix CW, Murnane P, et al
    Short and long-term pharmacologic measures of HIV pre-exposure prophylaxis use among high-risk men who have sex with men in HPTN 067/ADAPT.
    J Acquir Immune Defic Syndr. 2019 Jul 4. doi: 10.1097/QAI.0000000000002128.
    >> Share

  739. ARCHAMPONG T, Ojewale O, Bears K, Chen Y, et al
    Relationship between ABCC4 SNPs and hepatitis B virus suppression during tenofovir-containing antiretroviral therapy in patients with HIV/HBV coinfection.
    J Acquir Immune Defic Syndr. 2019 Jul 3. doi: 10.1097/QAI.0000000000002136.
    >> Share

  740. SHABA F, Offorjebe OA, Phiri K, Lungu E, et al
    Perceived Acceptability of a Facility-Based HIV Self-Test Intervention in Outpatient Waiting Spaces Among Adult Outpatients in Malawi: A Formative Study.
    J Acquir Immune Defic Syndr. 2019;81:e92-e94.
    >> Share

  741. EL-SADR WM, Beauchamp G, Hall HI, Torian LV, et al
    Brief Report: Durability of the Effect of Financial Incentives on HIV Viral Load Suppression and Continuity in Care: HPTN 065 Study.
    J Acquir Immune Defic Syndr. 2019;81:300-303.
    >> Share

  742. LAM JO, Hurley LB, Udaltsova N, Alexeeff SE, et al
    Colorectal Cancer Screening in People With and Without HIV in an Integrated Health Care Setting.
    J Acquir Immune Defic Syndr. 2019;81:284-291.
    >> Share

  743. CHAPIN-BARDALES J, Rosenberg ES, Sullivan PS, Jenness SM, et al
    Trends in Number and Composition of Sex Partners Among Men Who Have Sex With Men in the United States, National HIV Behavioral Surveillance, 2008-2014.
    J Acquir Immune Defic Syndr. 2019;81:257-265.
    >> Share

  744. ROTHENBERGER M, Nganou-Makamdop K, Kityo C, Ssali F, et al
    Impact of Integrase Inhibition Compared With Nonnucleoside Inhibition on HIV Reservoirs in Lymphoid Tissues.
    J Acquir Immune Defic Syndr. 2019;81:355-360.
    >> Share

    June 2019
  745. GOLUB SA, Fikslin RA, Starbuck L, Klein A, et al
    High Rates of PrEP Eligibility but Low Rates of PrEP Access Among a National Sample of Transmasculine Individuals.
    J Acquir Immune Defic Syndr. 2019 Jun 20. doi: 10.1097/QAI.0000000000002116.
    >> Share

  746. BEDIMO RJ, Mar H, Bosch RJ, Drechsler H, et al
    No Evidence for an Association between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART.
    J Acquir Immune Defic Syndr. 2019 Jun 20. doi: 10.1097/QAI.0000000000002124.
    >> Share

  747. HAGHIGHAT R, Toska E, Cluver L, Gulaid L, et al
    Transition Pathways out of Pediatric Care and Associated HIV Outcomes for Adolescents Living with HIV in South Africa.
    J Acquir Immune Defic Syndr. 2019 Jun 20. doi: 10.1097/QAI.0000000000002125.
    >> Share

  748. GRAY KM, Banez Ocfemia MC, Wang X, Li J, et al
    Characteristics and care outcomes among persons living with perinatally acquired HIV infection in the United States, 2015.
    J Acquir Immune Defic Syndr. 2019 Jun 4. doi: 10.1097/QAI.0000000000002091.
    >> Share

  749. EL KAMARI V, Thomas A, Shan L, Sattar A, et al
    Advanced Glycation End Products Are Associated With Inflammation and Endothelial Dysfunction in HIV.
    J Acquir Immune Defic Syndr. 2019;81:e55-e62.
    >> Share

  750. LEMOS MP, Lazarus E, Isaacs A, Dietrich J, et al
    Daily Vaginal Swabs and Mobile Phone Sex Report for Assessing HIV Virion Exposure Prospectively Among a Cohort of Young Sexually Active Women in South Africa (HVTN 915).
    J Acquir Immune Defic Syndr. 2019;81:e39-e48.
    >> Share

  751. KOURTIS AP, Wiener J, Hurst S, Nelson JAE, et al
    Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
    J Acquir Immune Defic Syndr. 2019;81:163-165.
    >> Share

  752. SPINELLI MA, Glidden DV, Anderson PL, Gandhi M, et al
    Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing.
    J Acquir Immune Defic Syndr. 2019;81:158-162.
    >> Share

  753. NJUGUNA IN, Cranmer LM, Wagner AD, LaCourse SM, et al
    Brief Report: Cofactors of Mortality Among Hospitalized HIV-Infected Children Initiating Antiretroviral Therapy in Kenya.
    J Acquir Immune Defic Syndr. 2019;81:138-144.
    >> Share

    May 2019
  754. NGUYEN N, Powers KA, Miller WC, Howard AG, et al
    Sexual Partner Types and Incident HIV Infection among Rural South African Adolescent Girls and Young Women Enrolled in HPTN 068: A Latent Class Analysis.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002096.
    >> Share

  755. VOJNOV L, Penazzato M, Sherman G, Ghadrshenas A, et al
    Implementing an indeterminate range for more accurate early infant diagnosis.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002081.
    >> Share

  756. HARGREAVES S, Rustage K, Nellums LB, Bardfield JE, et al
    Do quality improvement initiatives improve outcomes for patients in antiretroviral programmes in low- and middle-income countries? a systematic review.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002085.
    >> Share

  757. FAVARATO G, Townsend CL, Peters H, Sconza R, et al
    Stillbirth in women living with HIV delivering in the UK and Ireland: 2007-2015.
    J Acquir Immune Defic Syndr. 2019 May 29. doi: 10.1097/QAI.0000000000002087.
    >> Share

  758. WEINBERG A, Huo Y, Kacanek D, Patel K, et al
    Markers of Spontaneuous Preterm Delivery in Women living with HIV: Relationship with Protease Inhibitors and Vitamin D.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002111.
    >> Share

  759. BONACCI RA, Bradley H, Rosenberg ES, Holtgrave DR, et al
    Evaluating HIV Transmission Rates for the US National HIV/AIDS Strategy, 2010-2015.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002113.
    >> Share

  760. POTEAT T, Wirtz A, Malik M, Cooney E, et al
    A Gap Between Willingness and Uptake: Findings from Mixed Methods Research on HIV Prevention among Black and Latina Transgender Women.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002112.
    >> Share

  761. CHAN P, Dumrongpisutikul N, Subra C, Colby DJ, et al
    Neurosyphilis during Acute HIV Infection: A CNS Immunologic and Virologic Characterization.
    J Acquir Immune Defic Syndr. 2019 May 28. doi: 10.1097/QAI.0000000000002114.
    >> Share

  762. NOEL N, Gominet M, Meyer L, Boufassa F, et al
    Cardiovascular events in the French ANRS HIV controller cohort.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002108.
    >> Share

  763. JOHNSON KA, Hessol NA, Kohn R, Nguyen TQ, et al
    HIV Seroconversion in the Era of Pharmacologic Prevention: A Case-Control Study at a San Francisco STD Clinic.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002107.
    >> Share

  764. MORSICA G, Galli L, Bossolasco S, Bagaglio S, et al
    OUTCOME OF ACUTE HEPATITIS B VIRUS INFECTION IN HIV-1 INFECTED PATIENTS: POSSIBLE FACTORS ASSOCIATED WITH RESOLUTION OR CHRONICITY.
    J Acquir Immune Defic Syndr. 2019 May 27. doi: 10.1097/QAI.0000000000002106.
    >> Share

  765. BECKER ML, Bhattacharjee P, Blanchard JF, Cheuk E, et al
    Response to Hodson and Bewley Letter to the Editor.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002102.
    >> Share

  766. MATHUR S, Roberts-Toler C, Tassiopoulos K, Goodkin K, et al
    Detrimental Effects of Psychotropic Medications Differ by Sex in Aging People with HIV.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002100.
    >> Share

  767. VICTORIA D O, Rivet AK, James P H, Ethan W, et al
    Low Disclosure of PrEP nonadherence and HIV risk behaviors associated with poor HIV PrEP adherence in the HPTN 067/ADAPT Study.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002103.
    >> Share

  768. NGUYEN T, Delaugerre C, Valantin MA, Amiel C, et al
    Shared HCV Transmission Networks among HIV-1 Positive and Negative Men Having Sex with Men by Ultra-Deep Sequencing.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002099.
    >> Share

  769. JAUMDALLY SZ, Liebenberg LJP, Gumbi PP, Little F, et al
    Partner HIV serostatus impacts viral load, genital HIV shedding and immune activation in HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2019 May 21. doi: 10.1097/QAI.0000000000002089.
    >> Share

  770. CRANE HM, Nance RM, Heckbert SR, Ritchings C, et al
    Association between bilirubin, atazanavir, and cardiovascular disease events among people living with HIV across the US.
    J Acquir Immune Defic Syndr. 2019 May 16. doi: 10.1097/QAI.0000000000002071.
    >> Share

  771. ESCOTA G, Baker J, Bush T, Conley L, et al
    Aging attenuates the association between coronary artery calcification and bone loss among HIV-infected persons.
    J Acquir Immune Defic Syndr. 2019 May 6. doi: 10.1097/QAI.0000000000002092.
    >> Share


  772. Transmission Networks of HCV Genotype 1a Enriched With Pre-existing Polymorphism Q80K Among HIV-Infected Patients With Acute Hepatitis C in Poland: Erratum.
    J Acquir Immune Defic Syndr. 2019;81:e27.
    >> Share

  773. CAI J, Sebastiani G
    HIV, Elevated Transaminases, Fatty Liver: The Perfect Storm?
    J Acquir Immune Defic Syndr. 2019;81:e23-e25.
    >> Share

  774. MORAKA NO, Moyo S, Mayondi G, Leidner J, et al
    Cytomegalovirus Viremia in HIV-1 Subtype C Positive Women at Delivery in Botswana and Adverse Birth/Infant Health Outcomes.
    J Acquir Immune Defic Syndr. 2019;81:118-124.
    >> Share

  775. MCCREE DH, Williams AM, Chesson HW, Beer L, et al
    Changes in Disparities in Estimated HIV Incidence Rates Among Black, Hispanic/Latino, and White Men Who Have Sex With Men (MSM) in the United States, 2010-2015.
    J Acquir Immune Defic Syndr. 2019;81:57-62.
    >> Share

  776. FEARON E, Phillips A, Mtetwa S, Chabata ST, et al
    How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis.
    J Acquir Immune Defic Syndr. 2019;81:24-35.
    >> Share

  777. NYAGAH LM, Young PW, Kim AA, Wamicwe J, et al
    HIV-Related Deaths in Nairobi, Kenya: Results From a HIV Mortuary Surveillance Study, 2015.
    J Acquir Immune Defic Syndr. 2019;81:18-23.
    >> Share

    April 2019
  778. SALONER R, Marquine MJ, Sundermann EE, Hong S, et al
    COMT Val158Met Polymorphism, Cardiometabolic Risk, and Nadir CD4 Synergistically Increase Risk for Neurocognitive Impairment in Men Living with HIV.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002083.
    >> Share

  779. REIF LK, Rivera V, Bertrand R, Belizaire M, et al
    "FANMI": A Promising Differentiated Model of HIV Care for Adolescents in Haiti.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002088.
    >> Share

  780. LO RE V 3RD, Newcomb CW, Carbonari DM, Roy JA, et al
    Determinants of Liver Complications Among HIV/Hepatitis B Virus-Coinfected Patients.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002094.
    >> Share

  781. SHAVA E, Moyo S, Zash R, Diseko M, et al
    High rates of adverse birth outcomes in HIV and syphilis co-infected women in Botswana.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002082.
    >> Share

  782. DASTGHEYB RM, Sacktor N, Franklin D, Letendre S, et al
    Cognitive trajectory phenotypes in human immunodeficiency virus infected patients.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002093.
    >> Share

  783. NGUYEN H, Thorball CW, Fellay J, Boni J, et al
    HIV transmission chains exhibit greater HLA-B homogeneity than randomly expected.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002077.
    >> Share

  784. JANUEL E, Godin O, Moulignier A, Lescure FX, et al
    Impact of ART classes on the increasing risk of cerebral small-vessel disease in middle-aged, well-controlled, cART-treated, HIV-infected individuals.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002084.
    >> Share

  785. NANCE RM, Vannappagari V, Smith K, Calingaert B, et al
    Virologic failure among people living with HIV initiating dolutegravir-based versus other recommended regimens in real-world clinical care settings.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002075.
    >> Share

  786. BILLINGS E, Kijak GH, Sanders-Buell E, Ndembi N, et al
    New Subtype B Containing HIV-1 Circulating Recombinant of sub-Saharan Africa Origin in Nigerian Men who have Sex with Men.
    J Acquir Immune Defic Syndr. 2019 Apr 29. doi: 10.1097/QAI.0000000000002076.
    >> Share

  787. SEBIKARI D, Farhad M, Fenton T, Owor M, et al
    Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial.
    J Acquir Immune Defic Syndr. 2019 Apr 23. doi: 10.1097/QAI.0000000000002072.
    >> Share

  788. ASUNDI A, Robles Y, Starr T, Landay A,